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Background: Assessment of intracranial pressure (ICP) is an essential aspect in the 
management of most neurosurgical conditions in children. While invasive ICP monitoring 
is considered the criterion standard, the need for a reliable, non-invasive, easy-to-use and 
accurate method to detect and monitor raised ICP has inspired the development of many 
useful techniques. The present study examined the relationship between transorbital 
ultrasound measurement of the optic nerve sheath diameter (ONSD) and invasively 
measured ICP in children, as well as the influence of relevant physiological and 
demographic variables on this relationship.    
Methodology: ONSD measurement was performed using a high frequency, small 
footprint linear array probe, prior to invasive ICP measurement. All patients were under 
general anaesthesia and being mechanically ventilated. Physiological variables including 
systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure 
(MAP), pulse rate, temperature, respiratory rate and end tidal carbon dioxide (ETCO2) 
level were recorded at the time of ONSD measurement. The ONSD measurements were 
analysed for repeatability, intra- and inter-observer variability as well for correlation 
between images acquired in different planes and those obtained from either eye. The 
diagnostic accuracy of ONSD measurement for detecting ICP at different thresholds of 
20, 15, 10 and 5 mmHg was analysed. This analysis included evaluation of age-related 
thresholds for defining different ONSD cut-off values in children. Dynamic image 
acquistion was performed and analysed to evaluate the relevant pulsatile motion of the 
ONS as a marker of the sheath stiffness. 
Results: One hundred and seventy four children undergoing diagnostic or therapeutic 
surgical procedures were included in this study. ONSD measurement demonstrated good 
correlation with ICP across the entire patient cohort (r = 0.66, p < 0.001), but was better 
in children > 1 year or with a closed anterior fontanelle (AF) (r = 0.7, p < 0.001). Age 
above and below 1 year was found to be an appropriate age threshold for defining two 
different sets of ONSD cut-off values. The study however, supported using patency of the 
AF as a stronger clinical marker for describing different ONSD cut-off values in children. 
The second part of this work described a dynamic technique for analysing the pulsatile 
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motion of the ONS. Analysis of the deformability index (DI) as an indirect marker of ONS 
stiffness, revealed a statistically significant relationship with ICP (sensitivity of 90%, 
specificity of 87% for detecting ICP ≥ 20 mmHg). 
Conclusion: Measurement of the ONSD is a sensitive surrogate marker of raised ICP, but 
demonstrated poorer specificity. This relationship was more reliable in older children, 
particularly when the AF was closed. Analysis of the dynamic characteristics of the ONS 
appeared to provide useful additional information as an independent marker, and may 
contribute to our overall understanding of ONSD measurement in raised ICP.                                                                         
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Diagnosing neurological disease in children is a formidable challenge for modern medical 
practitioners, given the spectrum of conditions and the wide array of clinical presentation. 
The presenting features of most paediatric neurosurgical conditions are often due to an 
increase in ICP, a condition where early diagnosis is critically important.  
The current standard of care for diagnosing raised ICP involves intracranial placement of 
an invasive monitoring device. This technique has the distinct benefit of providing 
continuous, real-time monitoring, but is generally limited to patients in a neurocritical care 
or high care unit.1,2 Disadvantages of invasive ICP monitoring include the risk of 
haemorrhage, infection and catheter misplacement.3,4 The ideal ICP monitor would 
therefore be non-invasive, portable, easy to use, cost effective and allow for continuous 
monitoring. 
There has been a longstanding quest for a reliable, non-invasive technique to assess ICP. 
In children specifically, decreasing the radiation exposure from repeat computerised 
tomography (CT) scans, the potential to avoid unnecessary invasive diagnostic surgical 
procedures and the possibility of improving early detection have been the key elements 
supporting this avenue of research. The opportunity to make the diagnosis of raised ICP 
earlier using an appropriate non-invasive technique, makes the applicability of such a 
method broader than just neurocritical care patients. Despite several promising advances, 
no single non-invasive method of assessing ICP has been accurate enough as a quantitative 
measure of ICP to replace invasive monitoring.4 
The use of ultrasound as a diagnostic and navigation modality in neurosurgery has 
historically been limited by poor image quality and bulky probes.5 Despite the fact that 
one of the earliest descriptions of ultrasound as a diagnostic tool in medicine involved the 
attempted diagnosis of a brain tumor,6,7 this modality has enjoyed limited use in 
neurosurgery. However, recent advances in image quality and development of novel 
techniques have stimulated a resurgence in the use of this modality within neurosurgery, 
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both as a diagnostic and intra-operative navigation tool.7,8,9 The obvious benefit of being 
radiation-free, portable, widely available and relatively cost effective, makes this modality 
very appealing,10,11 especially in a resource-limited environment.  
The diagnostic application of ultrasound in neurosurgery has also been limited by the poor 
acoustic properties of the bony skull.7 In children, use of the AF as a sonographic window 
has been widely described.12,13 The accessible, natural bony windows in the human skull, 
i.e. orbit, auditory canal and AF (neonates), can potentially allow access to important 
information about the brain and ICP. In particular, the eye has served as a natural window 
to the brain, allowing insight into a variety of neurological and other systemic 
conditions.14,15 Transorbital ultrasound measurement of the ONSD as a surrogate marker 
of raised ICP has enjoyed increasing interest recently.16-27 The direct cerebrospinal fluid 
(CSF) connection between the peri-optic and intracranial subarachnoid spaces, make this 
technique a particularly appealing option for assessing ICP.28 This appeal is further 
enhanced by the favourable acoustic properties and superficial anatomical location of the 
eye, making it very suitable for transorbital sonographic assessment of the ONS. 
 
1.1) Scope of the thesis 
This study investigates the relationship between measurement of the ONSD using a high 
frequency, small footprint, transorbital ultrasound probe and invasively measured ICP, in 
a paediatric patient cohort. The goal of validating and defining optimal ONSD cut-off 
values for detecting raised ICP in children is best approached by comparing this technique 
to the current ‘gold standard’, which is invasive ICP measurement. In children, this 
requires evaluating age-related recommendations for defining ONSD cut-off values. The 
described age thresholds range between 1 year and 4 years old (28-34).  This study has 
therefore used the following age categories for this evaluation, i) ≤ 1 year old, ii) ≥ 1 year 
old, iii) subcategory analysis of ages  1 to ≤ 4 years and > 4 years old, to for comparison 
with current literature.28-34 The diagnostic accuracy of ONSD measurement was 
investigated within these age categories, to describe the nature of the ONS response at 
ICP thresholds of 20 mmHg, 15 mmHg, 10 mmHg and 5 mmHg. An alternative 
3 
 
physiological and anatomical marker, viz patency of the AF, was also assessed as a 
potential clinical marker for defining different ONSD cut-off values in children. 
Physiological and demographic factors which may influence this relationship have been 
analysed for significance.  
The elastic nature of the ONS has been described as a significant factor in the ability of 
the ONS to distend when subjected to increasing ICP. Using a dynamic imaging 
technique, the final part of this work describes an analysis of the pulsatile motion of the 
ONS as a potential marker of its stiffness.  
 
1.2) Outline of the thesis 
 
SECTION A 
This section provided an overview of the relevant anatomical and sonographic features of 
the eye that allow transorbital sonographic ONSD measurement. The current 
measurement techniques for ICP, their underlying principles, benefits and shortcomings 
and a specific review of the literature describing ONSD measurement in children and 
adults, are included here. 
 
SECTION B 
This section described the working hypothesis, aims and methodology. The results are 
presented in age-related categories and also use of the AF as a clinical marker for 
describing different ONSD cut-off values at various ICP thresholds, followed by a 






This section discussed the available literature using ‘dynamic’ assessment of the ONSD, 
and its association with ICP. Novel data is presented using a technique that analyses the 
dynamic pulsatile motion of the ONS to describe an index termed the deformability index 




This section provided an overview of the study findings, placing them in perspective of 






The eye as a window to the brain 
The eye as a window to the soul is an ancient philosophical concept that can be dated all 
the way back to the biblical era. In particular the size of the pupil has been linked to levels 
of excitement and arousal.35,36 This realization was perhaps best illustrated by Italian 
women in medieval times who used drops from the dangerous night shade plant (later 
called ‘belladonna’) to artificially dilate their pupils in an effort to make themselves 
appear more attractive. This proved to be quite a dangerous practice, and was later 
abandoned, but certainly highlighted their recognition of the eye not only as an organ 
facilitating vision, but also as a window into our hidden thoughts and emotions. 
These underlying principles were advanced upon in 1964 by the famous psychologist 
Eckhardt Hess. In his seminal work, Hess provided evidence that the eye is a valuable tool 
in evaluating mental processes.37 This work was built on by others who demonstrated 
convincingly that the pupillary response of the eye is linked to cognitive function, a field 
of study eventually called ‘cognitive pupillometry”.38-43  
The abstract value of the eye as a window into the soul and mind is of great interest, but 
as physicians our focus tends to be more on the physical benefit of this natural window to 
the brain. The ocular manifestation of systemic diseases including diabetes mellitus (DM), 
hypertension, cardiac disease and neurofibromatosis (NF) have been well described.14,44 
Examination of the eye specifically as a non-invasive method for detecting underlying 
disease of the central nervous system (CNS) remains a very attractive option for 
neurodegenerative diseases like multiple sclerosis (MS), Parkinson disease (PD) and 
stroke.15 
The description of oedema of the optic disc as a consequence of increased ICP was first 
made by von Graefe in 1860.45,46 By inflating balloons placed in the subdural space of 
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rhesus monkeys to increase ICP, Hayreh described an increase of CSF in the ONS as being 
‘essential for the development of oedema of the optic disc’.46 Subsequent work has 
indicated that enlargement of the ONS in conditions of raised ICP may actually precede 
oedema of the optic disc.296 Several authors have since described a strong association 
between enlargement of the ONS and an increase in ICP.17,28,47-51 
This work describes the relationship between transorbital sonographic measurement of the 
ONSD and invasively measured ICP. A discussion of the relevant anatomic details is 
necessary as the structure of the ONS is fundamental to its ability to distend as ICP 
increases and its relation to the bony optic canal is very important in determining the CSF 
flow within the ONS.46,52,53 The relevant vascular anatomy described has significant 
impact in SECTION C of this work which involves analysis of the dynamic pulsatile 
motion of the ONS, a direct consequence of the anatomical relationship between the ONS 
and the arteries in proximity to it. The sonographic features of the ONS, the measurement 




2.1. The optic nerve sheath (ONS): Anatomical concepts 
 
The ONS complex is composed of: 
2.1.1 the optic nerve (ON) 
2.1.2 the subarachnoid space between the optic nerve and sheath 
2.1.3 the optic nerve sheath (ONS) 
2.1.4 blood vessels within the optic nerve sheath complex. 
 
 
2.1.1. The optic nerve (ON) 
The optic nerve has a length of about 40 – 50 mm, and an average diameter of about 4 
mm. This nerve is a white matter tract of the central nervous system that originates from 
within the diencephalon. It grows anteriorly and laterally extending through the optic 
canal and into the orbit. The optic nerve itself is surrounded by CSF within the 
subarachnoid space and enveloped by the ONS, which is a continuation of the intracranial 
dura mater. Anatomically the ON can be divided into 4 parts: an intra-ocular segment, an 
intraorbital segment, an intracanalicular segment and an intracranial segment. 
 
2.1.1.1 The intraocular segment (optic nerve head) of the optic nerve measures about 1 
mm in length and is 1.5 – 1.8 mm in diameter. It is composed of the lamina cribrosa, 
prelaminar region and surface nerve layer, and is the shortest segment of the ON. The 
mode of insertion of the ON into the eyeball and the shape of the sclera canal determine 
the shape of the optic disc.54 This shape is important for interpreting ophthalmoscopic 
findings. 
2.1.1.2. The intraorbital segment extends from the eyeball to the optic canal. It is 
surrounded by the meningeal sheath consisting of dura, arachnoid and pia mater, and CSF 
within the subarachnoid space. It is 20 – 30 mm in length and has about 6 mm of slack to 
accommodate orbital movements.46 The central retinal artery perforates the optic nerve 
8 
 
with its accompanying vein and runs within the optic nerve to the retina. This part of the 
optic nerve has longitudinal and transverse connective tissue septae, which contain blood 
vessels. The pia mater has a dense vascular plexus on the surface of the orbital optic nerve. 
The ophthalmic artery lies in close proximity to the optic nerve, initially inferolateral, then 
usually crosses over the nerve to lie supero-medial to the ON. As the nerve enters the optic 
canal, the surrounding dural sheath becomes continuous with the dural lining of the orbit 
and optic canal.The orbital segment of the optic nerve is subdivided into a bulbar segment 
that is adjacent to the globe and a mid-orbital segment, connecting the bulbar to the 
intracanalicular component.54 
2.1.1.3. The intracanalicular segment lies in the bony optic canal, surrounded by the 
meningeal sheath. The ophthalmic artery lies below and lateral to the ON.  
2.1.1.4. The intracranial segment is about 10 mm in length and culminates in the optic 
chiasm. The ON lies above the diaphragma sellae initially, then above the cavernous sinus, 
and is in close relation to the ophthalmic artery inferolaterally, ICA laterally and ACA 
superiorly. 
 
2.1.2. The subarachnoid space between the optic nerve (ON) and optic 
nerve sheath (ONS) 
The ONS itself has a thickness of 0.4 mm, with the subarachnoid compartment estimated 
at 0.1 – 0.2 mm in width.49 The subarachnoid space surrounding the optic nerve is a 
heterogeneous, blind-ending (cul de sac) space, which holds about 0.1 ml of CSF.52,53 
In the bulbar segment, the enlarged subarachnoid space contains a trabeculated network 
anchored between the pial and arachnoid layers. These trabeculae are composed of 
leptomeningeal cells and delicate collagenous fibrils; occasionally they contain one or two 
blood vessels. In the mid-orbital segment the subarachnoid space is distinctly smaller, 
containing numerous broad septae and pillars connected through large perforations. These 
septae and pillars contain leptomeningeal cells and numerous collagen fibrils. 
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In the intracanalicular segment the subarachnoid space is largely continuous, with one or 
two larger pillars.49,53 The hydrodynamics of CSF within the subarachnoid space 
surrounding the optic nerve is therefore quite complex. The series of compartments and 
septae, as well as the ‘cul de sac’ anatomy of the ONS impact not only on the dynamics 
of the flow but also on the direction of CSF flow which may not follow the same principles 
as fluid travelling within an ideal tube.53  
Direct communication between the perioptic subarachnoid space and the chiasmal cistern 
has been demonstrated.46,55 CSF pressure could build up in this perioptic subarachnoid 
space if CSF were forced unidirectionally into this compartment via the chiasmal cistern 
due to an increase in ICP.  
These findings are especially relevant in this study as they explain to some degree the 
microstructure determining the expansile nature of the ONS. The description of a 
subarachnoid space that is widest at the bulbar segment and narrows progressively in the 
mid-orbital and intracanalicular segment of the ON, provides useful information on where 
it would be best to measure the diameter of the ONS.50,53 
 
2.1.3. The optic nerve sheath (ONS) 
The sheath surrounding the optic nerve is made up of three layers, which are in continuity 
with the leptomeninges of the brain. In the optic canal the ON is attached to the 
surrounding dura by thick fibrous bands. At the apex of the orbit the ONS is attached to 
the annular tendon, to which the various recti muscles are attached. The two layers of the 
dura are attached within the optic canal, but split at the orbital end of the canal, with the 
outer layer forming the orbital periosteum and the inner layer forming the dural ONS. 
The anatomy of the ONS in the optic canal is especially important as it functions 
effectively as the ‘access portal’ for CSF entering the ONS from the intracranial 
subarachnoid space SAS. The thick fibrous bands connecting the dura and pia in the optic 
canal hold the ON firmly in position, but also maintain the dura and optic nerve in close 
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proximity. The subarachnoid space is consequently reduced in size to virtually the size of 
a capillary.54 
According to Hayreh, the assumption that the bulbous appearance of the ONS was due to 
distension caused by an increase in ICP, was a contentious one. He initially suggested that 
the firm, non-elastic collagen fibers of the dural ONS were less capable of being stretched 
by an increase in CSF volume. This observation was based on experimental evidence from 
monkeys showing that the ONS was normally a distended space filled with CSF.46 
The anatomy of the sheath in the region of the optic canal plays a crucial role in the 
dynamics of CSF between the orbital ONS and the intracranial space. Communication 
between these two spaces is almost always present,54,56 but the percolation of CSF through 
this space determines the temporal response of ONS distension to an increase in ICP.  
The dural sheath accompanies the ON from the optic canal to the sclera. The collagen 
fiber architecture of the ONS provides distinctive mechanical properties, as a 1 mm 
diameter collagen fiber is estimated to have a resistance of 10 kg.57 The ONS can be 
divided into the intracranial, intracanalicular and intraorbital segments. 
 
2.1.3.1. Intracranial segment 
This is a very short segment formed by invagination of the cranial dura mater at the 
sphenoid planum at the level of the optic canal. This dural invagination forms the 
falciform ligament which is a few millimetres in length and does not adhere completely 
to the bone.  
 
2.1.3.2. Intracanalicular segment 
The relationship between the ONS and the bony and meningeal structures in the optic 




Bony structures The optic canal guides the course of the ONS ventrally and laterally. The 
anterior clinoid process forms the lateral border of the optic canal, and is attached to the 
body of the sphenoid by two bony bridges, which form the roof and the floor of the optic 
canal.58 
Meningeal structures The dura mater covering the ventral surface of the clinoid process 
forms a ‘carotid-oculomotor membrane’ which is in contact with the ONS as the 
ophthalmic artery arises from the ICA. 
 
2.1.3.3. Intraorbital segment 
The important relations with this segment of the ONS are vascular and nervous elements. 
At the exit of the optic canal the ONS is a dense structure, giving rise to the annular tendon. 
The ONS runs within the orbital cone, together with the abducens nerve, nasociliary nerve, 
superior and inferior branch of the oculomotor nerve and the ophthalmic artery. The tissue 
surrounding the ONS is essentially adipose tissue. Five important structures cross the 
intraorbital segment of the optic nerve dorsally; these are the trochlear nerve, the frontal 
nerve, nasociliary nerve, the ophthalmic artery and the superior ophthalmic vein.  
 
 
2.1.4. Blood vessels within the optic nerve sheath( ONS) complex 
 
The arterial network within the ONS is quite intricate, but a working understanding of the 
anatomical relationship between the ON, the arterial network and the ONS is fundamental 
to interpreting the pulsatile dynamic response of the ONS described in SECTION C of 
this work. The following anatomical description is not intended to be exhaustive, but 
includes the relevant arterial anatomy within the ONS.  
     
2.1.4.1. Arteries within the ONS 
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The ophthalmic artery (OA) is the first major branch of the intracranial segment of the 
ICA. It provides the principal arterial supply to the contents of the orbit. The OA arises 
from the medial border of the ICA, usually between the distal and proximal carotid ring. 
The origin of the OA determines whether it enters the orbit through the superior orbital 
fissure or the optic canal. The OA accompanies the optic nerve inferomedially in its 
sheath.58,59 Beyond the optic canal, it travels obliquely through the ONS to join the orbital 
apex, lateral to the ON. It gives off a recurrent branch in the optic canal which contributes 
to the vascular supply of the ON in the canal. The OA crosses the ONS dorsally, to lie 
between the medial rectus and superior oblique muscles before giving rise to the anterior 
and posterior ethmoidal arteries. It also gives rise to the lacrimal, ciliary, supraorbital, 
medial palpebral, infratrochlear and dorsal nasal arteries.  
Perhaps the most significant branch of the OA, even though it is the smallest, is the central 
retinal artery, which enters the inferior surface of the ON at the junction between the 
anterior third and median third, about 20 mm from the optic canal following a short, 
serpiginous trajectory. It passes to the center of the optic nerve travelling up to the globe 
to supply the retina. 
The intraorbital segment of the optic nerve derives its blood supply from the rich 
anastomotic network within the pia mater, supplied by the ciliary artery. The optic head 
is supplied by branches of the ophthalmic artery; multiple anastomoses between the 11 
branches of the ophthalmic artery and the external carotid artery allow sufficient blood 
flow to the choroidal and central retinal arteries. 
Within the orbit the OA supplies five major branches and the pial network: 
 
 The central retinal artery  
The first branch of the ophthalmic artery enters the optic nerve 8 -15 mm behind the globe 
and arborises in the retina. This end artery supplies the inner two-thirds of the retina and 
surface nerve layer of the optic nerve (these branches are seen on fundoscopy). It provides 
little to no vascular supply to the prelaminar, laminar and retrolaminar layers. The central 
retinal artery may rarely originate from the middle meningeal artery.60 
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 The posterior ciliary arteries  
The short ciliary branches arise from the ophthalmic artery as it crosses over the optic 
nerve. The OA divides into 10 – 20 branches as it moves around the optic nerve anteriorly, 
intertwining with branches of the short ciliary nerves. There are 6 – 8 short branches and 
2 longer ones which extend anteriorly to the ciliary bodies and supply the choroid. 
 The lacrimal artery 
This branch extends laterally and anteriorly along the superior surface of the lateral rectus 
muscle and supplies the lacrimal glands, globe and muscle. 
 Terminal branches  
The terminal branches of the ophthalmic artery are the supratrochlear and supraorbital 
arteries, which lie superior and medial to the globe. 
 The circle of Zinn-Haller  
This is a rich vascular network, receiving branches from the short posterior ciliary arteries, 
including the recurrent pial branches and recurrent choroidal arteries. 
 The pial network  
This network is made up of small meningeal branches that come off the central retinal 











 Lamina cribrosa 
Blood supply to this area is mainly from fine centripetal branches originating from the 
posterior ciliary arteries. Interestingly, the central retinal artery does not supply this 
region. The vessels lie in the fibrous septae of the lamina cribrosa and form a dense 
capillary network.54,61 
 Prelaminar region  
This area is supplied mostly by centripetal branches from the peripapillary choroidal 
vessels, which are mostly end vessels and have little communication with other vessels. 
This region may also receive some supply from the vessels in the lamina cribrosa region. 
The central retinal artery does not usually contribute blood supply to this region.61 
 Surface of the optic disc 
This surface contains the main retinal vessels and a large number of capillaries, which are 
derived from branches of the retinal arterioles. In this part of the optic disc it is common 
to find vessels of choroidal origin derived from the prelaminar part of the optic disc which 
lies adjacent to it. These may enlarge to form the cilioretinal artery. The capillaries on the 
disc are all interconnected, mostly venous, draining into the central retinal vein or its 
tributaries. The arterial supply to all the retinal capillaries, except for the cilioretinal artery, 




Venous drainage of the optic nerve head is simpler than its arterial supply. The main 
venous drainage of the optic disc is carried out by the central retinal vein. The superior 
ophthalmic vein exits the orbit via the superior orbital fissure and drains into the cavernous 
sinus. The inferior ophthalmic vein drains into the pterygoid venous plexus via the inferior 
orbital fissure. There are numerous connections between these veins, which usually 
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accompany the arteries. The central retinal vein is susceptible to increased ICP transmitted 
through the CSF as it passes through the subarachnoid space. 




2.2. Transorbital ultrasound 
 
2.2.1. Background 
The first reported use of A-scan ultrasonography to examine the eye was performed by 
Mundt and Hughes in 1956.63 The lack of anatomical detail and considerable operator 
experience required for A-mode ultrasound use limited the widespread use of the 
technique. The use of B-mode ultrasonography in ophthalmology was first described by 
Baum and Greenwood in 1958, using a water bath immersion technique.64 This technique 
was later improved on by Bronson in 1972, who developed a contact method for using 
ultrasound which made the examination easier to perform on patients, and later became 
commercially available.65 With further advances in the imaging quality of ultrasound 
technology, the indications for imaging the eye, orbit, optic nerve and its sheath began 
expanding.  
Ossoinig initiated the ‘standardised echography’ concept, using A-mode scans, in clinical 
settings.66 This early work describing imaging of the ONS was later followed by several 
important contributions supporting the technique of ONSD measurement using 
ultrasound.49,67,68 The early description of distension of the ONS as a consequence of an 
increase in CSF volume in the perioptic subarachnoid space due to raised ICP was made 
by Hayreh,46,69 stimulating later work on this topic.28,30,68 
Transorbital ultrasonography remains the quickest and simplest method of imaging the 
eye and the ONS. The additional benefits of real-time imaging and high spatial resolution 
make ultrasound the preferred imaging modality. The unique anatomy of the eye makes it 
ideal for ultrasound imaging for the following reasons70 : 
 It is a fluid-filled, superficial and easily accessible organ. 
 
 The acoustically empty anterior chamber (defined by the structures anterior to the 
lens, extends from the cornea to the iris and contains the aqueous humour) and 
vitreous cavity make the outline of the normal structures of the eye clearly visible. 
 Moving the transducer over the eye allows the ultrasound beam to reach all parts 




 There is limited demand for depth penetration, requiring only 30 mm depth for the 
eye itself and 60 -70 mm for the orbital apex; this allows higher frequency probes 
than is feasible in other anatomical settings. 
 
 The associated shorter wavelength allows better resolution, with the possibility of 




                       
                     Figure 2.1. Axial ultrasound image of the eye. 








                          







2.2.2. Sonographic anatomy of the eye (Figures 2.1 and 2.2) :  
CSF in perioptic 
subarachnoid space 




 The cornea appears as an isoechoic layer, just below the soft tissue of the eyelids 
 
 The anterior chamber is anechoic 
 
 The posterior chamber (extends posteriorly from the iris to the posterior surface of 
the lens, also contains aqueous humour) is also anechoic 
 
 The posterior chamber includes the ciliary body, which in cross section is seen as 
isoechoic triangles lateral to the lens 
 
 The iris appears as linear echogenicities anterior and lateral to the lens 
  
 The lens is mostly anechoic, except for a thin echogenic anterior and posterior rim 
 
 The vitreous chamber which is the largest of the three chambers, contains vitreous 
humour and extends from the posterior surface of the lens to the ocular wall 
 
 The retina, choroid and sclera (which form the walls of the vitreous chamber) are 
depicted as a single isoechoic layer 
 
 The optic disk appears as a slight discoid protrusion in the vitreous 
  
 The optic nerve is depicted as a hypoechoic band, posterior to the optic disk, 
surrounded by the echogenic retrobulbar fat 
 
 Generally the anterior two thirds of the course of the ON can be seen 
sonographically 
 







2.2.3. Indications for transorbital sonography 
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According to Brunell71 there are two clinical categories for the use of ophthalmic 
ultrasound, i) clinical diagnosis by ophthalmologists, and ii) in emergency departments 
for diagnosing ocular trauma and raised ICP. The use of ocular sonography has also been 
described by intensive care physicians as well as neurosurgeons for the non-invasive and 
early detection of raised ICP.16-18,30,72,73 The broader indications for ocular sonography are 
listed in Table 2.1. The specification of the ultrasound probes required for purely 
ophthalmological use are different to those used for measuring the ONSD.71 
 
Anatomical region Indication 
Front of the eye Foreign bodies 
 Lens dislocation or subluxation 
 Afferent pupillary defects 
 Changes in the size of the anterior chamber 
 Neoplastic lesions 
Optic nerve Increased ICP (measurement of the ONSD) 
 Neoplastic lesions of the optic nerve and sheath 
Vitreous Retinal haemorrhage 
 Retinal detachment 
 Vitreous haemorrhage 
 Vitreous detachment 
 Lens dislocation 
 Endophthalmitis 
Extraocular Retrobulbar haemorrhage 
 Globe disruption 
 Foreign bodies 
Artery/vascular Central retinal artery occlusion 
 Central retinal vein occlusion 
 
Table 2.1. Anatomical regions and indications for transorbital ultrasound 
 




2.2.4.1. Equipment  
The ideal transducer is a linear array, high frequency (> 10 Mhz) probe, with a small 
footprint to allow adequate imaging of the orbit and its contents, especially in children. 
The size and shape of the orbit in smaller children is often a limiting factor to optimal 
image quality.74 Although higher frequency transducers are available, in the range of 20 
Mhz, their field of view is too limited to evaluate the entire globe. For the purpose of 
imaging the ONS, a small footprint, high frequency (> 10 Mhz) probe is recommended.  
 
2.2.4.2. Patient positioning 
Patients are usually positioned supine, with the head slightly elevated at about 30 degrees. 
This may vary however, depending on clinical history and age. It is preferable to place the 
ultrasound machine on the patient’s right side and orient the probe so that the indicator is 
pointing towards the patient’s head or toward the patient’s right side. 
 
2.2.4.3. Technique 
A generous amount of coupling gel is applied over the closed upper eyelid (Figure 2.3). 
The transducer then can float over the layer of gel and won’t come into direct contact with 
the patient’s eyelid. The coupling gel optimises image quality and precludes any pressure 
being applied to the globe.75 A protective transparent dressing can be placed over the 
closed eyelid in sedated or ventilated patients as an additional measure to prevent any 
irritation of the conjunctiva. The probe should be held with a pincer grasp between the 
thumb and index finger, using the remaining fingers for stability by resting them on the 
maxilla, supraorbital ridge or other bony structures (Figure 2.4). This technique is 
especially important to prevent any pressure being applied on the globe. The probe is 




The depth should be adjusted to optimise the visualisation of the intended structures, i.e. 
the optic nerve, the surrounding CSF space and the ONS.  
The gain should be adjusted to create a hypoechoic posterior chamber. If the gain is too 
high, echoic artefacts could lead to image distortion, and if the gain is too low, image 
quality can be inadequate. Most modern ultrasound machines have default settings to 
improve image quality in specific organs. 
The eye should be examined in at least two planes: the axial or transverse plane, with the 
probe oriented in the horizontal, left to right direction; and the sagittal plane, which is 
imaged by rotating the probe and positioning it in a cranial to caudal orientation (Figures 
2.3 and 2.4). The imaging should be performed in both eyes.77,78 
The mechanical index should always be adjusted lower than the recommended values for 
the eye, in order to limit the amount of energy absorbed by the eye (safety guidelines will 
be discussed below).  




        






             Figure 2.4. Axial imaging                                                    Figure 2.5. Sagittal imaging 
 
 
2.2.5. Safety of transorbital ultrasonography  
The acoustic energy used for diagnostic purposes has no described adverse effects.77, 79 
Despite stringent output standards for ocular exposure to diagnostic ultrasound, there is 
limited literature on the subject. The recent bioeffects and safety report by the American 
Institute of Ultrasound in Medicine (AIUM) makes no specific mention of the eye.80 A 
recent review article provides a very helpful summary of the safety recommendations for 
transorbital sonography.158  The United States Food and Drug Administration Center for 
Devices and Radiological Health (US FDA/CDRH) describes an output intensity limit for 
all eye exposure of 50 mW/cm2, recommending the use of a mechanical index (MI) < 
0.23, and a thermal index (TI) < 1.81  
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The European Federation of Societies for Ultrasound in Medicine and Biology 
(EFSUMB)82 recommend that particular care should be taken to reduce the risk of thermal 
and non-thermal effects during investigations of the eye.83 To eliminate potential injury to 
the eye it is recommended that ultrasound output power be kept as low as reasonably 
achievable (ALARA principle)79,84 without impeding the diagnostic quality of the 
examination, and that examination times be kept as short as possible.85,86,158 An equally 
important prerequisite is that transorbital sonographic ONS examination only be 
performed by operators adequately trained and experienced in performing the technique. 
The definition of an experienced operator differs, but this study defined an experienced 
operator as having performed more than 25 prior transorbital ultrasound examinations.23   
 
2.2.6. Shortcomings of transorbital ultrasonography 
Ocular trauma or disease of the optic nerve complex precludes sonographic examination 
of the ONS. The technique requires a certain amount of training or experience, as novice 
users may be prone to erroneous measurement.23 The artefactual shadow which is thought 
to be due to the poor insonation angle, has been described by some authors and often 
makes accurate and repeatable measurement of the echoic borders of the ONS unclear. 
The lack of consensus regarding the optimal ONSD cut-off value to detect raised ICP, has 
limited universal acceptance of the technique, despite a growing number of studies 
demonstrating a good relationship between ONSD and ICP. While the technique causes 
very minimal discomfort and is well tolerated by most patients, examinition in small 
childen can often be quite challenging. 
Transorbital sonography of the ONS is a safe and effective technique for visualising the 
lamina cribrosa, optic nerve and its sheath. In our experience and that of numerous other 
authors, the technique is promising as a surrogate marker of raised ICP. There are no 
described adverse effects when the technique is performed by experienced operators, 
utilising correct equipment and according to safety recommendations.78-82 
This study focussed on the use of transorbital sonography of the ONS to detect raised ICP, 
using thresholds of 20, 15, 10 and 5 mmHg in neurosurgical patients. 
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Chapter 3.  
Methods of assessing intracranial pressure 
 
3.1. Introduction 
The early work by Guillaume and Janny in 1951,87 followed by Lundberg’s magnum opus 
in 1960 88 laid the foundation for monitoring of ICP. Several investigators have since made 
significant contributions in this field.60,89-98,122 The association between raised ICP and 
poor neurological outcome has been widely reported and has distinct clinical and 
therapeutic implications.90,100-102 Although some reports have questioned the merits of 
monitoring ICP,103,104 the role of invasive monitoring techniques in a neurocritical care 
environment as a diagnostic and therapeutic tool, especially in TBI are widely 
supported.92,99,105-108 Invasive ICP monitoring has the distinct benefit of allowing 
continuous, real-time analysis of the ICP waveform.88   
The benefits of reliably and non-invasively assessing ICP have also been described, and 
while invasive ICP monitoring remains the gold standard, development of accurate, non-
invasive alternatives are ongoing.2,109 Perhaps the most significant benefit of a reliable 
non-invasive technique, lies in the promise of earlier detection of conditions where the 
clinical presentation of raised ICP may be subtle, a scenario perhaps most applicable to 
children.  
In children determining the threshold for raised ICP is complex because of the variation 
in physiological norms associated with different ages. Lower ICP treatment thresholds for 
younger children are often considered appropriate, but there is still a lack of data to support 
this. The current recommendation in the guidelines for acute medical care of severe 
traumatic brain injury in neonates, children and adolescents is a treatment threshold of 20 
mmHg for children recommendations.110,111 These guidelines don’t make any age-specific 
recommendations. As children are a heterogeneous group with significant age-related 
physiological and anatomical variation, there are likely to be differences in ICP treatment 
thresholds within children. Chambers et al. described age-related ICP thresholds of 2 to 6 
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years – 6 mmHg, 7 to 10 years – 9 mmHg and 11 to 15 years – 13 mmHg.95 An ICP 
threshold of 20 mmHg demonstrated a significant correlation with outcome in children 
with traumatic brain injury94. It is possible that cerebral herniation occurs at intracranial 
pressures < 20 – 25 mmHg, depending on the type and location of the intracranial space 
occupying lesion. It therefore remains specifically relevant to interpret any recommended 
ICP threshold in the context of clinical presentation, monitoring of physiological variables 
(where appropriate) and imaging findings in an individual patient. Recommendations that 
account for age-related ICP thresholds would be ideal. 
 
3.2. Monitoring of ICP 
There is still no ideal method for evaluating ICP. While the benefit of continuous, real-
time monitoring provided by invasive ICP monitoring is clear, it comes with distinct 
limitations, and the appeal of non-invasive ICP monitoring lies in obviating the need for 
placement of an intracranial device, and avoidance of the risks associated with these 
procedures. However, current non-invasive ICP monitoring techniques have the limitation 
of inadequate accuracy4,109 for detecting elevated ICP. Most non-invasive techniques are 
able to provide qualitative estimates of ICP, but lack quantitative value. The benefits and 








3.3. Invasive ICP monitoring 
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Invasive ICP monitoring devices are either fluid-coupled or non-fluid-coupled and can be 
further classified according to the anatomical compartment into which they are placed. 
These include: 
3.3.1 Intraventricular monitoring 
3.3.2 Intraparenchymal monitoring 
3.3.3 Subdural monitoring 
3.3.4 Extradural monitoring 
3.3.5 Telemetric ICP monitoring 
3.3.6 Spinal monitoring 
 
3.3.1. Intraventricular monitoring 
Insertion of an external ventricular drain (EVD) and measurement of the cerebrospinal 
fluid CSF pressure is still considered the ‘gold standard’ technique for monitoring ICP.88,92 
This is a fluid-coupled system, consisting of a catheter placed into the lateral ventricle and 
connected to a fluid-filled column, which transmits the ventricular pressure to an external 
strain gauge.112 The opportunity to transduce the pressure readings for continuous 
monitoring as well as the added benefit of being able to release CSF when ICP is elevated, 
make this method very appealing as a diagnostic and therapeutic option. Calibration of the 
system is very simple once it is properly zeroed at the level of the external auditory meatus. 
A limitation to placement of a ventricular catheter in rasied ICP, is ventricular 
compression or anatomical distortion, which can make accurate insertion into the ventricle 
quite challenging. As a fluid filled system, blood or debris in the ventricle can cause 
obstruction. The main risks associated with EVD placement are infection and 
haemorrhage. The risk of infection starts to increase after day 5 post-insertion, and is 
reported as between 1 and 11%.113-115 The risk of haemorrhage from EVD placement is 
quite low, described as 1.1%, with a 0.5% incidence of clinically significant 
haematoma.116 
 
3.3.2. Intraparenchymal monitoring 
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The use of intraparenchymal, fibre-optic, microtransducer probes to monitor ICP has 
increased significantly.2,92,112,117-119 These transducers are usually placed and secured 
using a twist drill and skull bolt, but can also be placed freehand via a burr hole. The 
transducers must be calibrated according to the manufacturer specifications, i.e. either in 
air or water, prior to insertion. These devices have a lower rate of infection and 
haemorrhage than EVD placement.3,114,120-121 
A limitation with microtransducer monitoring is the drift of the readings over time, 
described as being about 2.1 mmHg over five days.123,124 Generally these microtransducers 
cannot be re-zeroed; however, pneumatic transducers such as the Spiegelberg transducer 
may be zeroed in-vivo at set time intervals.95 Variation in the correlation between fibre-
optic microtransducer readings and transduced EVD readings has been reported.125,126 The 
use of invasive, intraparenchymal ICP monitoring is generally limited to neurocritical care 
or high care units.  
 
3.3.3. Subdural monitoring 
The placement of microtransducer probes in the subdural space requires burr hole and 
freehand placement, as bolt insertion precludes placement into this space. The indications 
are similar to intraparenchymal placement, but potentially carry a lower risk of 
intraparenchymal haemorrhage.  
 
3.3.4. Extradural monitoring 
The main concern with placement of probes in the extradural space remains poor 




3.3.5. Telemetric (Implantable) ICP monitoring  
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Implantable ICP monitors with a catheter-tip transducer connected to a telemetry unit 
implanted in a skin pouch outside the cranium have been used for long-term ICP 
monitoring. This technique has the particular advantage of providing continuous data on 
ICP patterns and has gained increasing interest,127 particularly in patients with complicated 
CSF dynamic disturbances, where repeat invasive pressure monitoring may be required.128 
 
3.3.6. Lumbar spinal monitoring 
In the neurocritical care setting lumbar CSF pressure is rarely measured. The use of this 
technique is largely limited to certain forms of hydrocephalus and benign intracranial 
hypertension. The opening pressure is usually measured with a CSF manometer; 
depending on the indication a spinal drain could be inserted. Lumbar puncture (LP) 
opening pressures in children may also overestimate ICP, with a recent study 
recommending verification of LP opening pressures by formal ICP monitoring.129 
Neuroimaging to rule out a space occupying lesion or radiological contraindication is 




Type of placement Advantages Disadvantages 
Intraventricular catheter Provides a global measure of ICP 
Can be used to release CSF for 
control of ICP 
Can be calibrated in-vivo 
Significant risk of infection, 
haemorrhage, disconnection 
Difficult insertion in small ventricles 
Intraparenchymal Low complication rate 
Insertion is simple 
Drift of reading over time 
In-vivo calibration not possible 
Provides a focal representation of 
ICP 
Subdural Low complication rate 
Insertion is simple 
Drift of reading over time 
In-vivo calibration not possible 
Provides a focal representation of 
ICP 
Extradural Simple insertion 
Minimal risk of infection 
Accuracy unreliable 
Telemetric  Continuous data Indwelling device 
Lumbar spine Extracranial procedure 
Can be performed in ambulatory 
patients 
May not reliably reflect ICP 
Dangerous if ICP is very high or 
SOL is present 
  














3.4. Limitations of invasive ICP monitoring 
The use of invasive ICP monitoring, despite distinct benefits, is suboptimal in clinical 
practice. Insertion of intracranial monitoring devices is performed by neurosurgeons, 
however, a significant number of patients with raised ICP are initially seen by non-
neurosurgeons, who do not have access to invasive monitoring. Patients being ventilated 
in a neurocritical care environment are good candidates for invasive monitoring, but 
ambulant patients are less suitable, and as a result ICP monitoring may not be performed 
in many patients in whom it is indicated. Conversely, a suitable non-invasive technique 
that could reliably screen patients with raised ICP could identify appropriate candidates 
for invasive monitoring.  
The risks associated with the procedure, mainly haemorrhage, infection, misplacement 
and inaccurate readings, must be weighed against the potential benefits. Sophisticated MR 
and CT imaging techniques provide invaluable information regarding space occupying 
lesions, oedema, haemorrhage and hydrocephalus. These images are necessary despite 
ICP monitoring to describe the actual underlying pathology. ICP monitoring as a 
standalone modality may provide imprecise impressions of what is actually occurring, 
depending on the experience of the treating clinician, and subsequently may elicit 
inappropriate therapeutic interventions. The benefit of multimodal monitoring versus ICP 
monitoring alone is a contentious issue.  
 
Invasive ICP monitoring remains the standard against which all non-invasive methods of 
assessing ICP are compared.92,116 The gold standard for invasive ICP monitoring remains 
measurement via a transduced intraventricular catheter. The risks and limitations 
associated with invasive ICP monitoring have inspired considerable efforts towards the 
development of non-invasive techniques that are reliable, easy to use, cost-effective and 
reproducible.2,3,4,109 A variety of non-invasive techniques have been described for 
assessing ICP; their widespread use, however, remains quite limited. The shortcomings of 
these non-invasive techniques include the range of cut-off values for detecting raised ICP, 
inter-rater variability and qualitative rather than quantitative measurement of ICP.2,3,109 
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For a non-invasive technique to be considered reliable, it would have to correlate well 
with invasively measured ICP, predict ICP within 2 mmHg in the 0 – 20 mmHg range, 
with a maximum error of 10% for ICP > 20 mmHg, which are the specifications supported 
by the Brain Trauma Foundation.130 
 
3.5. Non-invasive assessment of ICP 
A method for reliably assessing ICP that does not require surgery and poses no risk of 
infection or haemorrhage, is certainly appealling. The ideal technique should be relatively 
inexpensive, repeatable, portable, radiation-free, user-friendly and allow continuous 
monitoring. The uses of a non-invasive technique could include screening and triage at 
point of contact, long-term monitoring (invasive monitoring has a limited duration due to 
risk of infection and drift), monitoring of ICP for routine assessment in patients with other 
conditions that may present with raised ICP, e.g. chronic hydrocephalus or stroke 
survivors.  
Methods of non-invasive ICP monitoring usually involve assessing physiological or 
anatomical characteristics influenced by an increase in ICP. There are a variety of 
techniques, both clinical and technological, qualitative and quantitative for non-invasively 
assessing ICP. The accuracy of these techniques varies considerably,2,3,109 and for ease of 
reference, can be divided into the following groups: 
 
3.5.1 Clinical assessment  
 
3.5.2 Techniques utilizing the natural bony windows in the skull 
 
3.5.3 Techniques assessing fluid dynamics  
 
3.5.4 Electrophysiological techniques  
 





3.5.1 Clinical assessment 
Clinical neurological assessment remains the most important initial diagnostic and 
monitoring tool. Despite notable advances in non-invasive monitoring in the modern era, 
ongoing clinical assessment should remain a fundamental pillar of monitoring.  
 
3.5.1.1. History 
Careful history taking can be an invaluable tool in making the diagnosis of raised ICP. 
The symptoms suggestive of raised ICP are: 
 Headache 
 Impaired level of consciousness 
 Visual disturbance 
 Nausea and vomiting 
 Developmental delay (in younger children) 
 Failure to thrive (in younger children) 
 
In children with an open anterior fontanelle (AF), increasing head circumference and a 
bulging fontanelle are symptoms that parents will often notice themselves. 
These symptoms should always raise the suspicion of raised ICP; however they lack 
specificity and when interpreted alone can often be misleading to the treating clinician. It 
is therefore important to interpret these findings in the appropriate clinical context. 
 
3.5.1.2. Clinical examination 
The benefit of the clinical evaluation differs in the paediatric and adult population. In 
children with an open AF, where the skull sutures have not yet fused, an abnormal increase 
in the head circumference and bulging of the fontanelle are good indicators of raised 
ICP.131,132 In severely raised ICP the sutures may often be separated and palpable. 
Distended scalp veins may be visible when the head circumference is increased in 
longstanding raised ICP. 
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After the sutures have fused, assessment of ICP becomes more difficult. Finding 
papilledema on fundoscopy is a reliable indicator of raised ICP,133 however this finding is 
not consistent, especially where there is atrophy of the optic nerve.134 Fundoscopic 
examination can provide significant additional evidence of underlying raised ICP, which 
includes papilledema, haemorrhage, loss of spontaneous venous pulsation and optic 
atrophy. Papilledema is usually bilateral and generally develops within 5 days of an 
increase in ICP.135,136 
Cranial nerve palsies, usually the third and sixth cranial nerves and abnormalities of gaze 
(mostly upward gaze palsy) are usually ominous signs that raised ICP may be present. 
Bradycardia and hypertension with abnormal respiration (Cushing’s response) may 
accompany cerebral herniation syndromes and are late features, usually signalling 
critically raised ICP, requiring emergent treatment. The benefit of a thorough history and 
clinical examination can therefore, not be emphasized enough. 
 
3.5.2 Techniques utilising the natural bony windows of the skull 
The most accessible anatomical windows in the bony skull which can be used to assess 
ICP are, transorbital, the auditory canal and the anterior fontanelle (AF) in infants. 
 
3.5.2.1. Transorbital methods 
 
This thesis focused on the use of ONSD measurement, and it is discussed first in this 
subsection, but other useful transorbital techniques are also discussed here. 
 
i. Optic nerve sheath diameter (ONSD) 
The optic nerve originates ontogenetically from the central nervous system. It is encased 
by a dural sheath, with a perineural, subarachnoid space between the nerve and the dural 
sheath. This perineural space is filled with CSF and is in direct communication with the 
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intracranial subarachnoid space. An increase in ICP results in displacement of CSF along 
its various pathways. The increase in CSF within the space surrounding the optic nerve 
results in expansion of the ONS. The region of the ONS located 3mm posterior to the 
lamina cribrosa of the retina is considered the most distensible and recommended as the 
most consistent region to acquire the ONSD measurement.50 Changes in the ONSD can 
be visualized using images from ultrasound, MRI and CT scans.17,30,151-153 Several studies 
have demonstrated a strong association between distension of the ONSD and an increase 
in ICP.18,19,73,151,154,155 The suggested cut-off values in these studies range between 4.1 - 
5.9 mm and the definition of increased ICP also varies considerably, between 14.7 and 30 
mmHg.4,18,73,151,154 The main limitations of ultrasound-based ONSD measurements are 
hyperechoic artefacts, inter-examination variability, small size of the structures and 
measurements, variation in optic nerve sheath cut-off values and heterogeneity of the 
patient population.15,18,157,158 These shortcomings are accentuated in children because of 
the age-related variations.28-34 Despite these limitations, ONSD measurement has been 
described as a useful screening method to detect clinically suspected raised ICP, especially 
where invasive monitoring is not readily available.22,23,25,30 
 
ii. Intraocular pressure (IOP) 
The appeal of this technique lies in the anatomical proximity and direct communication 
between the eye and the intracranial space.137 The indirect transmission of ICP to the orbit 
via intervening venous anatomy has long been recognized.138 The use of handheld 
tonometers by clinicians without any specialised training, has increased the interest in IOP 
as a rapid screening tool for raised ICP.137,139-143 Lehmann et al. demonstrated in their 
study on rhesus monkeys that a relationship between IOP and ICP did exist, albeit at rather 
high mean values of ICP (46.8mmHg).144 Later studies evaluating the relationship 
between IOP and ICP provide mixed results.138,139 A meta-analysis by Yavin et al. 
concluded that the pooled diagnostic accuracy suggested IOP may be a useful clinical 
adjunct in the detection of raised ICP, but felt the benefit of the technique would be best 
assessed in future studies where clinical equipoise exists regarding the use of invasive ICP 
monitoring.145 While there appears to be a relationship between an increase in IOP and 
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Infrared pupillometry has been used to quantitatively measure subtle changes in pupil size 
in response to light stimulus. Pupillometers have been found to be more sensitive than 
manual scoring for noting small changes in pupil size.147,148 In normal individuals the pupil 
decreases by 34-36% in size, in response to a standard light stimulus. This response is 
reduced to 20% in head-injured patients, with a reduction of less than 10% associated with 
an ICP > 20 mmHg.149,150 While promising, the clinical applicability of this technique 
requires further investigation. 
 
iv. Optical coherence tomography (OCT) 
OCT is a technique using broad-band near-infrared light. This technology can be used to 
quantitatively measure and monitor the thickness of the retinal nerve fibre layer (RNFL) 
and the optic nerve head morphology,159 making it a useful, objective method for 
distinguishing nerves with papilledema from normal nerves, and optic atrophy. This 
application has been found useful in adults and children with raised ICP and 
papilledema.160,161 
 
v. Scanning Laser Tomography (SLT) 
SLT uses a laser to produce a 3D scan of the retinal surface. It can be used as an alternative 
to OCT when measuring the RFNL. The technique has been described as being highly 
reproducible.162,163 Though SLT measurement of the optic nerve volume and height have 
been found reliable in quantifying papilledema,164 and have been correlated with CSF 




vi. Spontaneous venous pulsation (SVP) 
SVP occurs due to the variation in the pressure gradient between the intraocular and CSF 
pulse pressure when the retinal vein crosses the lamina cribrosa.166 SVP is considered to 
be present when ICP is normal,167 however SVP may be absent in normal individuals as 
well. The presence of SVP is therefore a very sensitive marker for normal ICP, but should 
be interpreted in the context of the patient’s clinical presentation.168  
 
vii. Venous Ophthalmodynamometry (vODM) 
This method was originally described by Baurmann in 1925, and involves measurement 
of the retinal venous outflow pressure (VOP) while observing the retinal vessels with an 
ophthalmoscope.169 The technique usually involves applying a suction cup to the globe in 
order to increase the IOP until the central retinal vein (CRV) collapses, and begins to 
pulsate, which usually happens at the point when the applied external pressure nears the 
VOP, which is an approximate of ICP. The venous outflow pressure which has a close 
linear relationship with ICP170 is calculated by adding the pressure from the 
ophthalmodynamometer to the IOP. The technique requires the pupils to be dilated and 
should be performed by an experienced ophthalmologist. The application of external 
ocular pressure could also trigger the oculo-cardiac reflex, leading to hypotension, which 
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   Table 3.2. Non-invasive ICP monitoring techniques: Transorbital methods 
 




The cochlea of the ear is in direct communication with the intracranial subarachnoid space 
via the cochlear aqueduct. Methods investigating displacement of the tympanic membrane 
and measurement of sound generated by movement of the ossicles have been described as 
markers of ICP. 
 
i. Tympanic Membrane Displacement (TMD) 
Tympanic membrane vibration is usually transmitted through the ossicles in the middle 
ear to the cochlea. Contraction of the stapedius and tensor tympani muscles is 
accompanied by a small, measurable displacement of the tympanic membrane from its 
resting position. As the perilymph and CSF communicate through the cochlear aqueduct, 
an increase in ICP is directly transmitted to the footplate of the stapes leading to a change 
in the direction and magnitude of the TMD. 
Movement of the tympanic membrane caused by stimulation of the stapedial reflex can 
be quantitatively assessed. This movement is altered by increased ICP, but limited 
accuracy of the technique means it is merely suited to providing qualitative information 
about ICP.171,172 In the study by Shimbles et al, no valid measurement of TMD could be 
made in about 60% of patients, casting doubt on the clinical value of the technique.173 
Patency of the cochlear aqueduct, integrity of the tympanic membrane and strength of the 
acoustic reflex influence the TMD, which is further limited by poor inter-subject 
reproducibility.174 
 
ii. Otoacoustic emissions (OAEs) 
OAEs are sounds originating from movement of the sensory hair cells within the cochlea 
in response to auditory stimulation. These sounds can be recorded by a probe placed in 
the ear canal. OAE is often used in clinical practice to test for hearing deficits in young 
children where cooperation is poor.  
Auditory measurements of OAEs that depend on middle-ear function are theoretically 
influenced by changes in ICP.175 This method has been used as an alternative to TMD, 
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specifically a technique called distortion product otoacoustic emissions (DPOAEs) has 
been shown to change with ICP.175,176 It has the advantage over TMD of not requiring the 
middle-ear reflex arc, which involves brainstem pathways. Poor inter-subject variability 
limits its use in measuring ICP, but it could be useful for monitoring patients once baseline 
ICP has already been measured.4,177 
 
















OAEs Medium Qualitative Potentially Excludes the 
brainstem 
pathway 
Difficult in older 
patients 
 
 Table 3.3. Non-invasive ICP monitoring techniques: Methods utilising the auditory canal 
 
 
3.5.2.3. Assessment of the anterior fontanelle (AF) 
 
The term fontanelle refers to a fibrous, membrane-covered space or ‘soft spot’ occurring 
between two juxtaposed cranial bones. There are usually two prominent fontanelles in the 
midline, the AF and posterior fontanelle (PF). The AF is roughly diamond shaped and 
located at the junction between the sagittal and coronal sutures, between the frontal and 
parietal bones. It usually closes between the ages of 6 – 18 months (median age of 13.8 
months).178 The PF usually closes by age 8 weeks and is of less clinical significance. 
Palpation of the AF, measurement of the head circumference, assessing shape of the head 
and palpation of suture ridges during clinical examination are basic, but extremely 
valuable assessments which can be performed by health care workers at all levels. 
Evaluation of the AF provides a window for determning whether raised ICP is present in 
infants. The size and shape of the AF vary significantly according to age, position and 
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pathology and delayed closure of the AF is associated with a number of conditions. The 
most common causes, which usually have other associated features as well, include 
achondroplasia, congenital hypothyroidism, Down syndrome, rickets and raised ICP. 
Raised ICP in infants usually causes a bulging or tense AF, and this should serve as a 
warning prompting further investigation. 
Described techniques for assessing ICP via the AF include measuring pulsation of the 
AF,179,180 use of an aplanation transducer and modified Shiotz tonometer132 and the 
Rotterdam Teletransducer (RTT).181 None of these have been widely used in routine 
practice and are largely of historical significance. Where the AF is closed or not reliably 
patent, other non-invasive techniques may be required to assess ICP. 
 
 
3.5.3. Methods based on fluid dynamic properties 
 
Studying the dynamic changes in ICP, cerebral blood flow (CBF) and cerebral compliance 
can be quite challenging. Non-invasive techniques for assessing these parameters are 
therefore rather limited. Ultrasound, MRI and infrared spectroscopy have been used to 
examine some of these dynamic changes and will be discussed below.  
 
 
3.5.3.1. Transcranial Doppler sonography (TCD) 
 
TCD measures the velocity of blood flow through major intracranial vessels by emitting 
a high frequency (> 2 MHz) wave, and detecting the frequency shift between the incident 
and reflected wave. This difference directly correlates with the speed of blood flow (the 
Doppler effect).182  
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TCD as a technique for evaluating cerebral haemodynamics was first described by Aaslid 
in 1982.183 It has since been used to measure the cerebral blood flow (CBF) velocity in the 
circle of Willis and the vertebrobasilar system, both diagnostically and to adjust treatment 
strategies in a variety of neurovascular disorders.184-187 Insonation of one of the arteries, 
usually the middle cerebral artery, produces an arterial waveform. Using this arterial 
waveform, the most commonly assessed parameters are the peak systolic and diastolic 
velocity, mean velocity, resistance index (RI) and pulsatility index (PI). The criteria for 
adequate vessel insonation are: the cranial window used, transducer position, angle of 
insonation, depth of sample volume, direction of blood flow, relative flow velocity and 
experience of the investigator.182,188  
The measurement is taken over regions of the skull with the thinnest bony windows 
(temporal region, through the eye or at the back of the head). TCD is most suited to 
providing a qualitative estimate (low, normal or high) of ICP.189,184 
In an adult study, the PI (difference between systolic and diastolic flow velocity divided 
by the mean flow velocity) correlated well with ICP (correlation coefficient of 0.938, p < 
0.001).184 A study in children with severe traumatic brain injury (TBI) found the PI to be 
a less reliable indicator of absolute ICP values,190 while a subsequent study also in children 
found TCD to be an excellent first-line examination for identifying patients likely to need 
invasive ICP monitoring.191 
TCD remains an attractive alternative to invasive ICP because of its ability to detect 
cerebral ischemia, its relative cost effectiveness and widespread availability. The main 
disadvantages are that it requires a trained and skilled operator to perform and interpret 
the measurements and the limited accuracy for estimating absolute ICP.190  
Two-depth TCD assessment involves pressure application to the orbit in order to equalize 
blood flow in the intra- and extracranial segments of the ophthalmic artery. This technique 
was shown to correlate well with absolute ICP measurements,192,193 but also appears 
currently limitated by operator dependence and inadequacy of the current indices to 




3.5.3.2. Magnetic resonance imaging (MRI)-based elastance index 
 
MRI-based cine phase-contrast pulse sequences are used to determine the blood and CSF 
volumetric flow rates within the brain. A method described by Alperin uses the arterial 
inflow, venous outflow and CSF flow between the cranium and spinal compartment to 
calculate changes in intracranial volume; these measurements can then be used to derive 
ICP using an elastance index.194,230 Prediction of ICP using this dynamic MRI technique 
has been strongly correlated with invasive ICP measurement. In children with 
hydrocephalus, dynamic MRI was shown to correlate well with the shunt valve opening 
pressure.195 A significant association with symptom resolution in hydrocephalic patients 
has also been demonstrated.196 This promising technique still requires investigation in a 
larger cohort of patients. It is also quite expensive and impractical for continuous 
monitoring. 
 
3.5.3.3. Near infrared spectroscopy (NIRS) 
 
Transcranial NIRS is a method for assessing regional changes in cerebral blood oxygen 
saturation (rSO2) and cerebral blood volume (CBV) and CBF.197 NIRS works in the infra-
red spectrum (700-1000 nm) of light, where low absorption allows it to easily pass through 
skin and bone resulting in deep-tissue penetration. This light is both scattered and 
absorbed as it passes through brain tissue. Variations in the absorption of infrared light by 
different substances allow the detection of changes in deoxyhaemoglobin and 
oxyhaemoglobin concentration. A significant difference in rSO2 values was demonstrated 
in a study of severe TBI patients with normal and raised ICP.198 Changes in cerebral 
oxygenation were also shown to correlate with vasogenic ICP slow waves in CSF infusion 
studies and patients with TBI.199 NIRS allows for the calculation of certain indices which 
have been correlated with cerebrovascular pressure reactivity in patients with TBI.200 At 
present NIRS does not provide an estimation of absolute ICP values nor does it facilitate 
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the detection of changes in ICP.109 The technique is also limited by the requirement for 
specialised equipment and the extended period required to obtain the required indices.200 
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Table 3.4. Non-invasive ICP monitoring techniques:  Methods based on fluid dynamic properties 
 
 
3.5.4 Electrophysiological techniques 
 
3.5.4.1. Electroencephalography (EEG) 
 
EEG represents spontaneous electrical activity of the cerebral cortex recorded through 
electrodes placed on the scalp. These electrical signals are then amplified, filtered and 
displayed according to the number of channels required (generally 8 or 16 channels). 
The use of a novel technique called EEG power spectrum analysis has recently been 
reported on by Chen et al.201 Power spectral analysis allows a graphical representation of 
the EEG readings over time. An index called the intracranial pressure index (IPI) was 
derived using the EEG power spectrum analysis, and this was then correlated with ICP 
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measurements obtained via lumbar puncture. The authors concluded that there was a 
correlation between the IPI and ICP. Its clinical utility will depend on validation in further 
studies. EEG can be continuously recorded for 8 -12 hours, before the conductive gel dries 
out, requiring the leads to be replaced. Recent development of both wireless, portable and 
field deployable EEG systems have improved the application of this technique.201 
 
3.5.4.2. Visual evoked potentials (VEP) 
 
VEPs are recorded from electrodes positioned in the occipital scalp and accurately reflect 
disturbances of the visual pathways.202,203 Rosenfeld described a method using flashing 
light into the eye and estimating ICP through recordings obtained from a few occipital 
EEG electrodes, using the latency of the second negative-going wave (N2).203 A linear 
relationship between ICP and the latency of the third positive-going wave (P3) has also 
been reported using high-density electrode arrays and independent component analysis 
extraction.204 The N2 wave appears to be stable and easily identifiable using flash evoked 
VEPs in healthy control patients. Earlier studies by York et al. demonstrated a strong 
correlation between the N2 latency of the VEP and ICP in children with hydrocephalus 
and young adults with head trauma.205,206 The relationship between a prolonged N2 latency 
period and raised ICP has subsequently also been reported in children.207,208 A recent study 




3.5.4.3. Ocular vestibular evoked myogenic potentials (oVEMPs) 
 
This technique employs vestibular stimulation of the extraocular muscles to generate 
electromyographic activity. These evoked potentials can be recorded from the 
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contralateral eye using surface electrodes. A recent study has suggested this technique 
may have a role in non-invasive ICP assessment.172 
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Radiological imaging has historically been a fundamental tool in making the diagnosis of 
raised ICP. Skull x-rays were used to assess whether chronically raised ICP was present 
by detecting separation of the skull sutures, ‘copper beaten’ appearance of the skull and 
erosion of the clinoid.210,211,212 This technique has been found less useful in the modern 
era.213 Imaging features on CT and MRI consistent with clinical findings of raised ICP 
have been well described.210,214-218  These features are discussed below. 
 
3.5.5.1. CT scan 
 
CT scan still remains the most commonly used diagnostic imaging modality when 
assessing patients with acutely raised ICP. A variety of findings on CT have been 
associated with raised ICP, depending on the underlying aetiology. These findings 
include: 
 Absence/compression of the basal cisterns and/or ventricles 
 Midline shift 
 Enlarged ventricles (hydrocephalus) 
 Transependymal fluid shift 
 Presence of haematoma/space occupying lesion 
 Blood in the subarachnoid space 
 Size of sulci 
 Gray/white differentiation 
 
The benefit of the initial CT scan has been investigated widely in the context of traumatic 
brain injury.210,215,218,220 CT scan still forms the cornerstone of acute imaging in 
hydrocephalus, where imaging features depend on the aetiology and relate to the level of 
obstruction, presence of transependymal fluid shift, volume of CSF in the subarachnoid 
space and shape of the the third ventricle.267,268 Planning of specific surgical interventions 
for hydrocephalus, eg. endoscopic third ventriculostomy (ETV), usually requires an MRI 
scan. 
The discussion regarding which of these CT findings and correlate best with raised ICP is 
still ongoing.4,109,218-220 While CT scans remain a valuable diagnostic adjunct in the acute 
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diagnosis of raised ICP, it must be remembered that a ‘normal’ CT scan does not rule out 
raised ICP. In children the additional radiation exposure to the susceptible, developing 
brain and the possible sequelae over the lifetime of the child must always be 
considered.221-225 To this effect the ‘image gently’ recommendations for children should 
always be kept in mind (www.imagegently.org).  
 
3.5.5.2. MRI scan 
 
MRI provides superb quality images of the brain, but can be time consuming and costly 
as a first line diagnostic modality in the acute care setting. MRI techniques for evaluating 
ICP are based on the relationship between intracranial compliance and pressure.194,226 
Using a motion-sensitive technique to measure the arterial, venous and CSF flow into and 
out of the cranial cavity during the cardiac cycle, Alperin et al. demonstrated a strong 
correlation between the MRI-derived elastance index and invasively measured ICP.194 
These results, however, were found to have poor repeatability in a subsequent study, due 
to technical errors in measurement and intra-individual variation, with the authors 
suggesting caution when interpreting individual measurements.227 Despite these 
shortcomings, specific MRI sequences appear promising, both for screening in acutely 
raised ICP and for assessment of ICP in other conditions, like hydrocephalus.229  MRI has 
also been used to evaluate the optic nerve sheath diameter as a marker for raised ICP,228 
and appears to be more accurate then ultrasound in assessing the CSF filled subarachnoid 
space surrounding the optic nerve.231 The current role of MRI as a diagnostic and 
monitoring tool in neurosurgery, far outweighs its function as a purely non-invasive 
technique for assessing ICP. 
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Despite a relatively long history of innovative thinking inolving the pursuit of suitable 
techniques for non-invasively assessing ICP, the process is still in a relatively exploratory 
phase. The main limitations remain inadequate diagnostic accuracy for consistently 
detecting raised ICP, poor quantitative estimation of ICP and lack of continuous 
monitoring capability. Most methods appear suitable to identify subjects with low to 
normal ICP or very high ICP, but are poor at detecting moderately raised ICP, which 
arguably, is the most important group. The idea of combining selected non-invasive 
techniques to improve accuracy, in a ‘non-invasive multi-modality model’ is certainly 
appealing in principle.  
Non-invasive ICP assessment is still most suitable as a screening tool for patients with 
suspected raised ICP. Patients in a neurocritical care unit often require continuous ICP 
monitoring, usually as part of a multimodal monitoring approach. These objectives are 
currently only achievable using invasive monitoring techniques.  
Future development of non-invasive techniques will likely depend on substantial 
improvements in the accuracy, ease of use and potential for continuous monitoring. This 
need is perhaps most distinct in the children, where early detection of increasing ICP may 
facilitate the diagnosis of a number of underlying neurological conditions. The potential 
to spare the developing nervous system unnecessary exposure to radiation from repeated 
CT scans or limit the need for invasive monitoring in certain cases makes this quest 
worthwhile.  
This study has identified measurement of the ONSD using transorbital ultrasound as a 
promising technique in children, and the next section of this work discusses the role of 
ONSD measurement as a non-invasive marker of raised ICP.  
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Chapter 4.  
Measurement of the optic nerve sheath diameter (ONSD) as a 
non-invasive marker of intracranial pressure (ICP) 
 
The optic nerve originates from the diencephalon and is an extension of the white matter 
tract of the central nervous system (CNS). As the optic nerve extends into the orbital cavity 
it is enveloped by a dural sleeve which is continuous with the intracranial dura mater. CSF 
within the intracranial subarachnoid space is in continuity with the perineural 
subarachnoid space surrounding the optic nerve. This perineural space, surrounded by a 
dural sheath, is known as the ONS.53,56 
An increase in ICP above a certain threshold can result in displacement of CSF from the 
intracranial cavity. Depending on the underlying aetiology, this CSF displacement can 
often be seen on imaging as a decrease in the volume of CSF surrounding the cerebral 
cortex.33,232 The direct continuity between the intracranial and perineural subarachnoid 
space allows the displacement of intracranial CSF causing an increase in the CSF volume 
within the optic nerve sheath.28,50 This increase in CSF volume within the ONS results in 
distension of the ONS and widening of its diameter. The space between the optic nerve 
and dural sheath is not a homogeneous space, but rather a trabeculated, septated system 
that likely plays a role in the CSF dynamics between the perineural space surrounding the 
optic nerve and the subarachnoid space of the intracranial cavity.53   
The relationship between an increase in ICP, increase in CSF within the ONS and oedema 
of the optic disc was described by Hayreh in 1964.46 The initial ultrasound-based 
observation of the thickness of the optic nerve, the amount of perineural fluid and the 
thickness of the surrounding dural sheath were described by Ossoinig in his seminal work 
entitled “Standardised Echography” in 1979.66 This was later followed by the description 
of an increase in subarachnoid fluid surrounding the optic nerve and the link to increased 
ICP.47 This observation was validated by Galetta who demonstrated a reduction in the 
optic nerve diameter after lumbar puncture in a patient with pseudotumor cerebri.48 Liu 
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demonstrated a linear relationship between subarachnoid pressure of the optic nerve and 
ICP in a cadaver model.49  
Hansen and Helmke performed a study using specially prepared optic nerve specimens. 
The technique involved forcefully injecting gelatin into the perineural space surrounding 
the optic nerve, demonstrating that dilatation of the ONS was maximal in the anterior 3 
mm segment. The observation that the change in ONSD may be influenced by dural 
elasticity and the trabecular network density as well as different pressure loads, remains 
an important consideration when interpreting the ONS response to an increase in ICP. 
This study marked one of the earliest validations of ultrasonic measurement of pressure-
induced distension of the ONS.28 The distensibility of the ONS, its elastic properties, 
individual baseline variability and the bony anatomy of the optic canal were further 
explored in experimental studies by the same group, highlighting the complexity of the 
relationship between ONS distension and ICP-related changes.50,154   
Following on this early work, numerous investigators have explored the relationship 
between distension of the ONS and ICP.16-33 The most relevant literature on this topic will 
be discussed in this section, reviewing material on paediatric and adult studies involving 
ONSD separately. The different modalities for measuring ONSD, i.e ultrasound, MRI and 




4.1. Studies in children 
Literature evaluating the role of ONSD measurement as a non-invasive marker of ICP in 
children is quite sparse. The discussion of paediatric studies has been divided into two 
parts. The first part evaluates studies supporting the use of ONSD measurement and the 
second part evaluates studies against its use. 
 
4.1.1 Support for the use of ONSD measurement  
 
4.1.1.1. Ultrasound-based measurement 
 
Some of the earliest work on this concept was done by Helmke and Hansen28 who 
performed a prospective study on 39 children admitted to the intensive care unit (ICU), 
and compared them to 51 control patients. The study aimed to investigate whether the 
‘phenomenon’ of ONS distension happened under conditions of acute intracranial 
hypertension. 15 patients did not have elevated ICP, while 24 had elevated ICP (7 with 
invasive ICP monitoring to verify elevation above 20 mmHg). In control subjects the 
range of ONSD measurements differed in the first 4 years of life when compared to ONSD 
measurements in older children. The difference between mean ONSD in the ICU groups 
with and without raised ICP was 2.3 mm (p = 0.007).  This study remains fundamental as 
it marks one of the earliest efforts to demonstrate dilatation of the ONS in acutely raised 
ICP. Taking into consideration the error under repeated measurements of 0.3 mm, the 
authors recommended that in children older than 4 years, an ONSD of 4.5 mm may be 
considered ‘borderline’, while an ONSD exceeding 5.0 mm is definitely enlarged, whereas 
in children under 4 years old, an ONSD of > 4 .0 mm can be considered ‘definitely’ 
enlarged.28      
Aiming to establish normal age-related values for ONSD in infants and older children (up 
to the age of 15 years old), Ballantyne and colleagues conducted a prospective study in 
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102 children without any neurological or ophthalmological disease. This study 
demonstrated a clear increase in ONSD during the first year of life, approaching maximum 
(adult) values by the age of 2 years. Results from this study suggest that an ONSD value 
greater than 4 mm in children under 1 yo, and greater than 4.5 mm in older children should 
be considered abnormal.29   
Children with ‘shunted hydrocephalus’ were evaluated in a later study by Newman et al,30 
comparing 23 children with shunted hydrocephalus with 102 control patients. The shunted 
hydrocephalus group was further subdivided into i) normotensive (n=6), ii) symptomatic 
but not requiring intervention (n=5) and iii) symptomatic requiring intervention (n=12). 
The mean ONSD values were 3.1 ± 0.36 mm in the control group, 2.9 ± 0.5 mm in group 
i), 3.1 ± 0.4 mm in group ii) and 5.9 ± 0.6 mm in group iii). The authors demonstrated a 
correlation between increasing age and increasing optic nerve sheath diameter (r2 =0.48), 
with the greatest increase occurring in the first year of life. The most significant 
recommendation from this study was an age related cut-off point for normal ONSD values 
of 4.0 mm in children under the age of 1 year, and 4.5 mm in children over the age of 1 
year. This finding was consistent with the recommendation by Ballantyne et al,29 but at 
odds with the findings from the Helmke study.28 
The majority of studies evaluating the role of ONSD measurement, are based on using a 
combination of clinical assessment and imaging findings as the reference standard for 
diagnosing raised ICP. Malayeri and co-workers conducted a case-controlled, prospective 
study on 156 children, 78 control patients and 78 patients symptomatic of raised ICP. The 
investigators found a mean ONSD value of 5.6 ± 0.6 mm in the symptomatic group and 
3.3 ± 0.6 mm in the control group (p < 0.01). They also found no significant age-related 
difference in the ONSD measurement in the symptomatic group, but a significant age-
related difference in the control group, citing a probable difference in the expansile 
structure and anatomic characteristics of the optic nerve sheath as a possible explanation 
for the disparity. The study made no recommendation regarding the optimal ONSD cut-
off value in children.32 
A Malawian study conducted by Beare and colleagues prospectively investigated the 
benefit of ONSD measurement in 51 children, 21 with neurological disease and 30 control 
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patients. 14 patients had clinically suspected raised ICP, with a mean ONSD of 5.4 mm. 
The mean ONSD was 3.6 mm in the group without clinically raised ICP and 3.5 mm in 
the control group. The investigators suggest a cut-off point of 4.2 mm with a sensitivity 
of 100% and specificity of 86%, as the upper limit of normal, with measurements ≥ 4.5 
mm indicative of raised ICP. A limitation of the study was that the control group included 
patients with gastroenteritis and sepsis, both of which are particularly susceptible to 
dehydration, making the ONSD values quite difficult to interpret, as they were potentially 
lower than would be expected for ‘normal children’. No age-related threshold was 
investigated in this study.33 
The first study to suggest that ONSD values in children may be higher than previously 
desribed was performed by McAuley and colleagues. In a review of ONS ultrasound 
examinations in children with a clinical suspicion of hydrocephalus, the study presented 
data on 331 examinations performed in 160 children. The authors did not recommend 
specific cut-off values in this paper but concluded that the baseline ONSD value in 
asymptomatic patients was higher than previously reported by Newman et al.30 The 
change in mean ONSD values in symptomatic patients from their own recorded 
asymptomatic baseline was significant. Another relevant finding was that in 24/29 
(82.8%) patients the ONSD correlated with shunt block, and in 19/24 (79.2%) of these 
patients, no change in ventricular configuration was demonstrated on imaging findings. 
The authors concluded that ONSD measurement was increased in symptomatic patients 
from their own baseline, and that multiple examinations might be useful in evaluating the 
ONSD pattern in individual patients, possibly playing a better predictive role in the 
assessment of ventriculoperitoneal shunt (VPS) malfunction.234 Even though no specific 
cut-off values were provided, this study was significant in that it highlighted the role of 
repeat measurement of the ONSD in assessing patients with shunted hydrocephalus. 
Tsung et al. reported on 3 paediatric cases of TBI in the emergency department (ED), 
concluding that bedside ocular ultrasonography may be useful in the ED for screening 




The only study in children that specifically compared ONSD measurement to invasive 
ICP assessment was performed by Agrawal and co-workers.This study was conducted on 
patients admitted to a paediatric neurosurgical ICU, and included only 11 children. The 
authors did however manage to demonstrate a difference in the ONSD measurements in 
patients with raised ICP compared to those with normal ICP. Using 15 mmHg as the ICP 
threshold, the median ONSD was 5.15 mm where ICP was considered raised, compared 
to 3.95 mm in the normal ICP group, suggesting that ONSD measurement might be helpful 
in selecting TBI patients requiring invasive ICP monitoring, and possibly avoid the risk 
of unnecessary procedures. No ONSD cut-off value for predicting raised ICP was 
suggested in this study.236   
 
 
                                













Study size Year Type of 
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 Described ONSD values  Diagnostic 
accuracy 
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1996 7.5 MHz 
linear array 
probe) 
< 4 years old – 4 mm,  
> 4 years old - 4.5 mm  
(borderline), 5 mm 
(definitely abnormal) 
Not done ONSD is useful in acutely 
raised ICP, and the upper 
limit differs in children 











102 1999 7 Mhz 
sector probe 
4.0 mm < 1 year old,    4.5 
mm > 1 year old is 
considered abnormal 
Not done Maximal increase in 
ONSD occurs in the first 
year of life, with a 
diminished growth rate 
over the next 14 years 
Newman Prospective Clinical 
symptoms and 














2002 7 Mhz 
phased array 
probe 
4.0mm < 1 year old 
4.5mm > 1 year old 
Not performed ONSD measurement is a 
reliable technique for 
rapid diagnosis and 













2005 7.5 Mhz 
linear probe 
Mean 5.6 ± 0.6 mm in 
symptomatic group, and 
3.3 ± 0.6 mm in control 
group. Children with 
elevated ICP have an 
ONSD > 4.55 mm, 
irrespective of their age. 
Not specified Transorbital sonography 
could be a first-line 
diagnostic modality in 
patients with suspected 




Table 4.1. Ultrasound-based paediatric studies supporting the use of ONSD measurement 






Study size Year Type of 
probe used 
Described ONSD values Diagnostic 
accuracy 
Recommendation 
Beare Prospective Clinical signs 
and symptoms 
of raised ICP. 
CT scan 
diagnosis of 
















assessment is a useful 
method in resource 
limited settings. Control 
patients had pneumonia, 
gastro-enteritis, sepsis – 
the effect of these on the 
hydration status of the 
patients and also on 










160 2009 8 – 13 Mhz 
linear array 
probe 
The mean change from 
baseline ONSD in 
symptomatic patients 
requiring intervention was 
1.29 mm, vs 0.68 mm in 
symptomatic patients  
Not performed Symptomatic  patients 
demonstrate an increase in 
ONSD from their 
asymptomatic baseline.  
Agrawal Prospective Invasive ICP 
measurement 
TBI 11 2012 10 Mhz 
pobe 
Used historical cut-off 
value of > 4.5 mm to 
predict ICP > 15 mmHg 
Not specified Only study comparing 
ONSD to invasive ICP 
measurement, but in a 
small number of patients  
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4.1.1.2. MRI – based measurement 
 
MRI provides superb detail when dedicated sequences are performed through the orbit. 
The measurement of the ONSD is likely to be less variable between observers than on 
ultrasound imaging. The reported measurements in children also appear to be larger on 
MRI than on ultrasound,237,238,239 justifying a separate discussion.    
The ideal region for measurement of the ONSD was addressed by Shofty and colleagues 
in a study reviewing the MRI scans of 115 patients, 86 healthy control patients and 29 
patients with idiopathic intracranial hypertension (IIH). A positive correlation between 
age and ONSD was demonstrated in the control group (r = 0.414). A potential limitation 
to interpreting the results of this study is the location used for the MRI measurement, i.e. 
10 mm anterior to the optic foramen, which doesn’t conform to the historically 
recommended location 3 mm posterior to the globe.30,50 The authors validated using the 
more posterior location because of the possible confounding effect of globe position on 
the measurement. The two groups, were each subdivided into 4 age categories. The 
authors demonstrated significant differences in ONSD measurement between the two 
groups in each of the age categories, concluding that ONSD enlargement on MRI in the 
paediatric population, once population-based norms had been established, was an 
important non-invasive diagnostic tool for detecting increased ICP.240 
Change in ONSD measurement after successful treatment of hydrocephalus was described 
by Singhal and co-authors in a retrospective analysis of 16 patients with successfully 
treated hydrocephalus via endoscopic third ventriculostomy (ETV) and/or posterior fossa 
tumor resection. The study compared ONSD on axial T2-MRI scans pre- and post-surgery. 
The mean ONSD pre-surgery was 6.21 mm compared to 5.71 mm (p = 0.0017) post-
surgery. The authors also evaluated other optic nerve parameters, namely optic disc bulge 
and optic nerve tortuosity, concluding that serial ONSD measurement and optic disc bulge 
might be useful in assessing the outcome of hydrocephalus treatment.238 
Change in ONSD as a marker of outcome after a specific treatment intervention, was 
investigated in a recent retrospective study by Padayachy et al,  using pre- and post-
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operative MRI scans of patients who had undergone an ETV as treatment for their 
hydrocephalus. The study included 24 children (≤ 14 yo) where, among other parameters, 
the ONSD was measured pre- and post-operatively. The mean change in ONSD in the 
successfully treated group was 0.73 mm (SD 0.26), vs 0.18 mm (SD 0.34) in group where 
the ETV had failed (p < 0.0007). Change in ONSD demonstrated a sensitivity of 92.9%, 
specificity of 85.7% and a diagnostic odds ratio of 78 for predicting outcome from the 
procedure, suggesting that change in ONSD correlated well with outcome from ETV in 
hydrocephalus.239 
The described normal values for ONSD measurement were challenged in a study by 
Steinborn et al, which aimed to validate the accuracy of ONSD measurement by 
comparing transbulbar sonography to MRI measurement. The measurements were 
performed in a group of 65 patients for a wide range of indications, who had adequate 
MRI scans of the brain, which included sequences through the orbit. The mean ONSD 
values were 5.86 ± 0.66 mm on MRI and 5.86 ± 0.71 mm for transbulbar sonography, 
with an assumed mean normal value in the range of 5 mm for children, depending on age. 
The study also demonstrated good correlation between between the two modalities ( CCC 
= 0.68), dependent on image quality.237       
In a later study on 99 normal children, the same author described an overall mean ONSD 
of 5.75 ± 0.52 mm on ultrasound and 5.69 ± 0.31 mm on MRI. The most significant 
finding of this study is the ONSD value of around 5.7 mm which is substantially larger 










 Figure 4.3. Axial T2-weighted MRI showing ONSD measurement 
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useful radiological 
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5.86 mm on 
MRI and 5.86 
mm on 
ultrasound 
Not done ONSD values on 
transbulbar sonography 
correlate well with MRI 
values   
           




4.1.2. Studies not supporting the use of ONSD measurement in children 
Several studies examining the value of ONSD measurement in children have found the 
technique to be of limited benefit. All of these studies were performed using transorbital 
ultrasound.72,241,242 
The use of sonographic ONSD measurement was directly compared to fundoscopy in a 
study using ONSD measurement performed ‘during the daytime’ in 128 children with 
syndromic craniosynostosis. The authors found ONSD measurement less sensitive than 
fundoscopy when screening for raised ICP, and contrary to previous studies,30,46 found 
that a widened ONSD did not precede papilledema. This study also demostrated no 
relationship between increase in ONSD and age. While invasive ICP monitoring was 
performed in some patients, no comparison was made between ONSD and direct ICP 
measurement. The authors did, however, raise an interesting question regarding the 
change in ONSD in chronic or repetitive ICP elevation rather than acutely raised ICP. The 
study ultimately found that ONSD measurement was not accurate enough to replace 
fundoscopy as a screening tool for increased ICP.241  
Perhaps the most convincing work demonstrating a limited value of ONSD measurement 
was performed by Le and co-workers, who prospectively investigated 64 children 
presenting to the emergency department with suspected raised ICP. 24 (37%) had a 
confirmed diagnosis of raised ICP (CT scan criteria/invasive ICP monitoring/LP). The 
ONSD cut-off values for normality used in this study were based on recommendations 
from earlier studies.23,30,243 The authors tested the sensitivity and specificity of ONSD 
values of > 4.5 mm, as well > 5 mm for predicting raised ICP. Using 4.5 mm as a cut-off 
point provided a sensitivity of 83%, and specificity of 38%, whereas 5.0 mm as a cut-off 
point decreased the sensitivity to 78% and increased the specificity to 68%. The authors 
concluded that the use of a mean ONSD measurement was not adequate to guide clinical 
decision making in children with suspected raised intracranial pressure.242 
In a more recent study aimed at evaluating the role of ONSD measurement as a screening 
tool for VPS failure, Hall and co-workers prospectively evaluated 39 children presenting 
to the emergency department with a VPS in situ for hydrocephalus. The mean ONSD was 
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4.5 ± 0.9 mm in patients with clinical shunt failure and 5.0 ± 0.6 mm in patients without 
clinical shunt failure (p < 0.03). Using historical cut-off figures of > 4.0 mm in children 
under 1 year and > 4.5 mm in children over 1 year (30),  a low sensitivity and specificity 
for predicting VPS dysfunction was demonstrated (61.1% and 22.2% respectively). The 
decision regarding VPS failure was based entirely on the neurosurgical decision to 
operate. The authors acknowledge that lack of invasive ICP measurement limited the 






















128 2011 Ultrasound 
vs 
fundoscopy 
Not specified Sensitivity-11%; 
Specificity-97% 
ONSD is less sensitive 
than fundoscopy for 
screening in raised 
ICP 









Mixed 64 2009 Ultrasound Used mean 
ONSD of 4.5 
and 5.0 mm as 
cut-off points 
Using 4.5 mm 
sensitivity of 83%, 
and specificity of 
38%. Using 5.0 mm 
sensitivity decrease 
to 78% and 
specificity increased 
to 68% 
Sensitivity of 83% 
(95% CI: 0.6 – 0.94) 
and specificity of 38% 
(95% CI: 0.23 – 0.54) 
Hall  Prospective  Clinical 
presentation 
in patients 




39 2013 Ultrasound Mean ONSD 
value of  4.5 ± 
0.9 in patients  
with shunt 
failure, and 5.0 ± 












VPS dysfunction in 
children presenting to 
the ED.  Multiple 
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the imaging resulting 
in a wide range of 
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may have affected the 
accuracy of the 
technique 
        




The diagnostic accuracy of ONSD measurement for detecting raised ICP varies 
considerably.31,157,261 In children this issue is further complicated by the description of age 
categories defined at 1 and 4 years old to describe different upper ONSD limits.28-31 The 
variation in the recommended age categories makes interpretation of the ONSD 
measurement in children particularly challenging. 
The recommendation of age above and below 1 year as a threshold for defining different 
ONSD values for children was supported in the study by Newman,30 however other 
authors only describe a significant difference between mean ONSD measurements in the 
asymptomatic group.32 The use of ONSD cut-off values of 4.2 mm and 4.5 mm to predict 
raised ICP, has also yielded inconsistent findings.32,72,241,242 
A review paper described the recommended ONSD upper limit of normal in children as31 
: 
 4 mm for patients ≤ 1 year, 
 4.5 mm for patients aged between 1 and 4 years, 
 5 mm for patients > 4 years old  
 
Recent work using a high resolution ultrasound probe describes an ONSD upper limit of 
around 5.7 mm in children, substantially greater than previously reported, but doesn’t 
mention any specific age-related variation.34 
Issues like observer-varliability, different imaging modalities to visualise the ONS and 
limited data using invasively measured ICP for comparison, have hampered the 
widespread use of this technique as a non-invasive surrogate marker of ICP in children.  
The only study in children comparing ONSD to invasively measured ICP did not 
recommend any cut-off value for ONSD.236 
The positive  relationship between ONSD enlargement and increasing ICP in children has 




These studies demonstrate that the relationship between ONSD and ICP in children 
certainly warrants further investigation. The current literature also highlights a distinct 
paucity of data evaluating this non-invasive technique in children and the need for a 
prospective study comparing ONSD measurement to the gold standard of directly 
measured ICP.  
In an effort to address some of these shortcomings, the working hypothesis of this thesis 
was that ONSD measurement had a positive relationship with invasively measured ICP 
and the study therefore aimed to address some of the disparity surrounding inter-observer 
variability, age-related thresholds in children and limited understanding of the elastic 
nature of the ONS. 





4.2. Adult studies  
The volume of adult literature evaluating ONSD measurement as a non-invasive marker 
of ICP is significantly larger than in children. The majority of available literature 
compares ONSD to clinical or image-based assessment of ICP 21-26,244 however, there are 
a number of papers comparing ONSD to directly measured ICP.16-20,73,154,155,245-247 Some 
of these studies support the use of ONSD while others have found it of little value. This 
section will analyse these studies according to the reference standard and modality used. 
These studies will then be discussed together at the end of the chapter.  
 
4.2.1. Support for the use of ONSD as a marker of raised ICP 
Several studies evaluating ONSD measurement have demonstrated a significant 
relationship between ONSD and ICP. Most of these studies were performed using 
ultrasound, but some have used MRI and more recently also CT scans.   
 
4.2.1.1. Ultrasound-based studies 
 
i. Non-invasive ICP assessment (clinical and imaging-based assessment) 
 
The majority of studies evaluating the role of sonographic ONSD measurement were 
performed in an emergency department (ED) setting. The reference standard in most of 
these studies is clinical assessment or CT-evidence of raised ICP, given the lack of access 
to invasive ICP measurement in this environment.  
Aiming to evaluate the convenience and utility of optic nerve ultrasound (ONUS)  in the 
ED, Girisgin and co-workers reported their findings in 28 patients admitted to the 
emergency department with evidence of elevated ICP (EICP) on cranial CT scan (CCT). 
The findings were compared to 26 healthy volunteers. The mean ONSD measurement in 
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patients with EICP findings on CCT was 6.4 mm (SD 0.7), compared to a mean of 4.6 
mm (SD 0.3) in the control group (p < 0.001). The authors did not suggest a cut-off value, 
but recommended ONUS as a useful and practical method for evaluation and follow-up 
of ICP.22 
Several subsequent used an ONSD cut-off of > 5mm to evaluate the accuracy for detecting 
suspected raised ICP.  
One of the earliest studies evaluating the use of ONSD in a clinical setting in was 
performed on 35 adults with suspected raised ICP. The mean ONSD in patients with 
evidence of raised ICP on CT scan was 6.27 mm, compared with a mean of 4.42 mm in 
patients without evidence of raised ICP. The difference between ONSD measurements in 
the two groups was described as 1.85 mm (p = 0.001). Using a previously recommended 
ONSD cut-off value > 5.0 mm (248,249,154), the authors demonstrated a sensitivity of 
100% and specificity of 95%.243 
Using the described ONSD cut-off of 5 mm, Tayal et al. (the same team as the earlier 
Blaivas study), performed a prospective blinded observational study in the emergency 
department on 59 adult patients with a mean age of 38 years, suspected of having raised 
ICP. The mean ONSD in patients with CT evidence of raised ICP was 6.37 mm, and in 
the group without evidence of raised ICP, the mean ONSD was 4.94 mm. Using 5 mm as 
a cut-off point, the study described a sensitivity of 100%, and specificity of 63% for 
predicting raised ICP.23 
A comparison of clinical findings, ONUS and CT evidence of raised ICP in100 adults 
with head injury, interestingly demonstrated a poor correlation between clinical features 
of raised ICP and CT findings suggestive of raised ICP (p = 0.9267). The mean ONSD in 
the group with CT evidence of raised ICP was 5.8 ± 0.57 mm, vs 3.5 ± 0.75 mm (p < 
0.0001) in the group without evidence of raised ICP on CT. Using a cut-off value for 
ONSD of > 5 mm for predicting raised ICP on CT, the study demonstrated good diagnostic 
accuracy (sensitivity of 98.6%, specificity of 92.6%).24 
Again using CT evidence of raised ICP as the reference standard, Major and co-workers 
evaluated 26 adult patients presenting to the ED to determine if ONSD could accurately 
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predict the presence of raised ICP. Using an ONSD value > 0.5 cm, the described 
sensitivity was 86% with specificity of 100%.25 
The use of ONSD measurement specifically in the hyperacute phase (within 6 hours)  to 
detect intracranial haemorrhage (ICH), was investigated by Skoloudik and colleagues This 
study included 31 patients with ICH, comparing them to 31 control patients. Sonographic 
ONSD measurements were performed at 3 and 12 mm behind the globe. Relative ONSD 
enlargement of > 0.66 mm (> 21%) demonstrated an accuracy of 90.3% for predicting an 
ICH volume > 2.5cm3. The authors then used an ONSD value of > 5mm, demonstrating a 
sensitivity of 0.708 (95% CI 0.620 – 0.708), specificity of 1.000 (0.697 – 1.000), positive 
predictive value of 1.000 (95% CI 0.875 – 1.000) and a negative predictive value of 0.500 
(0.348 – 0.652), concluding that enlargement of the ONSD may be detectable in the 
hyperacute stage of increased ICP.(26) The use of ONSD to evaluate the clinical evolution 
of ICH beyond the acute stage was also later confirmed.250 
Qayyum et al. investigated the value of an ONSD > 5 mm for predicting features of raised 
ICP on CT scan in 24 adult patients, demonstrating a sensitivity of 100% and specificity 
of 75% for predicting elevated ICP on CCT scan. An interesting observation was the good 
quality of images, despite the limited intrinsic ability of the ultrasound machine, 
suggesting that a high specification machine / probe was not necessary to perform ONSD 
measurement.251  
In an ICU-based study on 101 adults (60 with suspected raised ICP and 41 control 
patients), a lower optimal ONSD-cut-off value of 4.716 mm was demonstrated. Shirodkar 
et al. The mean ONSD in the control group was 4.6 ± 0.09 mm for females and 4.8 ± 0.10 
mm for males, vs 5.1 ± 0.62 mm for females and 5.08 ± 0.58 mm for males in the study 
group. 35 patients displayed radiological findings consistent with raised ICP, in this 
subgroup the mean ONSD was 5.4 mm for females and 5.44 mm for males. Diagnostic 
accuracy analysis demonstrated a sensitivity of 77.8% and specificity of 100% for 
predicting raised ICP on imaging.244 
Bauerle and co-investigators conducted a prospective study in 40 adult volunteers to 
establish normal values and to assess the intra- and inter-observer reliability of ONSD 
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measurement. The mean ONSD was 5.4 ± 0.6 mm, with a wide range of normality 
between 4.3 – 7.6 mm and no significant difference between the right and left eyes. The 
investigators also demonstrated no correlation between ONSD and age, gender or body-
mass-index (BMI), but found that transorbital B-mode ultrasound was a reliable method 





          
















Blaivas Prospective  CT scan Mixed  35 2002 10 MHz 
linear array 
probe 
5.0 mm Sensitivity of 
100% and 
specificity of 95% 
There is a close correlation 
between ONSD on ocular 
ultrasound and evidence of 
raised ICP on CT scan 















2007 7.5 MHz 
linear probe 
6.4 (0.7) mm in 
patients with EICP, 
and 4.6 (0.3) mm in 
control patients 
Not performed ONSD measurement can be 
used to identify patients at risk 
for raised ICP, potentially 
prior to lumbar puncture and 
CT scan 




CT scan Mixed 59 2007 7.5 MHz, 
linear array 
probe 
5.0 mm Sensitivity 100%, 
specificity 63% 
Bedside ONSD measurement 
using ultrasound is beneficial 









Head injury 100 2008 7.5 MHz 
linear array 
probe 







ONUS is potentially useful in 
head injury patients by 
avoiding unnecessary CT 
scans and serial monitoring to 
detect enlarging hematomas 
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observation
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26 2010 7.5 MHz 
probe 
> 5 mm Sensitivity of 86% 
and specificity of 
100% for raised 







ONSD measurement with 
minimal training is a useful 





Table 4.4. Adult studies supporting the use of ONSD measurement (non-invasive ICP measurement) 
  

























2011 10 and 12 
MHz linear 
array probes 
Enlargement of the 
ONSD > 0.66 mm 
(>21%)demonstrate
d a 90.3% accuracy 
for predicting ICH 
volume > 2.5cm3 
 
Using an ONSD 




specificity of 1.0 
for predicting ICH 
> 2.5cm3 
Sonography of the ONSD may 
be useful in detecting raised 
ICP in the hyperacute phase 
after ICH 
Qayyum Prospective  
diagnostic  




> 5.0 mm Sensitivity of 
100% and 
specificity of 75% 
Ultrasound measurement of 



















2014 10 MHz 
linear array 
probe 
4.716 mm Sensitivity of 
84.6% in females 
and 75% in males, 
specificity of 
100% in both 
genders 
Bedside ONSD measurement 








40 2012 9-3 MHz 
linear array 
probe 
5.4 ± 0.6 mm as the 
mean in normal 
subjects 
Nil Transorbital B-mode 
sonography is a reliable 
method to assess the ONSD.  
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Summary – Ultrasound-based ONSD measurement (non-invasive ICP measurement) 
Most studies comparing ONSD measurement to clinical assessment or CT-based evidence 
of raised ICP have used 5.0 mm as a default cut-off value for predicting raised ICP. None 
of these studies evaluated an optimal cut-off value within their own environment, but 
rather validated pre-existing described values with variable diagnostic accuracy.22-26,243,251 
This limitation is described and acknowledged in most of these studies, and is entirely due 
to the lack of access to invasive ICP measurement in the ED setting. These studies, 
however, are important as they reflect the reality faced in most acute care units. The need 
for invasive ICP monitoring, as the ‘gold standard’ against which ONSD measurement 
should be validated has been highlighted repeatedly. The literature describing invasive 

















Early work by Hansen and Helmke50 involved a prospective, in vivo study in twelve adult 
patients with clinical suspicion of raised ICP. Patients underwent a lumbar spinal infusion 
test, where Ringer’s lactate was delivered into the thecal sac via lumbar. CSF pressure 
was transduced via a second spinal needle. Ultrasound evaluation of the ONS was 
performed in B-mode at regular intervals of 2 – 4 minutes during these infusion tests. 
Changes in the ONSD were clearly demonstrated, with maximum dilation of 0.7 – 3.1 mm 
(15 – 89%) from the baseline diameter. ONSD of > 5 mm consistently coincided with CSF 
pressures of ≥ 30 mmHg.  Testing the correlation between ONSD and CSF pressure 
yielded a high correlation coefficient (r > 0.83). The authors made the observation that 
changes in ICP would remain undetected by ONSD measurement if the ICP was too low 
(average ICP 22 mmHg), attributing this observation to the elastic structure, i.e. 
specialized collagen fibril texture, which determines the sheath’s pressure response. Two 
very important statements from this seminal paper are that “that elastic structures 
determine the sheath’s pressure response” and “At higher CSF pressure levels, the ONS 
may lose its ability for further dilation, which corresponds to a depleted capacity for 
further expansion.” These observations likely form the fundamental  principles of the ONS 
response to change in ICP. The pressure threshold for sheath dilation was found to be 
above the range of normal ICP (18 – 30 mmHg). The authors conclude that serial ONS 
assessment provides a fast, non-invasive estimate of the level of CSF pressure, but cannot 
accurately estimate absolute ICP.154   
Despite a number of studies using clinical assessment and imaging features as a surrogate 
marker of raised ICP against which ONSD measurement was compared,21,23,29,243 it was 
almost a decade later that Geeraerts and colleagues16 performed a prospective blinded 
observational study comparing ONSD measurements to invasively measured ICP. This 
study included 31 adult patients with severe TBI and compared them to 31 control 
patients, examining the relationship between ONSD measured on admission to ICU and 
raised ICP (> 20 mmHg for 30 minutes) within the first 48 hours after trauma. The mean 
ONSD in TBI patients with raised ICP was 6.25 ± 0.5 mm, in TBI patients with normal 
ICP was 5.05 ± 0.7 mm, and in control patients was 4.85 ± 0.4 mm (p < 0.0001 vs control 
and normal ICP groups). The authors suggest an optimal ONSD cut-off value of 5.9 mm, 
with a sensitivity of 87% and a specificity of 94% for predicting raised ICP in the first 48 
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hours.16,17 The same team later published results from a prospective study in 37 adult TBI 
patients evaluating the relationship between ultrasound measurement of ONSD and 
invasively measured ICP, again demonstrating a strong relationship between mean ONSD 
and ICP (r = 0.71) and described a cut-off ONSD value of 5.86 mm (sensitivity of 95%, 
specificity of 79%) for predicting raised ICP, concluding that ONSD was a promising 
method for estimating ICP and also that changes in ONSD were strongly related to 
changes in ICP.17 
The concept of combining two non-invasive techniques to assess ICP and potentially 
improve their accuracy, was described by Soldatos and co-workers.19 This study 
investigated the relationship between ONSD measurement, TCD and invasively measured 
ICP in 76 critical care patients. The investigators reported a good correlation between 
ONSD measurement, non-invasive (TCD) (r = 0.8, 95% CI: 0.62 – 0.9, p < 0.0001) and 
invasive ICP (r = 0.68, 95% CI: 0.43 – 0.83, p = 0.0002) measurement of ICP in severe 
TBI, but poor correlation in moderate TBI (r = 0.32, p = 0.11) and in healthy control 
individuals (r = 0.29, p = 0.15). The best ONSD cut-off value to predict an elevated ICP 
(> 20 mmHg) was 5.7 mm, with a sensitivity of 74.1% and specificity of 100%.19 
Also using an ICP threshold of 20 mmHg, Moretti and Pizzi demonstrated that ONSD 
measurement may be useful as a screening tool to assess the need for invasive ICP 
monitoring, but could not be used for absolute ICP measurement. In this prospective study 
including 53 patients with intracerebral haemorrhage (n = 23) and subarachnoid 
haemorrhage (n = 30), as well as 53 control patients, the group with ICP > 20mmHg 
demonstrated a mean ONSD of 6.2 ± 0.6 mm compared with 5.0 ± 0.5 mm in the low ICP 
group ( p < 0.01). The mean ONSD in the control group was 4.9 ± 0.4 mm. Correlation 
between ONSD and ICP at admission was significant (r = 0.69, p < 0.01). The optimal 
ONSD cut-off point for detecting an ICP > 20 mmHg, was 5.2 mm with a sensitivity of 
94% (95% CI: 88 – 100), specificity of 76% (95% CI: 65 – 87).20 
Rajajee et al. performed a prospective blinded observational study on 65 patients in the 
ICU. All patients in the study had either had an EVD or intraparenchymal ICP monitor in 
situ. The authors used individual as well as mean ONSD values to account for possible 
fluctuation in the ICP during ONSD measurement. For the individual ONSD 
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measurements the median was 0.53 cm for ICP > 20 mmHg, and 0.4 cm for ICP < 20 
mmHg (p < 0.0001). An ONSD of 0.48 cm demonstrated a sensitivity of 96% and 
specificity of 94% for predicting ICP > 20 mmHg. The authors suggested that the optimal 
criteria for ONSD measurement should be validated internally.18 The same author later 
published a retrospective review of this data, aiming to assess the accuracy of ONSD 
measurement in patients with acutely fluctuating ICP. 73 patients were included in the 
review. ‘Acutely fluctuating ICP’ was defined as measurements above and below 20 
mmHg during the same ONSD measurement cluster or a change in ICP of > 10 mmHg, 
demonstrating that the specificity and positive predictive value of ONSD measurement 
declined when ICP fluctuated acutely, suggesting this may be due to a delay in reversal of 
the nerve sheath distension.51  
In  another study also based in the neurocritical care unit, Frumin and co-workers 
investigated 27 patients with invasively measured ICP. The optimal ONSD for predicting 
raised ICP (> 20 mmHg) in this study was 5.2 mm, with a sensitivity of 83.3% (95% CI 
= 35.9 – 99.6%), specificity of 100% (95% CI = 83.9 – 100%), positive predictive value 
(PPV) of 100% (95% CI = 48 – 100%) and negative predictive value (NPV) of 95.5% 
(95% CI = 77.2 – 99.9%).246 
Despite not providing diagnostic accuracy analysis, the study by Cammarata and 
colleagues which compared ONSD measurement in 11 TBI patients in the ICU with 10 
non-trauma ICU patients, demonstrating a significant difference between the two. The 
ONSD in control patients was 5.51 ± 0.32 mm, 5.52 ± 0.36 mm in head trauma patients 
with normal ICP (< 20 mmHg) and 7.0 ± 0.58 mm in head trauma patients with raised ICP 
(> 20 mmHg).245 
Using an ICP threshold of 20 cmH20, Kimberly and co-workers conducted a prospectively 
studied 15 adult patients. The authors performed 38 ocular ultrasound examinations, 
demonstrating a mean ONSD of 5.4 ± 0.49 mm in the group with ICP >20 cmH20, and 
4.4 ± 0.49 mm in the group with ICP < 20 cm H20, with a mean difference between the 
two groups of 1.2 mm. The study also supported an optimal cut-off value for ONSD > 5.0 
mm, which yielded a sensitivity of 88% and a specificity of 93% for detecting raised ICP.73 
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Also using an ICP threshold of 20 cm H20 measured during LP, Amini and colleagues 
reported an ONSD > 5 mm demonstrating a sensitivity and specificity of 100% for 
predicting ICP ≥ 20 cm H20. In this study of 50 non-traumatised patients,  36 patients had 
a normal ICP and 14 had increased ICP.247 
A blinded cross-sectional study conducted only in Chinese patients also used a lumbar 
CSF opening pressure of 20 cm H20. The study conducted by Wang et al included 279 
subjects and sought to identify potential factors influencing the relationship between 
ONSD and ICP. A much lower ONSD cut-off point of 4.1 mm, with a sensitivity of 95% 
and a specificity of 92% was reported in this study. The authors described a number of 
possibilities for the discrepancy between their findings and previous reports, 
acknowledging that little was known about the factors influencing the relationship 
between ICP and ONSD, ascribing the inconsistency of their lower ONSD values to 
differences in ethnicity and severity of illness.155 
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Table 4.5. Adult studies supporting the use of ultrasound measurement of the ONSD (invasive ICP measurement) 
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AUROC 0.965.  
ONSD cut-off value in Chinese 
population may be smaller than 
historical values reported in the 
Caucasian population.  ICP 
threshold of 20cmH20 is not the 
ideal value for comparison, and 
ICP measured via lumbar 





Summary – Ultrasound based measurement of the ONSD (invasive ICP measurement) 
These studies all support a significant relationship between ONSD and increasing ICP. 
The reported ONSD cut-off values however, range from 4.1-5.9 mm.16-20,73,154,155,245-247 
The   variable diagnostic accuracy reflects the discrepancy regarding optimal ONSD cut-
off values to detect raised ICP. Studies using an ICP threshold of 20 mmHg, describe 
ONSD cut-off values between 4.8 and 5.9 mm and three studies using 20 cmH20 as the 
ICP threshold, describe ONSD cut-off values between 4.1 and 5.5 mm. These findings 
underscore the fact that using different ICP thresholds in these studies may influence the 
variability of described ONSD cut-off values, but it certainly isn’t the only factor. The 
variation in individual baseline measurements and the difficulty in estimating the 
distensibility of the ONS are perhaps the the two most significant factors responsible for 
the poor specificity of this technique.252 The effect of treatment modalities, sedation, 
physiological parameters that influence ICP and site of measurement (some studies use 
LP opening pressures) likely also have some effect on the relationship between ONSD 
and ICP. The imaging modality used for ONSD measurement has been described as a 
significant factor. MRI and CT-based studies will therefore be discussed separately in the 












4.2.1.2. MRI-based studies 
 
MRI provides exquisite detail and multiplanar imaging of the ONS, but unfortunately 
limits simultaneous measurement of ICP. Relatively limited access to MRI and the 
necessity for patient transfer to specialised MRI suites are the major limitations with this 
modality. 
Using MRI measurements acquired before and after drainage of subdural collections, 
Watanabe et al studied 12 adult patients who underwent bur-hole drainage of subdural 
collections. A high ICP in this group was defined as > 20 cmH20. Coronal fat saturated 
T2-weighted, fast spin echo sequences of the orbit were performed, demonstrating a mean 
ONSD before surgery of 6.1 ± 0.7 mm, and after surgery of 4.8 ± 0.9 mm (p = 0.003). An 
acknowledged limitation of the study was the use of subdural pressure measurement, 
which may not be representative of ventricular pressure, due to resistance from 
membranes within the subdural space. The authors proposed an ONSD measurement of 
5.8 mm taken just behind the globe as the upper limit of normal, suggesting that a value 
of 6.0 mm would be indicative of raised ICP in this population.253  
The study by Geeraerts et al. described ONSD measurements which were strikingly 
similar to previous reports from the same group, using ultrasound to measure the ONSD. 
This retrospective analysis on 38 adult patients with severe TBI, reviewed T2-weighted 
turbo spin-echo, fat-suppressed images acquired on a 3 Tesla MRI scanner, and compared 
the results with 36 healthy volunteers. Both the ONSD and optic nerve diameter (OND) 
were measured and correlated with ICP, using a threshold of 20 mmHg for raised ICP. 
The mean ONSD in TBI patients with raised ICP was 6.31 ± 0.5 mm, in TBI patients with 
ICP < 20 mmHg was 5.29 ± 0.48 mm, and in healthy volunteers ONSD was 5.08 ± 0.52 
mm. The inter-observer variability was 0.11 mm, which is lower that reported in 
ultrasound-based studies than. The authors suggested an optimal ONSD cut-off of 5.82 
mm, with a sensitivity of 90% and specificity of 92% for predicting raised ICP.151 
In a unique study, Xie et al. attempted to predict lumbar CSF pressure using a formula 
which includes orbital subarachnoid space width (OSASW), BMI and mean arterial blood 
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pressure (MABP). This was a prospective observational, comparative study on 72 patients 
with neurological disease requiring a lumbar puncture, aiming to evaluate the OSASW as 
a surrogate marker for ICP and develop an MRI-based method for assessing CSF-pressure. 
The MRI sequences in this study were performed on a 3-Tesla machine in an oblique 
coronal plane, perpendicular to the optic nerve, with measurements performed at distances 
of 3, 9 and 15 mm posterior to the globe. MR imaging was performed 24 – 48 hours prior 
to the lumbar puncture being performed. The authors also performed a bi-spectral OCT 
analysis of retinal nerve fibre thickness and measured intraocular pressure (IOP) as other 
non-invasive markers of ICP. The ICP measurements in this cohort ranged from 3.7 
mmHg to 26.5 mmHg (increased ICP defined as > 20 mmHg). The authors performed a 
four-step analysis of the data to identify and control for potential confounding factors, i.e. 
body-mass-index (BMI) and mean arterial blood pressure (MABP), to best describe the 
relationship between the OSASW and ICP. Applying the described analytic models to the 
data, the authors derived formulas for assessing ICP, based on OSASW, BMI and MABP. 
These formulas were applied to a subset of 30 test group patients and found to be 
‘relatively precise’ in assessing ICP, concluding that MRI-assisted OSASW measurement 
could be a helpful non-invasive tool in ICP measurement.254 
In  a study examining astronauts after exposure to microgravity during a space mission, 
Kramer and colleagues retrospectively analysed images from 8 astronauts, acquired using 
a 3-Tesla MRI scanner. Aiming to demonstrate the spectrum of intraorbital and 
intracranial findings following such a mission, the authors analysed a number of 
parameters, similar to those observed in idiopathic intracranial hypertension (IIH) 
including: OND, posterior flattening of the globe, optic nerve protrusion, kinking of the 
optic nerve sheath, central T2 hyperintensity of the optic nerve and concavity of the 
pituitary dome. The mean ONSD measured at 4 mm behind the sclera was 6.2 mm ± 1.1 
(range 4.7 – 10.8), and the mean OND was 3.0 mm ± 0.5 (range 2.4 – 4.5) The measured 
ONSD values in this study were considerably larger than other reported MRI 
measurements.151 The retrolaminar OND and ONSD appeared larger in cases where there 
was associated optic nerve kinking and central T2 hyperintensity of the optic nerve. The 
abnormal findings of the OND and ONSD in this group certainly highlight their value as 




Table 4.6. MRI-based adult studies supporting the use of ONSD measurement 



























of 6.0 mm to 
predict raised ICP 
Not done Measurement of ONSD on T2-weighted 
MRI can potentially identify abnormally 
high ICP in patients with subdural 
collections. Also the demonstrated 
decrease in ONSD following 
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72 2013 3T-MRI Measurements 
were taken at 3, 9 
and 15 mm behind 
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mmHg.. 
 
Measurement of the ONSD at various 
distances from the globe using MRI scans, 
could provide a means for invasively 
assessing ICP.   










27 2012 3T-MRI The  ONSD 
ranged between 
4.7 – 10.8 mm, but 
no cut-off values 
were 
recommended 
Nil Exposure to microgravity induces changes 
in the morphology of the optic nerve and 
its sheath. The conclusions are difficult to 
generalise to a clinical setting 
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Summary - MRI-based studies 
The number of MRI studies are quite limited and the described ONSD cut-off value in 
these studies are 5.8 and 5.82 mm, to detect ICP above 20 cmH20 and 20 mmHg, 
respectively. Kramer,255 however described a range of values between 4.7 and 10.8 mm, 
which are substantially larger than any other reported ONSD values. The values described 
in the other three studies, however, fall within the range described in previous ultrasound-
based reports of 4.1 – 5.9 mm.16-20,73,154,155,245-247 Three of the four studies were performed 
using a 3 Telsa Machine, which raises the question of whether images on 1.5 Tesla 
machine are sufficient, however reports in children 238-240 and the study by Watanabe,253  
suggests that these images are adequate. The general agreement is that MRI-derived 
measurement has lower inter-observer variability and provides better detail of the 
















4.2.1.3. CT-based studies 
 
More recently there has been an interest in CT-based measurement of the ONSD. This is 
especially interesting, as CT scans are widely used as an early imaging modality in the 
acute care setting, to detect features of raised ICP.  
The first study to investigate ONSD measurement on the initial CT scan and outcome 
from severe TBI was prospective study involving 77 TBI patients admitted to the 
neurosurgical ICU. ONSD measured on initial CT scan correlated well with survival and 
Glasgow outcome score (GOS) at 6 months (p = 0.03). The mean ONSD in the non-
survivor group was 7.8 ± 0.1 mm versus 6.8 ± 0.1 mm in the survivor group. The optimal 
ONSD cut-off value was > 7.3 mm, with a sensitivity of 86.4% and a specificity of 74.6% 
for predicting mortality.256 
In large, prospective cohort study involving 400 adults with healthy eyes and optic nerves, 
Vaiman and colleagues investigated the correlation between ONSD, the eyeball and the 
optic canal. The study demonstrated that the ONSD varied between 3.65 mm and 5.17 
mm at different locations within the orbit (3 mm and 10 mm behind the globe 
respectively), and  suggested that measurement at a distance of 10mm, rather than 3mm 
posterior to the globe was more suitable, largely due to changes in the ONSD caused by 
eyeball movements.50  Use of the ONSD/ETD (Eyeball Transverse Diameter) index, with 
a normal described value of 0.19, is suggested as a means of improving the precision of 
this technique.257  
Aiming to determine whether ONSD measured on intial CT scan could predict 
neurological outcome, Kim et al performed a retrospective analysis of 98 comatose 
cardiac arrest patients. The study used the cerebral performance category [CPC] scale to 
measure neurological outcome in post-cardiac arrest patients. The additional predictive 
feature assessed on brain CT scan was the grey matter-to-white matter ratio (GWR). The 
intra- and inter-rater correlation for ONSD measured on CT scan was 0.888 and 0.833 
respectively. The mean ONSD was 5.57 ± 0.30 mm in the good CPC group and 6.29 ± 
0.46 mm in the poor CPC group (p < 0.001). A cut-off value of 5.87 mm for ONSD, 1.21 
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for GWR and 3 for Glasgow Coma Scale (GCS) most accurately predicted poor 
neurological outcome. The authors then adjusted these to gain a specificity of 100%, 
resulting in ONSD of 6.21 mm (sensitivity of 55.9%, 95% CI: 43.3 – 67.9%) and GWR 
of 1.23 mm (sensitivity of 83.8%, 95% CI: 72.9 – 91.6%). The authors concluded that 
ONSD measured on initial brain CT scan acquired within 24 hours of return of 
spontaneous circulation following a cardiac arrest, was associated with neurologic 
outcome, and combining ONSD and GWR potentially improved prognostic performance, 
compared to either variable used alone.258 
Use of a portable bedside CT scan was investigated by Sekhon et al. in a retrospective 
study of 57 adult patients aimed at assessing the relationship between ONSD measurement 
and ICP. All patients in the study had invasive ICP monitoring. The mean ONSD 
measurement was 6.7 mm (SD 0.75) and the mean ICP during CT was 21.3 mmHg (SD 
8.4).  The correlation between ONSD and ICP was significant (r = 0.74 p < 0.001). Using 
an ONSD cut-off value of 6.0 mm for predicting ICP > 20 mmHg demonstrated a 
sensitivity of 97%, specificity of 42%, positive predictive value of 67% and a negative 
predictive value of 92%. The authors performed a simple (model A) and multivariable 
linear regression models (models B and C). Model A demonstrated an R2 value of 0.56, 
model B (comparing CT predictors of raised ICP to invasive ICP readings) demonstrated 
an R2 of 0.21, while model C (addition of ONSD to CT predictors of ICP) improved the 
R2 value to 0.60. The ONSD measurements also demonstrated excellent agreement 
between raters of 0.89 (95% CI: 0.83 – 0.93) and between the right and left sides of 0.96 
(95% CI: 0.93 – 0.98). The authors concluded that ONSD measured on non-contrast, 
portable CT scan demonstrated a strong association with invasively measured ICP, was 
highly discriminatory of ICP > 20 mmHg, and demonstrated superior predictive value for 
increased ICP when compared to classical CT findings associated with raised ICP.153 The 
same author later published a separate retrospective study on 220 patients, involving 2 
centres, aimed at evaluating the relationship between ONSD measured on CT scan and 
mortality in patients with severe TBI. In a univariate analysis, a 1mm increase in ONSD 
demonstrated a twofold increase in odds of hospital mortality (OR 2.1, 95% CI: 1.4 – 3.2, 
p < 0.001). With multivariable adjustment, the relationship persisted (OR 2.0, 95% CI: 
1.2 – 3.2, p = 0,007). Linear regression indicated that ONSD was associated with increased 
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ICP (> 20 mmHg) in the first 48 hours, with and without multivariable adjustment. The 
authors determined that estimation of increased ONSD on initial CT scan in patients with 
severe TBI was associated with mortality, and also demonstrated a linear relationship with 
invasively measured ICP.259 
 
             







Table 4.7. CT-based adult studies supporting the use of ONSD measurement  















TBI 77 2013 CT scan 
(initial) 
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(portable
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20 mmHg 
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PPV of 67%, NPV of 
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TBI 220 2014  CT scan 
(porta-
ble) 
Nil Nil A 1mm increase in ONSD 
demonstrates twofold increase 
in odds of hospital mortality.  
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Summary – CT based studies 
Measurement of the ONSD on CT scan seems like a sensible approach, given the 
widespread used of CT as an early diagnostic modality in patients with raised ICP. The 
values described in the studies above range from 5.87 – 7.3 mm, when used to predict 
mortality from TBI and ICP above 20 mmHg. The study by Sekhon and colleague 242 
demonstrated that measurement of ONSD on bedside portable CT scan is a better predictor 
of raised ICP than classical CT findings associated with raised ICP. Definition of the ONS 
on CT scan is dependent on the imaging window used and not alwys as clear as the 


















4.2.2. Studies not supporting the use of ONSD measurement 
 
Blehar and co-investigators set out to compare visual with coronal axis measurements in 
27 healthy volunteers. The mean ONSD in the coronal view was 3.4 mm, which did not 
correlate (R: 0.51 – 0.69) with axial view measurements taken at various distances 
posterior to the globe (2, 3, 6, 9, 12 and 15 mm). The persistently larger axial view 
measurement was thought to be due to artefactual shadowing, which in the opinion of the 
authors was a likely explanation for the discrepancy in ONSD values described in the 
literature.260   
Assessing both unilateral and bilateral injuries, Strumwasser and co-workers investigated 
the accuracy of ONSD for detecting elevated ICP. This was prospective blinded study on 
10 trauma patients requiring ICP monitoring. Using data obtained from performing 114 
ONSD measurements, the authors demonstrated poor correlation of ONSD measurement 
with unilateral (R2 = 0.45, p < 0.01) and bilateral head injury (R2 = 0.21, p = 0.01). No 
significant difference in ONSD measurement was found pre- and post-ICP monitor 
insertion (p = 0.3). Despite a very small number of patients in the study, the authors 
concluded quite firmly that measurement of ONSD was not reliable enough as a basis for 
clinical decision-making regarding ICP assessment, and suggested the technique be used 
with caution.261 
Keyes and colleagues conducted a study on 57 adult volunteers to evaluate the relationship 
between increased ONSD and acute mountain sickness (AMS) related to rapid ascent. The 
authors found an increased ONSD at high altitude in subjects with AMS, but demonstrated 
no clear correlation between the variables they examined, i.e AMS symptoms, oxygen 
saturation, clinical response to oxygen and dexamethasone Lake Louise Score (LLS). The 
mean ONSD values of 0.4 cm in all subjects at baseline and 0.43cm in subjects with AMS 
symptoms 18 hours after ascent to 4300 m, while significantly different, are both relatively 
small measurements when compared to ONSD measurements described in other 
studies.17,18,19,20,24,253 The authors acknowledged this discrepancy and attributed this to 
differences in ascent profile and the scanning technique used in their study. They 
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concluded that raised ICP might not play a role in mild to moderate AMS, and that optic 
nerve sheath measurement with ultrasound might not be an adequate tool to investigate 
this issue.262   
Caffery and colleagues performed a prospective observational trial involving 51 adult 
patients presenting to the emergency department, who underwent an LP. In all cases the 
underlying aetiology was non-traumatic. Raised ICP was defined as an opening pressure 
on LP of ≥ 20 cmH20, and an ONSD cut-off value of ≥ 5 mm was defined as abnormal. 
24 (47%) of patients had opening pressures greater than 20 cmH20. There was a correlation 
between mean ONSD and opening CSF pressure (r = 0.53). The cut-off value of ≥ 5 mm 
yielded a sensitivity of 0.75 (0.53 – 0.9) and a specificity of 0.44 (0.25 – 0.65). The best 
cut-off value found by the authors was 5.5 mm, with a sensitivity of 0.58 (0.37 – 0.78) 
and specificity of 0.74 (0.54 – 0.89). The authors found that the cut-off value of ≥ 5 mm 
resulted in misidentification of 25% of patients with elevated ICP, and therefore 




Summary - adult studies not supporting the use of ONSD measurement 
The use of ONSD measurement as a non-invasive technique to predict raised ICP has 
also demonstrated limited diagnostic accuracy, using values > 5 mm to detect raised 
ICP resulted in misidentification of 25% of patients.(263) The issues involving 
measurement in a single plane, user variability and diagnostic modality all contribute 
to the inconsistency in reported diagnostic accuracy.72,193,241,242,260,261,263 The poor 




4.2.3. Discussion  
 
The majority of available literature evaluating the use of ONSD measurement in adults 
are from studies performed in the ED or ICU, using transorbital ultrasound. As a result, 
the reference standard against which ONSD was measured in these studies was often 
clinical or radiological evidence of raised ICP. The most commonly used ONSD cut-
off value was > 5mm.21-26,251,244  Not surprisingly this value is different in studies 
comparing ONSD to invasive measurement of CSF pressure, with a range of 4.1 -5.9 
mm.17,18,19,20,73,155,246,247 The difficulty in describing a universally acceptable reference 
range is largely due to variation in the definition of raised ICP, inter-observer 
variability, patient heterogeneity and a limited understanding of the elastic 
characteristics of the ONS. The use of MRI and CT imaging of the ONSD also further 
dilutes the value of this technique. Despite clear description of a strong relationship 
between ONSD and increasing ICP, the optimism surrounding this technique is blurred 
by the lack of consensus regarding optimal cut-off values. A pooled diagnostic odds 
ratio (OR) of 51 (95% CI: 22-121) for detecting raised ICP was described in a meta 
analyses, favouring the diagnostic accuracy of ONSD measurement.157 The best ONSD 
cut-off values for predicting raised ICP ranged between 5 - 5.9 mm  with a diagnostic 
OR of 25.68 (95% CI: 14.405 – 45.571) in a review by Moretti and Pizzi,31 which also 
described the upper ONSD limit in children as: 4 mm for patients aged < 1 year, 4.5 
mm for patients aged between 1 and 4 years old and 5 mm for patients aged > years. 
A research group was recently formed to establish an individual patient-level database 
and possibly define standardised ONSD cut-off values. This study group however 
excludes patients under the age of 18 years, but the results of this effort will be eagerly 
awaited.264  The specific limitations of ONSD measurement have been highlighted in 
a number of studies which have found the technique inadequate for detecting raised 
ICP.263, 260, 261,193,242,72,241 There are however no descriptions of any complications 
related directly to the use of transorbital sonographic measurement of the ONSD.31 
The lack of adequate specificity implies that a widened ONS may be present despite 
the absence of raised ICP, which is perhaps best explained in the work by Hansen and 
Helmke,154,252 describing the importance of the elastic characteristics or stiffness of the 
ONS as a factor determining the distensibility of the ONS. Improved understanding of 
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the elastic character of the ONS would certainly help with our interpretation of ONSD 
measurement and could help to differentiate a widened ONS due to individual baseline 
variation from one caused by raised ICP. The description of ‘hysteresis’ of the ONS 
by the same authors,252 further complicates our understanding of the ONS response, 
but raises very important issues fundamental to improving our understanding of this 
technique. An analysis of the dynamic response of the ONS would be helpful in 
deciphering the elastic nature of the ONS.  
The current literature highlights the need for a prospective study comparing ONSD to 
invasively measured ICP, defined according to an accepted treatment threshold. The 
ONSD study group is a promising initiative aiming to answer some of these questions 






Chapter 5.  
The relationship between optic nerve sheath diameter 
(ONSD) measurement and invasively measured intracranial 




As discussed in the preceding chapter, the need for a reliable, non-invasive technique 
to assess ICP in children is fundamental. 
The working hypothesis for this study was that ONSD measurement was a good 
surrogate marker of increasing ICP. ONSD was compared to the criterion standard of 
invasive ICP measurement in a large cohort of paediatric patients undergoing a 
neurosurgical procedure. Relevant physiological and demographic variables were 
analysed to best describe the the relationship between ONSD and ICP. Recommended 
age-related ONSD cut-off values that best predicted raised ICP28,29,30,32 were examined 
by selecting a range of ICP thresholds and analysing the relationship between ICP and 










5.2. Aims of the study 
 
Primary aim:  




 To identify and analyse confounding variables which may influence this 
relationship; 
 
 To examine the correlation between individual repeat measurements acquired 
in the same plane of the same eye as an assessment of repeatability of the 
technique; 
 
 To examine the correlation between mean ONSD measurements by the same 
observer at different timepoints as a marker of intra-observer variability; 
 
 To examine the inter-observer variability; 
 
 To examine correlation between the mean values in the sagittal and axial plane; 
 
 To examine correlation between the mean values acquired in each eye; 
 
 To determine the diagnostic accuracy of ONSD for detecting ICP above and 
below 20 mmHg (using 20 mmHg as a recommended treatment threshold),  
across the entire cohort of patients; 
 
 To examine the relationship between ONSD and ICP across the entire cohort 
of patients, at various ICP thresholds: 
 
 20 mmHg; 
 15 mmHg; 
 10 mmHg; 
 5 mmHg 
 
 To examine described age-related cut-off values for ONSD 28-30,32 : 
 
 ≤ 1 year old; 
 > 1 year old; 
 Children between 1 and 4 years old and those above 4 years old 
 
 To examine the use of patency of the AF as a reliable clinical marker for 





Study design: This study was a prospective, observational analysis of a paediatric 
cohort of patients who had direct measurement of ICP and concurrent ultrasound 
measurement of the ONSD.  
Reporting of data in this study was in accordance with the ‘strengthening the reporting 
of observational studies in epidemiology’ (STROBE) guidelines.265,266 (included as 
appendix I) 
Patients: Paediatric patients under the age of 14 years old treated at the Red Cross War 
Memorial Children’s Hospital, Cape Town, were eligible for enrolment into the study, 
if they were undergoing a surgical procedure for diagnostic or therapeutic purposes, 
and appropriate informed consent was obtained from the parents/caregivers to be 
enrolled into the study. The study was conducted between March 2013 and August 
2014. 
 
Inclusion criteria were: 
 Patients requiring invasive ICP monitoring, based on clinical/radiological 
findings; 
 
 Patients undergoing surgical procedures to treat suspected raised ICP, e.g. VPS 
insertion, evacuation of space occupying lesions and decompressive 
procedures; 
 
 Patients undergoing a neurosurgical procedure during which measurement of 
ICP could be performed safely, without negatively impacting the patients well-
being. 
 
Exclusion criteria were: 
 Patients who had ocular pathology, e.g. orbital trauma or cataract, which would 
preclude sonographic measurement of the ONSD; 
 
 Patients with signs of critically raised ICP, needing urgent surgery; 
 





 Patients receiving medication that would decrease ICP between ONSD 
imaging and ICP measurement, i.e. mannitol, hypertonic saline or steroids; 
  
 Time between ONSD imaging and ICP measurement exceeded 1 hour. 
 
Acquisition of the ONSD images did not influence the management of patients during 
the study, as this was purely an observational study.  
 
5.3.1. Acquisition of ONS images  
 
All ultrasound image-acquisition was performed by a single investigator, experienced 
in the use of ultrasound in neurosurgical patients. The investigator was blinded to the 
actual invasive ICP measurement at the time of image acquisition, as the ONSD 
measurements were always performed just prior to ICP measurement. While the 
investigator was blinded to actual ICP measurement, some bias may still have existed 
as the reason for patients requiring surgery was often known to the investigator. Repeat 
measurements of the ONSD were performed by two investigators, experienced in the 
use of transorbital ultrasound in 30 cases. Data from the examinations were used to 
test repeatability, intra- and inter-observer variability. 
In all cases, patients had undergone anaesthetic induction and were being mechanically 
ventilated. ONSD measurement was performed when haemodynamic parameters were 
most stable, just prior to insertion of the ICP monitor. All ONSD measurements were 
performed with patients in the supine position, with the head central and elevated to 
approximately 30 degrees. A clear film protective dressing was placed over both eyes 
to protect the globe from any potential injury. A layer of coupling gel was applied over 
the closed upper eyelid. To identify and image the ONS the ultrasound probe with the 
smallest available footprint – a 7-15 Mhz linear array probe with a ‘hockey stick’ 
configuration (See Figure 2.3) (Philips, Bothell, USA)  was used in all cases. 
Positioning of the probe over the eye was always carefully performed. This process 
included use of the middle finger and left hand to palpate the bony surface of the 
superior orbital rim, glabella and inferior orbital rim, to ensure that the application of 
the probe over the surface of the eyelid never exerted any pressure on the globe itself. 
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Recommended techniques for imaging of the ONS are discussed under ocular 
sonography (Chapter 3, Section B). 
The depth was set to 4 cm as a default setting and the magnification was then adjusted 
to provide the best quality of imaging for individual patients. The setting with the 
lowest MI and TI (as discussed below were always chosen). ONSD measurement was 
performed at an angle perpendicular to the optic nerve, at a depth of 3 mm posterior to 
the lamina cribrosa of the sclera surface.  
Three measurements were acquired in the sagittal plane, followed by clockwise 
rotation of the probe and acquisition of three measurements in the axial plane for each 
eye to ensure that the measurements could be appropriately analysed for correlation 
and accuracy. The mean binocular ONSD measurement for each patient was then 
obtained. This mean value was used for comparison with the invasively recorded ICP 
reading. The digital calliper measuring tool on the ultrasound machine was used to 
measure the ONSD. All images were saved in both JPEG and DICOM format on a 
secure external hard drive. The time of image acquisition, the length of the imaging 
and the time from ONSD measurement to ICP measurement were recorded. 
 
 
5.3.2. Measures to ensure safety of the technique 
 
The FDA/CDRH recommend using an MI < 0.23, and a  TI < 1.81 The 2006 revised 
statement by the EFSUMB (described in chapter 3) were used to guide our clinical 
safety practice when performing ocular ultrasonography.82,82  We adjusted the output 
settings on our machine to comply with these recommendations. In keeping with the 
ALARA (As Low As Reasonably Achievable) principle suggested in both the safety 






5.3.3. Haemodynamic and intracranial parameters  
 
Measurement of the ONSD was performed when the haemodynamic parameters were 
stable. The AF was palpated and described as open or closed. In cases where the AF 
was almost closed and barely palpable it was classified as closed. The systolic blood 
pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), pulse 
rate, respiratory rate, temperature, weight and end tidal carbon dioxide (ETCO2) were 
all recorded at the time of ONSD measurement. Any medication given after ONSD 
measurement was documented. If any of these agents given between ONSD 
measurement and ICP measurement were thought to affect the ICP, data from these 
patients were excluded from the analysis.  
 
5.3.4. Measurement of ICP 
 
All ICP measurements were recorded at the time of surgery. Intraparenchymal 
microsensor probes were generally inserted for ICP monitoring in TBI and 
craniosynostosis patients, using the initial and most stable reading from the monitor. 
A ventricular catheter was inserted if CSF drainage was required. For the remainder 
of patients requiring ventricular catheter insertion, CSF pressure was measured by 
connecting a CSF manometer to the ventricular catheter immediately after cannulating 
the ventricle. Particular care was taken not to lose any CSF between ventricular 
cannulation and connection of the manometer. The external auditory meatus was used 
as a reference point for ‘zeroing’ the CSF manometer readings. In cases where 
measurement was not possible or where the reading was not considered accurate, the 
data were excluded. 
Patients in whom intraparenchymal microsensors were placed had ICP recorded 
directly in mmHg, and patients with ventricular catheter placement had ICP measured 
at insertion of the catheter with a CSF manometer in cm H20. All ICP recordings were 
then converted to mmHg (1 mmHg = 1.36 cmH20) for uniformity and to allow 
comparison of data with similar published studies. 
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 5.3.5. Anaesthetic protocol 
 
The goal during each anaesthetic was to maintain normotension, normothermia, 
normonatremia, normocapnia and normovolemia. The agents used for induction, 
maintenance and analgesia differed depending on the procedure and anaesthetist. The 
effect of the anaesthetic on the ICP is always a challenging factor to quantify; 
especially volatile anaesthetics are known to cause cerebral vasodilation and a 
presumed increase in CBF. The effect of reduced smooth muscle tension in the vessel 
wall and subsequent vasodilation predominates when anaesthesia is maintained above 
1.0 MAC.269,270 ONSD image acquisition and ICP measurement were always 
performed during the same anaesthesia/procedure. Minimum alveolar concentration 
(MAC) of the volatile agent used was maintained as constant as possible between 
ONSD image acquisition and invasive ICP measurement. MAC values ranged between 
0.5 – 1.2 MAC. Use of positive end expiratory pressure (PEEP) was in accordance 
with the study by Pulitano et al,271 and age appropriate tidal volumes were used to 
maintain normocarbia. Selected physiological parameters recorded at the time of 
ONSD acquisition were included in a multivariate regression model to test for effect 
on the relationship between ONSD and ICP. 
Briefly, the anaesthetic for specific procedures involved: 
Hydrocephalus (VPS/EVD/ETV) 
 Induction was with sevoflurane, oxygen and air or nitrous oxide if no 
intravenous (IV) access was available. IV access was secured after induction. 
If IV access was present on arrival intravenous induction with propofol and 
remifentanil was performed 
 
 Maintenance was with isoflurane, oxygen and air. Analgesia consisted of an 
opiate based regime utilising a remifentanil infusion, fentanyl boluses and/or 
morphine with intravenous paracetamol 
 
Craniofacial/TBI 
 Induction was with sevoflurane, oxygen and air or nitrous oxide. IV access was 
secured after induction 
 
 Maintenance was with isoflurane, oxygen and air. Analgesia was administered 




Intracranial tumour resection 
 Intravenous induction was followed by a target controlled infusion of propofol 
for maintenance using the Paedfusor regime. Analgesia was achieved with a 
sufentanil infusion and IV paracetamol 
 
 
5.3.6. Sample size calculation 
 
Based on results from a local pilot study, the sample size estimate for comparison of 
means was calculated at 58 patients, to achieve 80% power, with an alpha of 5 (p < 
0.05). Based on the available literature the results were expected to differ according to 
age category, with described age-related variation at 1 year, between 1 and 4 years and 
old above 4 years old. Due to the variation and inconsistency in the ages of patients at 
presentation, and aiming to recruit around 58 patients into each of the 3 age categories, 
the total sample size for the study was set at 174 patients across all ages (≤ 14 years 
old). With an estimated 10% loss due to exclusion criteria and data loss, the study 
aimed to recruit 192 patients.  
 
5.3.7. Statistical analysis 
 
Data were tested for normality of distribution using the Shapiro-Wilks test. Parametric 
data were reported as means and standard deviations (SD) and non-parametric data 
reported as medians and interquartile ranges (IQR). All analyses were done using Stata 
IC version 12.0 (Stata Corporation LP, College Station, Texas, USA) statistical 
software. The general association between means of numeric variables was tested by 
applying either Pearson’s (PCC) or Spearman’s correlation coefficient (SCC), 
depending on normality of data distribution. Analysis of variance (ANOVA) testing 
was used to determine within and between group variances for the individual ONSD 
readings acquired per eye. 
Cronbach’s alpha statistic (α), which is a model of internal consistency, was used to 
test correlation and covariance for within observer testing, i.e. repeatability and intra-
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observer testing. Bland-Altmann analysis was used to test inter-observer agreement, 
using limits of agreement and mean differences. Statistical significance was set at p < 
0.05 and all significance testing was two sided. The independent Student t-test was 
used for comparing mean values, and the Wilcoxon sum rank test/Mann-Whitney test 
was used to compare median values. The diagnostic accuracy of ONSD measurements 
to detect ICP at various thresholds was described using sensitivity, specificity, positive 
predictive values (PPV), negative predictive values (NPV), area under the receiver 
operating characteristic (AUROC) curves and odds ratios (OR), as well as their 95% 
confidence intervals. 
The association between ONSD, ICP and various physiological parameters was tested 
in a univariate model. A multivariate regression model was then used to test the effect 
of the significant covariables on the relationship between ONSD and ICP. 
 
5.3.8. Study approval 
 
Approval for the study was granted by the Human Research Ethics Committee of the 
University of Cape Town (HREC REF: 674/2013). Approval for this study was also 
granted by the Research Committee of the Red Cross War Memorial Children’s 
Hospital. Written consent was obtained from parents/care-givers for all children 




The relationship between optic nerve sheath diameter 
(ONSD) measurement and invasively measured intracranial 
pressure (ICP) in children: Results, discussion and conclusion 
 
The results in this section are presented in four parts: 
6.1  General and demographic data, repeatability, observer variability and 
correlation testing; 
 
6.2  Relationship between ONSD and ICP over entire patient cohort; 
 
6.3  Relationship between ONSD and ICP according to historically described                                        
age-related thresholds; 
 
6.4  Using the anterior fontanelle (AF) as a clinical marker for defining OSND cut-
off values in children  
 
 
The results are followed by the: 
6.5  Discussion; 
 





6.1. General and demographic data, repeatability, observer 
variability and correlation testing 
 
6.1.1. Demographic data 
 
In total, ONSD measurements were performed on 195 patients. Data from 21 patients 
were excluded for the following reasons: 
i. Haemodynamic instability or time between ONSD imaging and ICP measurement 
exceeded 1 hour: n = 5 
 
ii. Physiological manipulation required to optimise ICP: n = 2 
 Hyperventilation to decrease PaCO2 
 Change in head position 
 
iii. ICP lowering agents administered between ONSD imaging and ICP measurement: 
n = 3 
 Steroid administration 
 Mannitol 
 Hypertonic saline 
  
iv. Incomplete datasets: n = 3 
 
v. Equipment failure: n = 1 
 
vi. Initial ICP measurement inaccurate: n = 7 
 Inaccurate catheter placement  
 Loss of CSF prior to measurement  
 
Data for the remaining 174 patients were available for the final analysis. In total 2,062 
out of a total of 2,088 (98.8%) ONSD measurements (acquiring 3 images in the axial 
plane and 3 images in the sagittal plane from each eye) were suitable for the analysis, 
with no measurement performed on 26 images because the image quality was 
considered suboptimal. 
Most excluded patient data (n =7) resulted from inaccurate measurement of ICP, 
mostly due to loss of CSF at the time of measurement during ventricular catheter 
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insertion. This exclusion was necessary to ensure the quality of the invasive ICP 
measurement. 
There were 52 (30.9%) females and 122 (69.1%) males, with a female to male ratio of 
0.43:1. The median age was 36 months (IQR 8-82). 56 (32.2%) children were ≤ 1 year 
old and 118 (67.8%) > 1 year old. The aetiology reflected the typical spectrum of 
neurological disease encountered in routine practice and included: hydrocephalus 
(52.9%), traumatic brain injury (17.2%), tumour (with or without hydrocephalus) 
(9.2%), craniosynostosis (9.2%), cystic malformation (6.9%), other (4.6%) [Chiari I 
malformation, spinal dysraphism, effusion and macrocephaly]. Demographic details 
are summarised in the table below. 
 
Parameter  Total ICP < 20 mmHg ICP ≥ 20 
mmHg 
Number (%)  174 100 (57.5%) 74 (42.5%) 
Age (median age 
in months) 
 36 (8 – 82) 16.5 
(IQR 4 – 72.5) 
59.5 
(IQR 21 -91) 
Aetiology     
 Hydrocephalus 92 (52.9%) 54 37 
 Traumatic brain injury 30 (17.2%) 20 10 
 Tumour 16 (9.2%) 0 16 
 Craniosynostosis 16 (9.2%) 9 7 
 Cystic malformation 12 (6.9%) 11 1 
 Other 
(Chiari I malformation, 
spinal dysraphism, subdural 
effusion, macrocephaly) 
8 (4.6%) 6 3 
Gender     
 Female 52 29 23 
 Male 122 71 51 
   







6.1.2. Intra-operative haemodynamic parameters 
 
Physiological parameters were recorded at the time of ONSD image acquisition, these 
parameters included: SBP, DBP, MAP, pulse rate, respiratory rate, end tidal CO2, 
weight and temperature. These physiological parameters were analysed in two groups 
according to ICP, < 20 mmHg and ≥ 20 mmHg (Table 6.2). The relationship between 
individual potential confounding variables, both physiological and demographic,  and 
ONSD were tested in a univariate model. Statistically significant variables were then 
entered into a multivariate logistic regression model.  
 
Physiological Parameter ICP < 20mmHg ICP ≥ 20 mmHg p – value 
Systolic Blood pressure (mean and SD in 
mmHg) 
81.77 (21.5) 88.94 (13.3) p = 0.02* 
Diastolic blood pressure 
(mean and SD in mmHg) 
49.48 (16.1) 51.65 (12.4) p = 0.39 
Mean arterial blood pressure 
(mean and SD in mmHg) 
62.87 (17.4) 67.05 (10.6) p = 0.1 
Pulse rate 
(mean and SD in beats per minute) 
121.75 (27.3) 114.91 (26.6) p = 0.14 
Respiratory rate 
(median and IQR in breaths per minute) 
21.00 (17 – 26) 19.00 (15.5 – 23) p = 0.89 
Temperature 
(median and IQR in degrees Celsius) 
36.40 (36.05 – 36.6) 36.20 (35.7 – 36.5) p = 0.06 
Weight 
(median and IQR in kilogr ANOVA) 
12.00 (IQR 5.27 – 
20) 
16.50 (IQR 9.2 – 
21.95) 
p = 0.15 
End tidal CO2 
(median and IQR in mmHg) 
4.10 (3.6 – 4.8) 4.40 (4 – 4.6) p = 0.26 
 
ICP 
(mean and SD in mmHg) 
11.68 (4.5) 23.87 (4.3) p < 0.001* 
ONSD 
(mean and SD in mm) 
5.08 (0.76) 6.28 (0.64) p < 0.001* 
 






6.1.3. Length of time for ultrasound image acquisition and time 
between image acquisition and ICP measurement 
 
The median length of time required to acquire ONS images in two planes from both 
eyes in this study was 116 seconds (IQR 95 - 129). The recorded median time from 
acquisition of ONSD images to ICP measurement was 23 minutes (IQR 15 - 32 
minutes).  
 
6.1.4. Testing for repeatability of individual measurements 
 
To evaluate the repeatability of ONSD measurement with transorbital ultrasound, the 
three individual measurements in the same plane of each eye (sagittal plane of the left 
and right eye and axial plane of the left and right eye) were compared using ANOVA 
testing, and Cronbach’s alpha statistic (CA). 
 
6.1.4.1. Sagittal plane of the left eye (LESag) 
A total of five hundred and nineteen ONSD measurements were acquired in the LESag, 
with a mean ONSD of 5.61 mm (SD 1) (Table 6.3). The measurements were repeated 
three times (LESag1, LESag2, LESag3), and the mean value was used for comparison 
with ICP.  
 




SD Min (mm) Max (mm) 
LESag 1 174 5.60 1 3.3 8.2 
LESag 2 174 5.57 1 3.2 8.0 
LESag 3 171 5.66 1 3.3 8.5 
Total 519 5.61 1 3.2 8.5 
 
Table 6.3. LESag values 
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Comparison of the individual measurements demonstrated excellent correlation (α = 
0.97, CA). No statistically significant difference was demonstrated between the 








6.1.4.2. Sagittal plane of the right eye (RESag) 
A total of five hundred and fifteen ONSD measurements were performed in the RESag, 
with a mean ONSD of 5.63 mm (SD 0.99) (Table 6.4). 
These results demonstrated excellent correlation between the measurements (α = 0.97, 
CA). There was no statistically significant difference between these readings 






















RESag 1 172 5.60 1.00 3.00 8.12 
RESag 2 173 5.64 0.98 3.00 8.00 
RESag 3 170 5.66 1.00      3.39 8.64 
Total 515 5.63 0.99 3.00 8.64 
 
























6.1.4.3 Axial plane of the left eye (LEAx) 
A total of five hundred and eighteen ONSD measurements were acquired in the LEAx, 
with a mean ONSD of 5.51 mm (SD 0.98) (Table 6.5). 
 








LEAx 1 174 5.49 0.97 3.0 7.58 
LEAx 2 173 5.50 0.96 3.4 8.0 
LEAx 3 171 5.55 1.00 3.0 7.87 
Total 518 5.51 0.98 3.0 8.0 
 
Table 6.5. LEAx values 
 
These measurements also demonstrated excellent correlation (α = 0.98, CA). Using 
ANOVA testing demonstrated no statistically significant variation between these 
readings (F = 0.21, 2 degrees of freedom, p = 0.81).(Figure 6.3) 
 
 














6.1.4.4. Axial plane of the right eye (REAx) 
In this plane, there were five hundred and ten ONSD measurements, with a mean 
ONSD of 5.59 mm (SD 0.96). (Table 6.6)There was excellent correlation between the 
individual measurements (α = 0.98, CA). There was no statistically significant 
difference between the individual readings in this plane according to ANOVA testing 
(F = 0.10, 2 degrees of freedom, p = 0.91). (Figure 6.4)  
 




SD Min (cm) Max (cm) 
REAx 1 173 5.62 0.97 3.0 8.0 
REAx 2 172 5.59 0.96 3.3 7.8 
REAx 3 165 5.58 0.96 3.5 7.5 
Total 510 5.59 0.96 3.0 8.0 
 
Table 6.6. REAx values 
 
 
















6.1.5. Testing for intra-observer variability 
 
To assess the intra-observer variability, repeat measurements of the ONSD were 
performed on 41 randomly selected patients at a later time, by the same observer, 
blinded to the original measurements. The mean ONSD at the first reading was 5.58 
mm (SD 0.85) and at the second reading was 5.56 mm (SD 0.84) (p = 0.92). The intra-
observer variability testing demonstrating excellent correlation (α = 0.99, CA) (Figures 
6.5 and 6.6). 
 
                  
 
Figure 6.5. Scatterplot for intra-
observer reliability  
 
             Figure 6.6. Box-whisker plot: 
measurement 1   (R1 AVE ONSD) and 
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6.1.6. Testing for inter-observer variability 
 
The test for inter-observer variability was performed by comparing the ONSD 
measurements performed independently by two observers experienced in the use of 
transorbital ultrasonography. Inter-observer variability was tested by comparing the 
mean ONSD measurements performed in 30 patients. The data were correlated using 
Pearson’s correlation coefficient (PCC) and Bland-Altman analysis to test for 
agreement between the observers. The mean ONSD measurement by observer 1 was 
5.63 mm (SD 0.071) and by observer 2 was 5.36 mm (SD 0.064). (Table 6.7 and Figure 
6.7)  
 








Observer 1 30 5.63 0.71 3.87 6.89 
Observer 2 30 5.36 0.64 3.47 6.31 
 















Figure 6.8. Bland-Altman plots. Outer solid lines represent limits of agreement (mean ± 1.96 times 
standard deviation, central line depicts the mean of differences). 
 
Bland-Altmann analysis revealed a mean difference between the two observers of 0.28 
mm (95% CI: 0.014 – 0.041), with limits of agreement between -0.44 – 0.99. (Figure 
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6.1.7. Correlation between sagittal and axial imaging 
 
The relationship between ONSD measurements performed in the sagittal and axial 
plane were examined, as well as their respective relationship with ICP. 
The average value of the three ONSD measurements performed in the sagittal 
(AVESag) and axial (AVEAx) plane of both eyes were calculated and the mean values 
in each plane were compared. (Table 6.8) 
The mean AVESag value was 5.62 mm (SD 0.96) and the mean AVEAx value was 
5.56 mm (SD 0.92) (p = 0.55, Student’s t-test).(Figure 6.10) The correlation between 
AVESag and AVEAx was excellent (r = 0.93, p < 0.001, PCC). (Figure 6.11) 
 




SD Min (mm) Max (mm) 
AVESag 174 5.62 0.96 3.39 8.00 
AVEAax 174 5.56 0.92 3.38 7.54 
 
Table 6.8. AVESag vs AVEAx ONSD measurements 
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6.1.8. Relationship between sagittal and axial plane measurements 
with ICP 
 
The image acquisition plane, which provides the optimal ONSD measurement for 
comparison with ICP is still quite unclear. The mean ONSD in each plane was 
therefore tested independently to describe their respective relationships with ICP. 
When correlated with ICP, AVESag demonstrated a slightly better relationship (r = 
0.66, p < 0.001, PCC) than AVEAx (r = 0.64, p < 0.001, PCC) (Figures 6.12 and 6.13). 
 
            
 Figure 6.12. Scatterplot mean sagittal 
ONSD vs ICP    
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6.1.9. Correlation between right and left eye measurements 
 
The correlation between ONSD measured in the right and left eye was tested using the 
mean values of three hundred and forty eight (sagittal and axial) measurements from 
the right left eye. The mean ONSD in the right eye was 5.61 mm (SD 0.95) and in the 
left eye was 5.55 mm (SD 0.97) (Table 6.9) 
 




SD Min (mm) Max (mm) 
Right 348 5.61 0.95 3.30 7.9 
Left 348 5.56 0.97 3.17 8.2 
 
Table 6.9. Right vs Left eye ONSD measurements 
 
 
Correlation of the ONSD measurements between the two eyes was excellent (r = 0.9, 
p < 0.001, PCC).(Figure 6.14) 
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6.2. Relationship between ONSD measurement and ICP over 
the entire cohort of patients 
 
The treatment threshold of 20 mmHg was used to evaluate the relationship between 
ONSD and ICP over the entire cohort of patients in this study. This relationship was 
further assessed at ICP thresholds of 15, 10 and 5 mmHg to evaluate relevant ONSD 
cut-off values for these ICP readings.  
 
6.2.1. ICP dichotomised at 20 mmHg for all patients 
 
There were one hundred and seventy four patients included in this study. The median 
age was 36 (IQR 8 – 82) months. 100 patients had an ICP < 20 mmHg, with a mean 
ICP reading of 11.68 mmHg (SD 4.5) and 74 patients had an ICP ≥ 20 mmHg, with a 
mean ICP reading of 23.87 mmHg (SD 4.33). The correlation between mean ONSD 
and ICP over the entire cohort was good (r = 0.66, p < 0.001, PCC).(Figure 6.15) 
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The mean ONSD in the group with ICP < 20 mmHg was 5.08 mm (SD 0.76), and in 
the group with ICP ≥ 20 mmHg was 6.28 mm (SD 0.64) (p < 0.001). (Figure 6.16) 
 
 
Figure 6.16. Box-whisker graph of ONSD for ICP < 20 mmHg (0), and ≥ 20 mmHg (1)  
 
The optimal ONSD cut-off point for detecting an ICP ≥ 20 mmHg was 5.5 mm with a 
sensitivity of 93.2%, a specificity of 74% , PPV of 72.6%, NPV of 93.7%, AUROC of 
0.84 (Figure 6.17), and an odds ratio (OR) of 39.3. (Table 6.16) 
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Applying a linear regression model to the data and controlling for age, revealed that 
with a baseline value of 4.03 mm, for every 10 mmHg increase in ICP the ONSD 
increased by 0.75 mm (95% CI: 0.62 – 0.88, R2 = 0.52, p < 0.001). In the group with 
ICP ≥ 20 mmHg, with a baseline value of 5.69 mm this change in ONSD was 0.24 mm 
(95% CI: 0.09 – 0.5, R2 = 0.03, p = 0.16) for every 10 mmHg increase in ICP. 
The effects of certain physiological and demographic variables were tested in a 
univariate analysis. Variables found to have a significant effect on the relationship 
between ONSD and ICP  were entered into a multivariate logistic regression model to 
adjust for this effect. In the unadjusted model, the OR was 39.28, for an ONSD value 
of 5.5 mm to detect an ICP ≥ 20 mmHg. In the adjusted model (adjusted for 
confounding variables, SBP, temperature, ETCO2, age, pulse and aetiology) the OR 
was reduced to 26.88. Even though the OR decreased in the adjusted model, the 
relationship between ONSD and ICP remained statistically significant in both the 
unadjusted and adjusted models (Table 6.10). 
 




p – value 
Unadjusted model for ONSD 
of 5.5 mm to predict ICP ≥ 20 
mmHg 
 39.28 14.28 – 108.03 p < 0.001 
Adjusted model for ONSD of 
5.5 mm to predict ICP ≥ 20 
mmHg 
 26.88 8.54 – 84.62 p < 0.001 
 SBP 1.00 0.97 – 1.03 p = 0.9 
 Temperature 0.48 0.24 – 0.98 p = 0.06 
 ETCO2 1.03 0.62 – 1.71 p = 0.92 
 Age 
(months) 
1.01 0.99– 1.01 p = 0.85 
 Pulse 1.00 0.98 – 1.02 p = 0.87 
 Aetiology 0.92 0.71 – 1.21 p = 0.57 
 
Table 6.10. Unadjusted and adjusted models for the relationship between ONSD and ICP  
 
Various aetiologies for raised ICP in children have been described in studies evaluating 
the usefulness of ONSD measurement.28,29,30-34,161 Aetiology was therefore analysed  
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to assess its effect on the ONSD measurement in this study. Results were reported in 
each aetiological group, and are summarised in Table 6.11.  
Aetiology Number (%) Age in months 
median (IQR) 
ICP in mmHg 
mean (SD) 
ONSD in mm 
mean (SD) 
Hydrocephalus 92 (52.9) 22.50 (5 -74) 16.9 (7.9) 5.4 (0.9) 
TBI 30 (17.2) 80.50 (55 -94) 16.4 (6.9) 5.8 (0.9) 
Tumour 16 (9.2) 66.50 (29 – 105.5) 23.4 (2.6) 6.4 (0.7) 
Craniosynostosis 16 (9.2) 15.50 (12 – 26) 17.5 (3.1) 6.1 (0.4) 
Intracranial cyst 12 (6.9) 0.55 (0.185 – 25) 13.0 (7.9) 4.8 (0.9) 
Other 8 (4.6) 60.00 (30 – 75.5) 9.7 (7.3) 5.4 (0.8) 
 
Table 6.11. Age, ICP and ONSD for specific aetiological groups 
 
The diagnostic accuracy of ONSD measurement for detecting ICP ≥ 20 mmHg in each 
aetiological group are summarised in Table 6.12. No diagnostic accuracy analysis was 




















































































Table 6.12. Diagnostic accuracy of ONSD for detecting ICP ≥ 20 mmHg in different aetiological 
groups. 
 




Seventy three patients had an ICP < 15 mmHg, with a mean ICP of 9.71 mmHg (SD 
3.54) and 101 patients had an ICP ≥ 15 mmHg, with a mean ICP of 22.04 mmHg (SD 
4.84). The mean ONSD in the group with ICP < 15 mmHg was 4.92 mm (SD 0.8), 
compared to 6.08 mm (SD 0.7) (p < 0.001) in the group with ICP ≥ 15 mmHg. The 
results and comparative p – values for the difference between groups with ICP above 
and below 15 mmHg are summarised in Table 6.13. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 174 36 (8 -82) 16.87 (7.5) 5.59 (0.9) 
< 15 73 (42) 17 (3 – 76) 9.71 (3.54) 4.92 (0.8) 
≥ 15 101 (58) 40 (14 - 82) 22.04 (4.84) 6.08 (0.7) 
p – value  p = 0.18 p < 0.001 p < 0.001 
 
Table 6.13. Age, ICP and ONSD for ICP dichotomised at 15 mmHg 
 
The optimal ONSD cut-off point for detecting ICP ≥ 15 mmHg was 5.29 mm, with a 












Thirty one patients had an ICP < 10 mmHg, with a mean ICP of 6.23 mmHg (SD 2.11) 
and 143 patients had an ICP ≥ 10 mmHg, with a mean ICP of 19.17 mmHg (SD 
6.1).The results and comparative p – values (comparing values above and below 10 
mmHg) for this group are summarised in the Table 6.14. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 174 36 (8 - 82) 16.87 (7.5) 5.59 (0.9) 
< 10 31 (17.8) 55 (1.6 – 82) 6.23 (2.11) 4.60 (0.7) 
≥ 10 143 (82.2) 34 (8 – 82) 19.17 (6.1) 5.81 (0.8) 
p – value  p = 0.58 p < 0.001 p < 0.001 
 
Table 6.14. Age, ICP and ONSD for ICP dichotomised at 10 mmHg 
 
The optimal ONSD cut-off point for detecting an ICP ≥ 10 mmHg was 5.04 mm, with 













Five patients had an ICP < 5 mmHg, with a mean ICP of 3 mmHg (SD 1.4) and one 
hundred and sixty nine patients had ICP ≥ 5 mmHg, with a mean ICP of 17.28 mmHg 
(SD 7.2). The mean ONSD in the group with ICP < 5 mmHg was 4.98 mm (SD 0.2), 
compared to a mean ONSD of 5.61 mm (SD 0.9) (p = 0.13) in the group with ICP ≥ 5 
mmHg. The results and comparative p – values are summarised in Table 6.15. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 174 36 (8 -82) 16.87 (7.5) 5.59 (0.9) 
< 5 5 (2.9) 76 (75 – 143) 3.00 (1.4) 4.98 (0.2) 
≥ 5 169 (97.1) 34 (8 – 81) 17.28 (7.2) 5.61 (0.9) 
p – value  p = 0.01 p < 0.001 p = 0.13 
 
Table 6.15. Age, ICP and ONSD for ICP dichotomised at 5 mmHg 
 
 
The optimal ONSD cut-off point for detecting ICP ≥ 5 mmHg was 5 mm, with a 
sensitivity of 72.8%, a specificity of 60% and an OR 4.01 (Table 6.16). 
 
The diagnostic accuracy of ONSD measurement for detecting ICP at thresholds of 20, 
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Table 6.16. Summary of ONSD cut-off values at different ICP values for all patients  
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6.3. Relationship between ONSD measurement and ICP: 
using described age-related thresholds for defining 
ONSD cut-off values in children 
 
The use of transorbital ultrasound as a non-invasive imaging tool to measure the 
ONSD in children is perhaps even more appealing than it is in adults. The limitation 
in children remains the disparity regarding the optimal cut-off values for different age 
groups. The available literature uses either 1 year of age 29,30 or 4 years of age28,31,32,33 
as suggested age-related thresholds for defining different ONSD cut-off values to 
detect raised ICP in children.  
This section of the study aims to evaluate the current age-related recommendations for 
ONSD cut-off values in children. The relationship between ONSD and ICP was 
assessed within the following age categories: 
6.3.1. Under 1 year old (≤ 1 year old); 
6.3.2. Above 1 year (> 1 year old);  
6.3.3. Subcategory analysis of children > 1 year: 
i. Ages between 1 year (> 1 year old) and 4 years (≤ 4 years old);  





6.3.1. Children under 1 year old (≤ 1 year old) 
 
The relationship between ONSD and ICP in this age group was analysed to describe 
the optimal ONSD cut-off value for detecting ICP at thresholds of 20, 15, 10 and 5 
mmHg. 
 
6.3.1.1. ICP dichotomised at 20 mmHg 
 
There were fifty six patients aged ≤ 1 year old. The median age in this group was 4.0 
(IQR 1 – 8) months. Forty six patients had an ICP < 20 mmHg with a mean ICP reading 
of 12.23 mmHg (SD 3.77) and 10 patients had an ICP ≥ 20 mmHg, with a mean ICP 
reading of 22.53 mmHg (SD 4.06). The results and comparative p – values are 
summarised in Table 6.17. There was good correlation between ONSD and ICP (r = 
0.65, p < 0.001, PCC) in this group.(Figure 6.18)  
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 56 4.0 (1 – 8) 14.07 (5.49) 4.9 (0.8) 
< 20 46 (82.1) 3.5 (0.75 – 8) 12.23 (3.77) 4.8 (0.8) 
≥ 20 10 ( 17.9) 7.5 (2 – 8) 22.53 (4.06) 5.6 (0.8) 
p – value  p = 0.095 p < 0.001 p = 0.003 
 





 Figure 6.18. Scatterplot of ONSD vs ICP for children ≤ 1 year old 
 
 
The mean ONSD in the group with ICP < 20 mmHg was 4.8 mm (SD 0.8) compared 
to 5.6 mm (SD 0.8) (p = 0.003) in the group with ICP ≥ 20 mmHg (Figure 6.19).  
 
 
Figure 6.19. Box and whisker plot of ONSD for ICP < 20 mmHg (0) and ICP ≥ 20 mmHg (1)  in  
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In children under the age of 1 year, the optimal ONSD cut-off point for detecting an 
ICP ≥ 20mmHg was 5.16 mm with a sensitivity of 80%, specificity of 76.1% , PPV of 
42.1%, NPV of 94.6%, an AUROC of 0.81 (Figure 6.20) and a diagnostic OR of 12.7 
(Table 6.20)  
 
 
 Figure 6.20. AUROC for ONSD to detect ICP ≥ 20 mmHg in children ≤ 1 year old. 
 
 
6.3.1.2. ICP dichotomised at 15 mmHg 
 
Thirty four children in this group had an ICP < 15 mmHg and 22 children had an ICP 
≥ 15 mmHg. The results are summarised in Table 6.18. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 56 4.0 (1 – 8) 14.07 (5.49) 4.90 (0.8) 
< 15 34 (60.7) 1.8 (0.5) 10.63 (2.96) 4.56 (0.8) 
≥ 15 22 (39.3) 7.5 (4 – 8) 19.40 (4.04) 5.50 (0.6) 
p – value  p < 0.001 p < 0.001 p < 0.001 
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The optimal ONSD cut-off value to detect an ICP ≥ 15 mmHg in this age group was 
4.97 mm, with a sensitivity of 86.4%, specificity of 82.4% and an OR of 29.6 (Table 
6.20). 
 
6.3.1.3. ICP dichotomised at 10 mmHg 
 
Twelve children in this age group had an ICP < 10 mmHg and 44 children had an ICP 







Table 6.19. Age, ICP and ONSD for ICP dichotomised at 10 mmHg in children ≤ 1 year old 
 
In the group of patients under 1 year of age, the optimal ONSD cut-off value for 
detecting an ICP ≥ 10 mmHg was 4.3 mm, with a sensitivity of 90.9%, specificity of 





ICP (in mmHg) N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in mm 
(SD) 
Overall 56 4 (1 – 8) 14.07 (5.49) 4.9 (0.8) 
< 10 mmHg 12 (21.4) 1 (0.11 – 3) 7.39 (1.44) 4.0 (0.5) 
≥ 10 mmHg 44( 78.6) 5 (1.63 – 8) 15.89 (4.71) 5.2 (0.7) 






6.1.3.4. ICP dichotomised at 5 mmHg 
 
Of the fifty six patients under 1 year old, the minimum ICP was 5 mmHg, so none of 
the patients in this group had an ICP <5 mmHg. 
The diagnostic accuracy of the ONSD cut-off values for predicting ICP readings of 20, 
































































≥ 5 Nil Nil Nil Nil Nil Nil Nil 
 
Table 6.20. ONSD cut-off values for predicting ICP readings of 20, 15, 10 and 5 mmHg in children 




6.3.2. Children above 1 year old (> 1 year old) 
 
One hundred and eighteen children over the age of 1 year were evaluated as a 
combined group in this section. The median age was 65.5 months (IQR 35 – 94), with 
a mean ICP of 18.19 mmHg (SD 7.94), and a mean ONSD measurement of 5.92 mm 
(0.7). There was good correlation between ONSD and ICP (r = 0.7, p < 0.001, PCC) 
in this age group. (Figure 6.21). The diagnostic accuracy of ONSD measurement was 
analysed at ICP thresholds of 20, 15, 10 and 5 mmHg. 
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6.3.2.1. ICP dichotomised at 20 mmHg 
 
In this age group fifty four patients had an ICP < 20 mmHg, with a median age of 64.5 
months (IQR 42 – 94) and a mean ICP reading of 11.22 mmHg (SD 5.02). Sixty four 
patients had an ICP ≥ 20 mmHg with a median age of 66.5 months (IQR 32.5 – 95) 
and a mean ICP reading of 24.08 mmHg (SD 4.37). The results and comparative p – 
values are summarised in Table 6.21.  
 
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD 
in mm (SD) 
Overall 118 65.5 (35 – 94) 18.19 (7.94) 5.92 (0.8) 
< 20 mmHg 54 64.5 (42 – 94) 11.22 (5.02) 5.36 (0.6) 
≥ 20 mmHg 64 66.5 (32.5 – 95) 24.08 (4.37) 6.38 (0.5) 
p – value  p = 0.96 p < 0.001 p < 0.001 
 
Table 6.21. Age, ICP and ONSD for ICP dichotomised at 20 mmHg in children > 1 year old 
 
 
The mean ONSD in the group with ICP < 20 mmHg was 5.4 mm (SD 0.6), compared 






Figure 6.22. Box and whisker plot of ONSD for ICP < 20 mmHg (0) and ICP ≥ 20 mmHg (1) in 
children > 1 year old 
 
 
The ONSD value with the best diagnostic accuracy for detecting an ICP ≥ 20 mmHg 
was 5.75 mm, with a sensitivity of 85.9%, specificity of 70.4% , PPV of 77.5%, NPV 
of 80.9% and AUROC of 0.78 (Figure 6.23). The diagnostic OR was 14.5. (Table 6.25) 
 
 
 Figure 6.23. AUROC for ONSD to detect ICP ≥ 20 mmHg in children > 1 year old 
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In this age group, thirty nine children had an ICP < 15 mmHg and seventy nine children 
had an ICP ≥ 15 mmHg. The data and comparative p – values are summarised in Table 
6.22. 
 
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 118 65.5 (35 – 94) 18.19 (7.94) 5.92 (0.7) 
< 15 mmHg 39 (33.1) 75.0 (55 - 98) 8.91 (3.85) 5.20 (0.63) 
≥ 15 mmHg 79 (66.9) 61.0 (30 - 92) 22.78 (4.81) 6.30 (0.59) 
p – value  p = 0.11 p < 0.001 p < 0.001 
 
Table 6.22. Age, ICP and ONSD for ICP dichotomised ay 15 mmHg in children > 1 year old 
 
The cut-off value for ONSD that best predicted an ICP ≥ 15 mmHg was 5.49 mm, with 















Nineteen children had an ICP < 10 mmHg and ninety nine had an ICP ≥ 10 mmHg in 
this age group. The results are summarised in Table 6.32. 
 
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 118 65.5 (35 – 94) 18.19 (7.94) 5.92 (0.7) 
< 10 mmHg 19 75.0 (57 – 116) 5.50 (2.2) 4.98 (0.5) 
≥ 10 mmHg 99 65.0 (32 - 94) 20.63 (6.1) 6.09 (0.7 ) 
p – value  p = 0.08 p < 0.001 p < 0.001 
 
Table 6.23. Age, ICP and ONSD for ICP dichotomised at 10 mmHg in children > 1 year old 
 
The cut-off value for ONSD that best predicted an ICP ≥ 10 mmHg was 5.2 mm, with 
















There were five children in this age category with an ICP < 5 mmHg and one hunded 
and thirteen with an ICP ≥ 5 mmHg. Table 6.24 summarises the results and 
comparative p – values in this group. 
 
ICP N (%) Median age 
in months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD 
in mm (SD) 
Overall 118 65.5 (35 – 94) 18.19 (7.94) 5.92 (0.7) 
< 5 mmHg 5 76.0 (75 – 143) 3.00 (1.4) 4.98 (0.2) 
≥ 5 mmHg 113 65.0 (34 – 94) 18.87 (7.42) 5.96 (0.8) 
p – value  p = 0.12 p < 0.001 p = 0.005 
 
Table 6.24. Age, ICP and ONSD for ICP dichotomised at 5 mmHg in children > 1 year old 
 
 
The cut-off value for ONSD that best predicted an ICP ≥ 5 mmHg was 5.1 mm, with 
a sensitivity of 81.4%, specificity of 60% and an OR of 6.6. (Table 6.25)
The diagnostic accuracy of ONSD measurement for detecting ICP at thresholds of 20, 



























≥ 20 5.75 85.9 
(75 – 93.4) 
70.4 
(56.4 – 82) 
77.5 










≥ 15 5.49 93.7 
(85.8 – 97.9) 
74.4 












≥ 10 5.20 88.9 
(81-94.3) 
84.2 













≥ 5 5.10 81.4 
(73 – 88.1) 
60 
(14.7 – 94.7) 
97.9 
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Table 6.25. ONSD cut-off values for detecting ICP at thresholds of 20, 15, 10 and 5 mmHg 
 
In children above and below the age of 1 year, the diagnostic accuracy of ONSD 
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ONSD cut-off values for ICP thresholds of  20, 15, 10 and 5 mmHg in children above 
and below the age of 1 year are summarised below in Table 6.36. 
 
ICP (in mmHg) Age threshold (in years) ONSD cut-off value (in mm) 
≥ 20 Overall 5.50 
 ≥ 1 5.75 
 < 1 5.16 
≥ 15 Overall 5.30 
 ≥ 1 5.49 
 < 1 4.97 
≥ 10 Overall 5.04 
 ≥ 1 5.20 
 < 1 4.30 
≥ 5 Overall 5.00 
 ≥ 1 5.10 
 < 1 N/A 
 














6.3.3. Subcategory analysis of children over the age of 1 year 
 
For comparison with the literature, a subgroup analysis of children over the age of 1 
year was performed to determine the validity of age at 4 years as an age-related 
threshold.28,31     
 
6.3.3.1. Children aged between 1 and 4 years (> 1 and ≤ 4 years old) 
 
Of the one hundred and eighteen children over the age of 1 year, thirty nine were > 1 
and ≤ 4 years old. The data for children in this age category are summarised according 
to ICP thresholds in Table 6.28. (A detailed analysis for this age category is included 
in the appendix, appendix II) 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 39 23 (17 – 35) 19.15 (6.04) 5.94 (0.6) 
< 20 mmHg 16 (41) 22.5 (16.5 – 34.5) 13.75 (4.3) 5.43 (0.6) 
≥ 20 mmHg 23 (59) 23 (18 – 35) 22.91 (3.8) 6.29 (0.4) 
< 15 mmHg 8 (20.5) 25.5 (16.5 – 43) 10.78 (4.1) 5.28 (0.6) 
≥ 15 mmHg 31 (79.5) 23 (18 – 34) 21.31 (4.3) 6.11 (0.5) 
< 10 mmHg 2 (5) 43  (42 – 44) 4.5 (0.7) 4.92 (0.4) 
≥ 10 mmHg 37 (95) 23 (17 – 34) 19.94 (5.1) 6.00 (0.6) 
< 5 mmHg 1 (2.5) 42 4 5.20 
≥ 5 mmHg 38 (97.5) 23 (17 – 34) 19.55 (5.6) 5.96 (0.6) 
 








The diagnostic accuracy of ONSD measurement for detecting ICP at the described 




























































16.7 (0.42 – 
64.1) 
0.93 (. - 1) Nil 
 




















6.3.3.2. Children over 4 years of age  (> 4 years old) 
There were seventy nine children over the age of 4 years in this study. The data for 
this age group are summarised according to ICP dichotomised at thresholds of 20, 15, 
10 and 5 mmHg respectively in Table 6.30. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 79 82 (65 – 108) 17.72 (8.7) 5.90 (0.8) 
< 20 mmHg 38 (48.1 ) 81.5 (63 – 107) 10.15 (5) 5.33 (0.6) 
≥ 20 mmHg 41 (51.9) 87 (69 – 125) 24.74 (4.6) 6.43 (0.6) 
< 15 mmHg 31 (39.2) 86 (63 -114) 8.43 (3.7) 5.22 (0.6) 
≥ 15 mmHg 48 (60.8) 82 (68 – 107) 23.72 (4.9) 6.34 (0.6) 
< 10 mmHg 17 (21.5) 76 (57 – 116) 5.61 (2.3) 4.99 (0.5) 
≥ 10 mmHg 62 (78.5) 89 (69 – 107) 21.04 (6.6) 6.15 (0.7) 
< 5 mmHg 4 (5.1) 109.5 (75.5 – 
148.5) 
2.75 (1.5) 4.93  (0.2) 
≥ 5 mmHg 75 (94.9) 82 (65 – 107) 18.52 (8.2) 5.96 (0.8) 
 
Table 6.30. Summary of patient data at different ICP thresholds 
 
The diagnostic accuracy of ONSD measurement for detecting ICP at the described 





















≥ 20 5.70 87.8 (73.8 – 
95.9) 
68.4 (51.3 – 
82.5) 
75 (60.4 – 
86.4) 
83.9 (66.3 – 
94.5) 
0.78 (0.69 – 
0.87) 
15.6 (5 – 
48.2) 




84.9 (72.4 – 
93.3) 
88.5 (69.8 – 
97.6) 
0.84 (0.75 – 
0.93) 
43.1 (10.9 – 
167) 
≥ 10 5.20 88.7 (78.1 – 
95.3) 
82.4 (56.6 – 
96.2) 
94.8 (85.6 – 
98.9) 
66.7 (43 – 
85.4) 
0.86 (0.75 – 
0.96) 
36.7 (8.8 – 
150) 
≥ 5 5.00 80 (69.2 – 
88.4) 




16.7 (3.6 – 
41.1) 
0.78 (0.53 – 
1) 
12 (1.6 - .) 
 




The optimal ONSD cut-off values for detecting ICP at thresholds of 20, 15, 10 and 5 
mmHg, within the various described age categories are summarised below in Table 
6.32. 
 
ICP in mmHg Age threshold (in years) ONSD cut-off values (in mm) 
≥ 20 Overall 5.50 
 ≤ 1 5.16 
 > 1 - ≤ 4 5.94 
 > 4 5.70 
≥ 15 Overall 5.30 
 ≤ 1 4.97 
 > 1 - ≤ 4 5.50 
 > 4 5.49 
≥ 10 Overall 5.04 
 ≤ 1 4.30 
 > 1 - ≤ 4 5.40 
 > 4 5.20 
≥ 5 Overall 5.00 
 ≤ 1 Nil 
 > 1 - ≤ 4 5.20 
 > 4 5.00 
 




6.4. The relationship between ONSD and ICP using patency 
of the anterior fontanelle (AF) to describe ONSD cut-off 
values 
 
The concept of using age limits in children to describe different cut-off values for 
ONSD has been analysed in the preceding section. The inconsistency of current 
recommendations contributes  to the difficulty in describing acceptable ONSD cut-off 
values in children. Using  patency of the AF as a clinical marker for defining different 
ONSD cut-off values may be a valuable alternative to approaching this challenge, and 
perhaps standardising these recommendations. Closure of the AF is quite variable, 
usually between 6 and 18 months, but the AF can usually be classified as either open, 
if reliably palpable or closed if not palpable. This section examined the validity of 
using patency of the AF as a physiological and anatomical indicator to define the 
diagnostic accuracy of ONSD measurement in children and also compared these 














6.4.1. Patients with an open anterior fontanelle (AF) 
 
Of the one hundred and seventy four patients included in this study, sixty two (35.6%) 
had an open AF, and one hundred and twelve (64.4%) had a closed AF. The diagnostic 
accuracy of ONSD for detecting ICP at thresholds of 20, 15, 10 and 5 mmHg were 
analysed within these two groups. 
 
The median age of the sixty two patients in this group was 5 months (IQR 1 – 8). 
Correlation between ONSD and ICP in the group of patients with an open AF was fair 
(r = 0.56, p < 0.001, PCC) in the (Figure 6.30). 
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6.4.1.1. ICP dichotomised at 20 mmHg 
 
In the group of patients with an open AF, forty eight had an ICP < 20 mmHg with a 
mean ICP reading of 12.29 mmHg (SD 3.7) and fourteen patients had an ICP ≥ 20 
mmHg with a mean ICP reading of 22.21 mmHg (SD 3.53) (Table 6.33).  
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 62 5 (1- 8) 14.52 (5.54) 5.0 (0.9) 
< 20 48 (77.4) 4 (0.88 – 8) 12.29 (3.7) 4.8 (0.8) 
≥ 20 14 (22.6) 8 (7 – 14) 22.21 (3.53) 5.8 (0.7) 
p – value  p = 0.003 p < 0.001 p = 0.001 
 
Table 6.33. Age, ICP and ONSD for ICP dichotomised at 20 mmHg in children with an open 
AF 
 
In the group with ICP < 20 mmHg, the mean ONSD was 4.8 mm (SD 0.8), and in the 
group with ICP ≥ 20 mmHg the mean ONSD was 5.8 mm (SD 0.7) (Figure 6.25). 
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In patients with an open AF, the ONSD cut-off value with the best diagnostic accuracy 
for detecting an ICP ≥ 20 mmHg was 5.16 mm with a sensitivity of 85.7%, specificity 
of 75%, PPV of 50%, NPV of 94.7%, an AUROC of 0.804 (Figure 6.32) and a 
diagnostic OR of 18.(Table 6.36) 
 
  




6.4.1.2. ICP dichotomised at 15 mmHg 
 
There were thirty six children in this group with an ICP < 15 mmHg and twenty six 
with an ICP ≥ 15 mmHg. The results and their comparative p – values are summarised 
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ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in mm 
(SD) 
Overall 62 5 (1 – 8) 14.52 (5.54) 5.0 (0.9) 
< 15 36 (58.1) 2.5 (0.5 – 7) 10.79 (2.96) 4.6 (0.8) 
≥ 15 26 (41.9) 8 (5 – 10) 19.7 (3.82) 5.6 (0.6) 
p – value  p = 0.002 p < 0.001 p < 0.001 
 
Table 6.34. Age, ICP and ONSD values for ICP dichotomised at 15 mmHg in children with an 
open AF 
 
In the group with an open AF, the optimal ONSD cut-off value for predicting an ICP 
≥ 15 mmHg was 5 mm with a sensitivity of 88.5%, specificity of 83.3% and an OR of 
38.3 (Table 6.36). 
 
 
6.4.1.3. ICP dichotomised at 10 mmHg 
 
There were twelve children in this group with an ICP < 10 mmHg and 50 with an ICP 








Table 6.35. Age, ICP and ONSD values for ICP dichotomized at 10 mmHg in children with an 
open AF 
 
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 62 5 (1 – 8) 14.5 (5.53) 5.0 (0.9) 
< 10 mmHg 12 (19.4) 1 (0.11 – 3) 7.39 (1.44) 4.0 (0.5) 
≥ 10 mmHg 50 (80.6) 6.5 (2 – 9) 16.24 (4.72) 5.2 (0.7) 
p – value  p = 0.009 p < 0.001 p < 0.001 
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In patients with an open AF, the optimal ONSD cut-off value for predicting an ICP ≥ 
10 mmHg was 4.4 mm, with a sensitivity of 86%, specificity of 75% and an OR of 
18.4.(Table 6.36) 
 
6.1.4.4. ICP dichotomised at 5 mmHg 
 
None of the patients with an open AF in this study had an ICP < 5 mmHg. 
 
The diagnostic accuracy of ONSD measurements for detecting ICP at thresholds of 























≥ 20 5.16 85.7 (57.2 – 98.2) 75 (60.4 – 
86.4) 






18 (3.84 - 
100) 


















18.4 (4.2 – 
79.5) 
≥ 5 Nil Nil Nil Nil Nil Nil Nil 
 
Table 6.36. Diagnostic accuracy of ONSD cut-off values for ICP at thresholds of 20, 15, 10 and 








6.4.2. Patients with a closed anterior fontanelle (AF)  
 
Of the one hundred and seventy four patients in this study, one hundred and twelve 
(64.4%) had a closed AF. The median age in this group was 70 months (IQR 41 – 97.5) 
with a mean ICP of 18.16 mmHg (SD 8.1) and a mean ONSD 5.9 mm (SD 0.8). The 
correlation between ONSD and ICP in patients with a closed AF was good (r = 0.7, p 
< 0.001, PCC). (Figure 6.33) 
 
 
Figure 6.27. Scatterplot for ONSD vs ICP in patients with a closed AF 
 
 
The diagnostic accuracy of ONSD measurement was analysed in children with a closed 
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6.4.2.1. ICP dichotomised at 20 mmHg  
 
Of the one hundred and twelve patients with a closed AF, fifty two had an ICP < 20 
mmHg with a mean ICP of 11.13 mmHg (SD 5.09). Sixty patients had an ICP ≥ 20 
mmHg with a mean ICP of 24.26 mmHg (SD 4.44). Table 6.37 summarises the results 
and comparative p – values. 
 





Mean ONSD in mm 
(SD) 
Overall 112 70 (41 – 97.5) 18.16 (8.1) 5.90 (0.8) 
< 20 mmHg 52 (46.4) 68 (45.5 – 96) 11.13 (5.09) 5.37 (0.6) 
≥ 20 mmHg 60 (53.6) 70 (38 – 101) 24.26 (4.44) 6.40 (0.6) 
p – value  p = 0.9 p < 0.001 p < 0.001 
 
Table 6.37. Age, ICP and ONSD values for ICP dichotomsied at 20 mmHg in children with an 
closed AF 
 
The mean ONSD was 5.37 mm (SD 0.6) in the group with ICP ≥ 20mmHg and 6.4 
mm (SD 0.6) in the group with ICP < 20 mmHg.(Figure 6.28) 
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In patients with a closed AF, the optimal ONSD cut-off value for detecting an ICP ≥ 
20 mmHg was 5.81 mm with a sensitivity of 85%, specificity of 73.1%, PPV of 78.5%, 
NPV of 80.9%, AUROC of 0.79 (Figure 6.29) and an OR of 15.4.(Table 6.41) 
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There were thirty seven children in this group with an ICP < 15 mmHg and seventy 
five with an ICP ≥ 15mmHg. Table 6.38 summarises the results and comparative p – 
values. 
 
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD 
in mm (SD) 
Overall 112 70 (41 – 97.5) 18.16 (8.1) 5.92 (0.8) 
< 15 mmHg 37 (33) 76 (57 – 98) 8.7 (3.8) 5.20 (0.6) 
≥ 15 mmHg 75 (67) 66 (33 – 93) 22.9 (4.9) 6.30 (0.6) 
p – value  p = 0.09 p < 0.001 p < 0.001 
 




In patients with a closed AF, the cut-off value for ONSD that best predicted an ICP ≥ 















There were nineteen patients in this group with an ICP < 10 mmHg and ninety three 
patients with an ICP ≥ 10 mmHg. The results and comparative p – values are 
summarised in table 6.39. 
  
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (SD) 
Mean ONSD 
in mm (SD) 
Overall 112 70 (41 – 97.5) 18.16 (8.1) 5.92 (0.8) 
< 10 mmHg 19 (17) 75 (57 – 116) 5.5 (2.2) 4.98 (0.5) 
≥ 10 mmHg 93 (83) 69 (35 – 97) 20.75 (6.2) 6.10 (0.7) 
p – value  p = 0.15 p < 0.001 p < 0.001 
 




In patients with a closed AF, the ONSD cut-off value that best predicted an ICP ≥ 10 
mmHg was 5.2 mm with a sensitivity of 89.2%, specificity of 84.2 and an OR of 44.3 
(Table 6.41). 












Five patients in this group had an ICP < 5 mmHg and one hundred and seven patients 
had an ICP ≥ 5 mmHg. Table 6.40 summarises the results and comparative                p 
– values in this group. 
 
ICP N (%) Median age in 
months (IQR) 
Mean ICP 
in mmHg (sd) 
Mean ONSD in 
mm (sd) 
Overall 112 70 (41 – 97.5) 18.16 (8.1) 5.92 (0.8) 
< 5 mmHg 5 (4.5) 76 (75 – 143) 3 (1.4) 4.98 (0.2) 
≥ 5 mmHg 107 (95.5) 67 (39 – 97) 18.9 (7.6) 5.97 (0.8) 
p – value  p = 0.15 p < 0.001 p = 0.005 
 
Table 6.40. Age, ICP and ONSD for ICP dichotomised at 5 mmHg in children a closed AF 
 
 
In patients with a closed AF, the ONSD cut-off value that best predicted an ICP ≥ 5 
mmHg was 5 mm, with a sensitivity of 86.9%, specificity of 60% and an OR of 10 
(Table 6.41). 
 
The diagnostic accuracy of ONSD measurement for detecting ICP at thresholds of 20, 























≥ 20 5.80 85 (73.4 – 
92.9) 








15.4 (6.1 – 
38.8) 
≥ 15 5.50 93.3 (85.1 – 
97.8) 










≥ 10 5.20 89.2 (81.1 – 
94.7) 










≥ 5 5.00 86.9 (79 – 
92.7) 








10 (3.8 – 
54.4) 
 
Table 6.41. Diagnostic accuracy of ONSD measurement for detecting ICP at various thresholds in 
children with a closed AF 
 
 
A summary of the results from assessing patency of the AF as a clinical marker for 
describing different ONSD cut-off values in children at ICP thresholds of 20, 15, 10 and 
5 mmHg, are provided in table 6.42. 
 
ICP threshold (in mmHg) Patency of AF ONSD cut-off value (in mm) 
≥ 20 Overall 5.50 
 Open AF 5.16 
 Closed AF 5.81 
≥ 15 Overall 5.30 
 Open AF 5.00 
 Closed AF 5.50 
≥ 10 Overall 5.04 
 Open AF 4.40 
 Closed AF 5.20 
≥ 5 Overall 5.00 
 Open AF Nil 
 Closed AF 5.00 
 





In this study the relationship between ONSD measurement and the criterion standard of 
invasive ICP measurement was prospectively examined in a paediatric group of patients. 
The aetiology demonstrated in this study reflects most of the commonly encountered 
paediatric neurosurgical conditions. Majority of the patients included in the study had 
hydrocephalus (52.9%), followed by TBI (17.2%), with tumors and craniosynostosis, each 
forming 9.2%. The benefit of a safe and reliable, non-invasive diagnostic tool for detecting 
raised ICP would be most beneficial in these clinical conditions. The concepts of 
repeatability and user variability remain core aspects of a suitable diagnostic modality. 
Specifically for transorbital ultrasonography, the most appropriate plane of imaging and 
the requirement for bilateral image acquisition remain relevant questions, especially with 
the paucity of data on this technique in children.34,156,272  
 
6.5.1. Repeatability, intra-observer variability and inter-observer variability  
Early work done by Ballantyne examined the observer variation in normal adult patients, 
demonstrating a median intra-observer variation of ± 0.2 – 0.4 mm and an inter-observer 
variation of ± 0.6 – 0.7 mm, reporting that standardisation of the technique reduced 
observer variability.29 A study analysing the correlation and agreement between two 
independent investigators, demonstrated good correlation (r = 0.83) and robust agreement, 
with mean differences close to zero between the two observers.27 A later study by the same 
group comparing the accuracy of ONSD measurement on ultrasound with MRI, 
demonstrated mean differences of < 5% (r ≥ 0.82, p < 0.001) between observers using 
MRI measurements, with increased inter-observer variability when using ultrasound 
measurements, with a mean difference of 9.4% (r = 0.62, p < 0.001).273 In a study 
evaluating ONSD on MRI, a mean difference between observers of 0.11 mm was 
described. 151  This difference was again shown to be larger when using ultrasound, with 
a median inter-observer difference of 0.25 mm described in an ultrasound-based study.20  
Different ultrasound probes and imaging techniques, i.e. axial vs coronal could impact on 
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ONSD measurement and inter-observer reliability with a reported adjusted difference of 
0.21 mm between observers, using a ‘standard probe’.274 Lagreze also described smaller 
coefficients of variation using MRI compared to ultrasound.231 
The factors described by Bauerle et al 27,273 were specifically addressed in the current 
study, by testing the relationship between repeat measurements performed in the same 
plane of the same eye, as a test for repeatability, and by testing intra-and inter-observer 
reliability. Three ONSD measurements were performed to allow adequate testing for the 
repeatability of measurements. The results from this study demonstrated excellent 
repeatability between each of the three ONSD measurements performed in the same plane 
of each eye (α = 0.97 – 0.98, CA). These findings were consistent in both the axial and 
sagittal plane. 
The intra-observer variability was excellent with mean ONSD values of 5.56 mm (SD 
0.85) and 5.58 mm (SD 0.84), from the first and second measurement respectively (α = 
0.99, CA). 
Inter-observer testing revealed a mean difference of 0.28 mm between observers. This is 
consistent with other described values of 0.2 mm and 0.34 mm.17,20,28,34,274 Correlation 
between the two observers was very good (r = 0.87, p < 0.001, PCC). These findings 
confirm that ONSD measurement on ultrasound yields consistent and acceptable intra- 
and inter-observer variability.  
 
6.5.2. Sagittal versus axial plane and correlation of values between right and left eye 
The ideal plane in which to measure the ONSD is still unclear. Axial images were usually 
obtained because of the ease of acquisition and the size of the ultrasound probes used. 
Early work by Hansen suggested that the axial plane provided more accurate 
measurements,154 but this was based on a relatively small sample size and did not factor 
in the benefit of the smaller footprint probes available today. As the ONS is not a perfect 
sphere,260,275 there is likely to be some difference in the measurements acquired in different 
planes, even if only minimal.  
162 
 
When evaluating the optimal plane for measurement, i.e. sagittal vs axial, this study 
demonstrated a slight advantage in the sagittal plane over the axial plane (r = 0.66 vs r = 
0.64). This difference however, was minimal, suggesting that measurement in either plane 
was an acceptable option. This study allowed adequate imaging in the sagittal plane 
largely because of the small footprint, high frequency probe used, a feature that 
differentiates it from most other studies which used high frequency probes with a larger 
footprint.23,30,33,234,241 Acquiring ONSD images in both planes and using the average of the 
two measurements, where possible, is likely the safer alternative, given the variety of 
probes available on the market. The image acquisition is also influenced by the 
unfavourable intromission angle of 180˚ to the ON which limits lateral resolution and in 
children the age of the child and size of the orbit also play an important role.34 
Differences between measurements obtained in the left and right eye were analysed and 
the results demonstrated a good correlation between ONSD values from both eyes  (r = 
0.9, p < 0.001, PCC). The benefit of using the mean value of ONSD measurements from 
both eyes however, remains a logical option based on described individual anatomical 
variation and the possibility of unilateral pathology.46,154 Given the findings from this 
study and the excellent correlation demonstrated between the three measurements, if the 
imaging quality is considered adequate, it may be acceptable to perform two 
measurements in each eye, in either the sagittal or axial plane (depending on the probe 
shape and size), and use the mean ONSD measurement for estimating ICP.  
 
6.5.3. Analysis over the entire cohort 
The linear relationship between ONSD and ICP has been described in a number of 
publications, recommending the technique as a simple bedside method for non-invasively 
assessing ICP.17,18,20,30,156,157 The diagnostic accuracy for raised ICP and the optimal cut-
off values are however, still unclear,31,157,261 making the relationship between ONSD and 




Specific limitations of this technique have hampered its widespread use; these include 
poor specificity, variation in the recommended ONSD cut-off values for predicting raised 
ICP, inter-rater variability and a limited understanding of the elastic properties of the 
ONS. The recommended ONSD cut-off value in adults ranges widely, from 4.1 – 5.9 
mm.17-20,73,155 In children there are recommended age-related upper limits of ONSD 
measurement. These age-related thresholds in children however, are inconsistent. Using 
age at 1 year to define different upper limits of normality for ONSD was supported by 
Ballantyne and Newman,29,30  while other authors recommend 4 years as the appropriate 
age-related threshold.28,32  In a review by Moretti and Pizzi, age categories of < 1 year old, 
1- 4 years old and > 4 years old were described with specific ONSD upper limits for each 
cateogory.31 
The issue of the optimal cut-off point is further limited by the sub-millimetric 
measurements involved in this technique, the wide variation in individual baseline values 
and limited knowledge about the elastic nature of the ONS.  
Evaluating the entire patient cohort in this study, demonstrated a mean ONSD in the group 
with ICP < 20 mmHg of 5.08 mm (SD 0.76), and in the group with ICP ≥ 20 mmHg of 
6.28 mm (SD 0.64) (p < 0.001). The optimal ONSD cut-off point in this study for detecting 
ICP ≥ 20 mmHg across the entire patient cohort, was 5.5 mm with good diagnostic 
accuracy revealing a sensitivity of 93.2%, a specificity of 74% and an OR of 39.3 (Table 
6.16). In a multivariate model adjusting for appropriate confounding variables, the OR 
was adjusted to 26.9 (Table 6.10), suggesting that the likelihood of detecting an ONSD 
measurement > 5.5 mm is 26.9 times higher in children with an ICP ≥ 20 mmHg than in 
children with an ICP < 20 mmHg. In a recent systematic review, Dubourg at al describe 
an even higher pooled diagnostic OR of 51, and recommended that a high sensitivity be 
favoured over a high specificity when using sonographic ONSD measurement to estimate 
ICP.157  It is worth noting that this review only included work done in adults. 
The number of patients included in the present study made it possible to perform both 
linear and logistic regression analyses. The described change in ONSD from a baseline 
diameter of 4.03 mm, was 0.75 mm  (95% CI: 0.62 – 0.88, R2 = 0.52, p < 0.001), after 
controlling for age as a confounding variable, for every 10 mmHg change in ICP. This is 
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useful in describing the relationship between ONS distension and increase in ICP. This 
relationship was weaker when ICP was ≥ 20 mmHg, i.e. 0.24 mm (95% CI: 0.09 – 0.5, R2 
= 0.03, p = 0.16) for every 10 mmHg change in ICP, suggesting a variation in the response 
of the ONS at different ICP thresholds. This is consistent with experimental data reporting 
that ONSD distensibility differed at certain ICP thresholds, and likely approached a 
maximum distensibility at higher ICP values.154,252 The described change in ONSD was 
0.25 mm for every 10 mmHg increase in ICP in the Hansen study, but no baseline diameter 
was described.154  These findings underscore the need to investigate the elasticity of the 
ONS as a marker of its stiffness or distensibility. 
The mean ONSD values, mean ICP values and relevant ONSD cut-off values in different 
aetiologies have been described in the results section (Table 6.11). Despite the sample size 
calculation in this study being based on age and not aetiology, the difference in 
aetiological groups is noteworthy. The higher cut-off values detected for children with 
craniosynostosis (6.17 mm) and lower cut-off values with intracranial cysts (4.5 mm) 
suggest that aetiology may have a role to play in determining the baseline ONSD and the 
response to an increase in ICP. While the mean ICP in these two groups was also 
significantly different (p = 0.047, Student’s t-test), this finding does raise the concern that 
ONSD cut-off recommendations should take aetiology into account. 
The diagnostic accuracy of ONSD measurements were also examined at ICP thresholds 
of 15 mmHg, 10 mmHg and 5 mmHg. The benefit of describing the ONSD at these ICP 
thresholds relates to the lack of uniformity regarding the optimal treatment threshold for 
raised ICP in children. Determining ONSD cut-off values at various ICP thresholds may 
provide additional diagnostic benefit in a clinical environment. 
The ONSD cut-off values with the best diagnostic accuracy for ICP ≥ 15 mmHg, ≥ 10 
mmHg and ≥ 5 mmHg described in this study were 5.3 mm, 5.04 mm and 5 mm 
respectively (Table 6.16). The diagnostic accuracy of ONSD was better for detecting an 
ICP ≥ 20 mmHg than it was for and ICP ≥ 5 mmHg (OR of 39.5 vs. 4.01). These values 
do support a significant overall relationship between ONSD and increasing ICP in this 
study. The paediatric literature evaluating ONSD measurement suggests that age is very 
likely a confounding factor.22,23,28,29,30,33  For this reason the historically described age 
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thresholds of 1 year old 29,30 and 4 years old 28,31  were used to subcategorise the data for 
further analysis and comparison to published data. 
6.5.1. Age-related threshold 
This study was unique in that it described ONSD cut-off values for various ICP thresholds 
and analysed the diagnostic accuracy of ONSD measurement for detecting ICP at 
thresholds ranging from 20 to 5 mmHg. This analysis was performed in the specific age 
categories, i.e. ≤ 1 year old and > 1 year old, and a subgroup analysis, i.e. ages > 1 to ≤ 4 
years and > 4 years old. 
≤ 1 year: the highest diagnostic accuracy for predicting ICP ≥ 20 mmHg was achieved 
with an ONSD cut-off  value of 5.16 mm, sensitivity of 80%, specificity of 76.1% and an 
OR of 12.7 (Table 6.23). At ICP thresholds of 15 and 10 mmHg, the optimal ONSD cut-
off values were 4.97 mm and 4.3 mm, respectively (Table 6.18). There were no ICP 
measurements under 5 mmHg in this age category. In children ≤ 1 year old, the diagnostic 
accuracy of ONSD measurement for detecting an ICP ≥ 15 mmHg was the strongest, with 
an OR of 29.6.   
> 1 to ≤ 4 years: 39 patients fell into this age category. The optimal ONSD cut-off value 
for detecting an ICP ≥ 20 mmHg was 5.92 mm, with a sensitivity of 82.6%, specificity of 
81.3% and OR of 20.6 (Table 6.23). At ICP thresholds of 15, 10 and 5 mmHg, the optimal 
ONSD values were 5.5, 5.4 and 5.2 mm respectively. Comparing these values to the next 
age category, i.e. > 4 years old, demonstrated ONSD values that were at odds with 
descriptions in the literature,31 as the optimal ONSD values described here were higher 
than those in the > 4 years old category, making this age category less useful as a 
recommendation. 
> 4 years old: there were 79 patients in this age category. The optimal ONSD cut-off 
value for detecting ICP ≥ 20 mmHg was 5.75 mm, with a sensitivity of 82.9%, specificity 
of 71.1% and an OR of 11.9 (Table 6.28). The ONSD cut-off values described in this age 
category were lower than in the previous category and similar to the results from children 
aged > 1 year (Table 6.29).  
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Children above the age of 1 year were analysed as a combined group. A total of 118 
children were included in this age category, with an optimal ONSD cut-off value of 5.75 
mm for predicting an ICP ≥ 20 mmHg, sensitivity of 85.9 %, specificity of 70.4% and an 
OR of 14.5.  
The ONSD cut-off values in this study appear larger than the described historic values in 
children,28, 29,30,33 but are similar to values reported more recently.34,237 A likely 
explanation for this finding is the high frequency, small footprint probe used, which 
provides excellent image quality, allowing clearer identification of the ONS borders.34,237 
The group of patients analysed in this study were under general anaesthesia, and were 
already due have a surgical procedure, which potentially biases the results, especially 
when comparing them to existing literature in children, which are almost entirely based 
on a clinical and image-based suspicion of raised ICP.23,28,29,30,31,32,33 The value of 5.75 
mm for predicting an ICP ≥ 20 mmHg in older children described in this study was 
consistent with some of the adult literature.17,20,31,151 
The described ONSD cut-off values at 15, 10 and 5 mmHg respectively are interesting 
findings, as they underscore the relationship between ONSD and increasing ICP, and 
possibly serve to flag patients at potential risk of developing raised ICP, in the correct 
clinical context. 
The relationship between ONSD and ICP in children below the age of 1 year appeared 
less robust than this relationship in children older than 1 year (r = 0.65 vs. r = 0.7). 
Interestingly though, the ONSD cut-off value of 4.3 mm for predicting an ICP ≥ 10 
mmHg, was consistent with values described by Newman et al,30 suggesting that some 
children in this group may become clinically symptomatic at an ICP above 10 mmHg. The 
best OR in children above and below the age of 1 year was described for detecting and 
ICP ≥ 15 mmHg (OR 42.9 and 29.6, respectively). 
The ONSD cut-off values at various ICP thresholds described in this study (Table 6.27) 
may be quite helpful in decision-making where patients are thought to be at risk of raised 
ICP. Even though 20 mmHg may represent a preferred treatment threshold, described in 
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children with TBI 111,276  in some centres, this threshold may differ in other centres treating 
children. 
 
v) Anterior Fontanelle (AF) 
Current literature in children suggests an age-related upper limit of ONSD to best detect 
raised ICP.28-34 The studies on which these recommendations were based however, largely 
compare ONSD to clinical and image-based estimates of ICP. The age-related ONSD 
values recommended for children can be quite useful, but the lack of uniformity makes 
the question of the appropriate upper limit of ONSD in children more difficult to 
determine. Data from this study support the use of age at 1 year as an appropriate age at 
which to describe different ONSD cut-off values for detecting raised ICP in children 
(Table 6.27). The difficulty however,  lies in using very different values for children that 
may be just above or below the age of 1 year, based on absolute age-related cut-off values. 
This can be quite problematic, given the physiological heterogeneity encountered in 
children of similar age. 
In an effort to simplify and improve the implementation of ONSD measurement in 
children, this study evaluated the patency of the AF as a clinical marker for determining 
the upper threshold of ONSD in children, and compared these findings to using age at 1 
year.  
The ONSD measurements listed in table 6.42 serve to demonstrate the significant 
difference between the two groups when using patency of the AF as a physiological 
threshold. This finding makes clinical and physiological sense as the open AF serves as a 
reliable clinical window for assessing ICP in neonates, and as such the measurement of 
ONSD in this group of patients is potentially less of a requirement. The presence of this 
natural window suggests that compliance of the bony skull is still present, making the 
displacement of CSF along the subarachnoid space somewhat unreliable, as explained by 
the Monroe-Kellie doctrine. Therefore using transorbital ultrasound ONSD measurement 
after the AF has closed is conceivably a physiologically more balanced approach, where 
the need for a reliable, non-invasive technique to detect raised ICP becomes more prudent.  
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In patients with an open AF the ONSD measurement that best predicted an ICP of ≥ 20 
mmHg was 5.16 mm, compared to 5.81 mm in patients with a closed fontanelle (p = 
0.007). This difference in ONSD cut-off values between the two groups was consistent at 
ICP thresholds of 15 and 10 mmHg. None of the patients in this study who had an open 
AF also had an ICP reading below 5 mmHg, hence no recommendation was made 
regarding the optimal ONSD cut-off for ICP < 5 mmHg in this group. The correlation 
between ONSD and ICP was also much better in children with a closed AF than those 
with an open AF (r = 0.7 vs r = 0.56, p < 0.001, PCC). 
In this study, the ONSD measurements in children with a closed AF compare very well 
with those for children over the age of 1 year old, for all the described ICP thresholds. 
(Table 6.47).  
 
ICP threshold (in 
mmHg) 
ONSD cut-off in children 
over 1 year old (in mm) 
ONSD cut-off in children 
with a closed AF (in mm) 
≥ 20 5.75 5.81 
≥ 15 5.49 5.50 
≥ 10 5.20 5.20 
≥ 5 5.10 5.00 
 
Table 6.43. ONSD cut-off values in children > 1 year old and children with a closed AF 
        
 
vi) Limitations 
This study was conducted on patients undergoing anaesthesia and a neurosurgical 
procedure. Despite efforts to control for possible confounding variables, this may bias the 
results when compared to studies performed on awake patients.  Assessment of the 
presence and patency of the AF remains a subjective clinical marker, albeit a reliable one. 
Palpation to determine whether the AF is normal, bulging or sunken could potentially vary 
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depending on patient position and examination technique; however, assessment of the AF 
is a fundamental clinical tool which all paediatric clinicians should be comfortable with. 
The use of this clinical assessment as a marker for describing ONSD upper limits may 
therefore be more helpful than using different values for children that are 1 year old versus 
those that are only slightly older. The described inter-observer variability in this study, 
while consistent with descriptions in the literature, needs to be factored into the 
interpretation of the findings. The ONSD values were compared to the initial and most 
stable ICP value at surgery, ideally the ICP trend  and repeated ONSD measurement 
















This study aimed to validate the technique of sonographic ONSD measurement  by 
comparison to directly measured ICP in a large cohort of paediatric patients. A good 
correlation between ONSD and ICP was demonstrated, with age at 1 year supported as an 
appropriate age at which to define different ONSD cut-off values for detecting raised ICP 
in children. Additionally, use of the AF was recommended as a more suitable clinical 
marker than age for defining these different ONSD cut-off values in children. Results from 
this study may likely serve as a platform for further work and recommendations using 





Chapter 7. Dynamic assessment of the ONS 
 
7.1. Theoretical background 
The current technique of ONSD measurement involves static ultrasound image acquisition 
to determine the size of the ONS.  The literature generally supports a good level of 
diagnostic accuracy for this technique.31,157,158 The static imaging technique however, 
provides limited information about the elasticity of the ONS and we therefore have little 
idea about the degree to which the ONS is distended from its baseline value. Hansen and 
colleagues describe a variation in the response of the ONS after exposure to different ICP 
levels and for different lengths of time, reporting that the tensile characteristics of the ONS 
have an influence on its response to change in ICP.50 The challenges when interpreting the 
ONSD measurement present mostly in cases where the sheath elasticity is low or where 
the ability to return to its baseline size is impaired.154,252 An improved understanding of 
the elastic nature and subsequent distensibility of the ONS which ultimately determine it’s 
reponse to change in ICP, would add significantly to our current understanding. A 
dynamic assessment of the ONS response under conditions of normal and raised ICP could 
provide valuable information regarding the elastic nature and distensibility of the ONS. 
Available literature describing a dynamic assessment of the ONS, generally compare the 
ONSD measured before and after a particular intervention or involve dynamic assessment 
of ocular blood flow using Doppler flow measurement. There are currently no data 
specifically evaluating the dynamic response of the ONS as a direct function of pulsation 
induced motion.  
The importance of evaluating the distensibility and elastic characteristics of the ONS were 
perhaps best emphasised in the study by Hansen.252  This was a post-mortem study 
performed on 10 optic nerve preparations, demonstrating that the ONS did not completely 
return to it’s baseline value after reduction in the SAS pressure, especially when the 
applied pressure exceeded 45mmHg. The investigators reported that the elastic properties 
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of the sheath influenced it’s capability to retract after exposure to high pressures, 
suggesting that the ONSD be interpreted with caution in certain circumstances due to an 
observation they call the ‘plastical deformation’ of the ONS.252 
The ‘dynamic change’ in ONSD due to hyperventilation induced CO2 fluctuation,was 
examined in 14 patients undergoing anterior cervical spine surgery. The study described 
a rapid response in ONSD caused by change in ETCO2. The investigators used a flexible 
clamp to hold the ultrasound probe in position in order to assess the dynamic response. 
The ONSD was measured at two seperate ETCO2 levels, i.e. 30 mmHg and 40 mmHg and 
at 1 and 5 minutes after reaching each of these levels, demonstrating a significant change 
between the ONSD values.277    
Drainage of CSF to reduce ICP and the subsequent change in ONSD measurement was 
reported by Moretti and Pizzi (20). This study was performed on 63 adult patients 
presenting with SAH (n = 34) or ICH (n = 29). The mean ONSD was 6.16 ± 0.57 mm in 
patients with an ICP > 20mmHg, and 5.0 ± 0.49 mm in the group with low ICP. The 
ONSD decreased from 5.89 ± 0.61 mm to 5 ± 0.33 mm in cases where CSF was released 
to control ICP. The optimal ONSD cut-off for identifying an ICP > 20 mmHg was 5.2 mm 
(sensitivity of 93.1%, specificity of 73.85%).20     
The use of mannitol to control increased ICP and the rate of ONSD variation was 
described in a study evaluating 13 severe TBI patients. The median ONSD prior to 
mannitol osmotherapy was 6.3 mm (6.1 - 6.7) versus 5.7 mm (5.5 – 6.3) (p = 0.0007) after 
mannitol administration, with a change in median ICP from a baseline of 35 mmHg to 25 
mmHg. TCD derived pulsatility indices also showed a significant decrease after mannitol 
administration. The authors conclude that change in ONSD can be useful to monitor 
interventions such as osmotherapy, but cautioned that there was some heterogeneity in the 
ONSD response to changes in ICP.278  
Using ultrasound analysis of the ONS, Whiteley and colleagues aimed to determine 
whether ICP increased to > 20 mmHg during robot-assisted laparoscopic radical 
prostatectomy (RARLP).279 Initial measurement of the ONSD was performed after 
induction of general anesthesia and then again at the end of the procedure. The mean 
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preoperative ONSD was 4.5 ± 0.5 mm, and the mean post-operative ONSD was 5.5 ± 0.5 
mm. A 10 mmHg rise in MAP resulted in a 0.023 mm increase in postoperative ONSD. 
Based on the ONSD findings, the authors concluded that ICP rises to > 20mmHg during 
RALRP surgery 279 A similar study, also during RALRP surgery demonstrated a 12.5% 
increase in ONSD after CO2 pneumoperitoneum and steep Trendelenberg positioning.280  
The change in ONSD related to a ‘quick’ change in ICP was studied in 18 ventilated, TBI 
patients. ONSD measurements were taken 30-60 seconds prior to suctioning, during 
suctioning and 30-60 seconds after suctioning of the endotracheal tube (ETT). ICP 
increased to > 20 mmHg in all patients during ETT suctioning, which was associated with 
an increase in the ONSD to > 5 mm, with both parameters returning to baseline after 
suctioning. Correlation between ONSD and ICP was good (R2 = 0.8). An ONSD cut-off 
value of  > 5.0 mm to detect ICP > 20 mmHg, demonstrated a sensitivity of 94%, 
specificity of 98%, confirming that ultrasonography of the ONSD is accurate to detect not 
only increased ICP but also immediate changes in ICP.281 
Aiming to describe the ONSD response to LP and its potential for detecting raised ICP 
Bauerle et al. studied 10 newly diagnosed patients with IIH, comparing the findings to 25 
control patients. The study describes an optimal ONSD cut-off value of 5.8mm and a 
significant reduction in ONSD after LP.156 
Karakitsos and colleagues reported that patients with an OND measurement of > 5.9 mm 
(sensitivity of 74% and specificity of 65%) and a 2.5 mm increase in OND between 
repeated measurements (sensitivity of 81% and specificity of 70%) had a high probability 
to progress to brain tamponade and death.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
The mean admission OND measurement of 4.84 ± 1.2 mm in the brain injury patients was 
significantly higher than that found in the control group at 3.49 ± 1.1 mm (p < 0.001).282 
A recent case report also describing a decrease in ONSD measurement in a patient with 
idiopathic intracranial hypertension (IIH), used measurements 30 minutes prior to and 30 
minutes after performing the LP. The opening and closing CSF pressures were measured 
via CSF manometry, demonstrating a ‘real-time’ reduction in ONSD, within 30 minutes 
of  LP induced pressure changes.283  
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The only other description involving dynamic assessment of the ONS, uses Doppler 
sonography to assess blood flow. A novel and promising dynamic technique described by 
Querfurth et al 284 involved color Doppler imaging to to measure arterial pulsatility indices 
for both the OA and CRA. By combining an adaptation of the Balliart 
ophthalmodynamometer, the VOP measured by CRV occlusion was combined with the 
arterial pulsatility indices to create an empiric index using venous and arterial parameters 
(VOP / Gosling Pulsatility Index [GPI]), which correlated better with absolute ICP (r = 
0.95, p < 0.005, ICP = 0.29 + 0.74 [VOP/ GPI (OA)]) than either parameter alone. Studies 
by the same group described ocular hemodynamics, using colour Doppler sonography to 
measure blood flow velocity and resistance indices in the OA, CRA and vODM and 
demonstrated a good relationship with actual ICP at mild to moderately elevated 
levels.285,286 
Using spectral Doppler imaging to determine the blood flow velocity in the CRA and 
CRV, Miller and co-workers demonstrated a reduction in these parameters in children 
with elevated ICP.287 
Data on this technique in children is quite sparse, as most studies evaluating the dynamic 
orbital and optic nerve blood flow using colour Doppler have been described in the context 
of diabetic retinopathy and other vascular eye disease.288,289 
A very promising study performed in patients with glaucoma, evaluated the relationship 
between ONSD and retrobulbar blood flow velocity using colour Doppler imaging (CDI). 
The authors demonstrated that there was a negative correlation between ONSD and 
retrobulbar flow velocities in glaucoma patients but not in healthy patients, concluding 
that the pressures determining the ONSD can have a significant impact on ocular blood 
flow. This study makes an interesting comment regarding the elasticity of the ONS and 





Summary – available literature describing dynamic assessment of the ONSD 
Change in ONSD measurements performed before and after interventions including 
hyperventilation, drainage of CSF, administration of mannitol , tracheal manipulation and 
LP appear to correlate well with the induced change in ICP.20,156,277,278,281,156 These 
reported changes in ONSD are useful in understanding the relationship between the ONS 
and ICP. The variability in the ONS response depending on the degree of ICP elevation, 
time of exposure and underlying elastic nature of the ONS described by Hansen, however, 
is still an important factor.50,68,154,252 The described techniques assessing dynamic ocular 
blood flow velocity using Doppler imaging are certainly promising,284-287,292 but as the 
authors acknowledge, still require validation in larger studies.  
The use of a dynamic imaging technique to detect pulsatile motion of the ONS and 
subsequent variation in this motion has not been described before. The possibility that 
such a technique could allow us some insight into the elastic nature and response of the 
ONS and evaluate differences in this elasticity at high and low ICP states is a promising 
one. The final section of this work describes a novel technique for analysing the pulsatile 









7.2. Relationship between pulsatile dynamics of the optic nerve sheath 






The relationship between ICP and optic nerve sheath diameter (ONSD) has been described 
by several authors, but with varying accuracy.17,18,20,30,156,157  As discussed in the previous 
section of this work, the relationship between the ONSD and ICP in children is important, 
but may involve a number of confounding variables. In children, age above or below 1 
year and patency of the AF play an important role in defining ONSD cut-off values. The 
elastic nature of the ONS however, remains a poorly understood factor in its response to 
changes in ICP. 
The final part of this study describes a novel, dynamic imaging analysis aimed at 
evaluating the motion of the ONS. An increase in ICP resulting in CSF displacement and 
subsequent distension of the ONS may lead to increased stiffness of the sheath. Analyzing 
ONS dynamics may then provide information that is complementary to the static 
measurements of ONSD. The objective of this part of the study was therefore to develop 
a method for analyzing in-vivo dynamic properties of the ONS using transorbital 
ultrasound imaging, and to investigate a possible relationship with ICP. This work was 
based on the idea that cardiovascular pulsation, (i.e. caused directly by arterial pulsation, 
or transmission of pulsatility through the CSF) induced motion of the ONS. Hypothesizing 
that the ONS becomes stiffer with increasing ICP, it was suggested that the transverse 
motion (i.e. perpendicular to the ONS) was more equal on each side of the sheath with 
high ICP compared to normal ICP. This was quantified by the absolute difference between 
the transverse pulsatile displacements on the left (dLeft) and right (dRight) side of the ONS, 
normalized by the sum of displacements. The value of this parameter indicates how much 
the ONS deforms during cardiovascular pulsation, and was therefore interpreted 
physically as a measure of deformability, and referred to as the deformability index. 








Figure 7.1 Formula for defining the Deformability Index Δ   
 
According to the hypothesis, since the ability to deform was inversely related to 
stiffness,297,298  this parameter was expected  to be smaller in the group with ICP ≥ 20 
mmHg when compared to the group with ICP < 20 mmHg. 
 
 




This was an exploratory research study, retrospectively analyzing data from 16 patients 
(age ≤ 14 years old) managed at the Red Cross War Memorial Children’s Hospital 
(RCWMCH) (Cape Town, South Africa). This study was nested within the parent study 
evaluating the relationship between ONSD and invasively measured ICP, and formed part 
of a collaborative research initiative between the Department of Neurosurgery at the 
University of Cape Town (UCT) and The Foundation for Scientific and Industrial 
Research (SINTEF), Trondheim, Norway.  Inclusion criteria were the same as described 





ii. Image acquisition 
 
A single investigator experienced in the use of transorbital ultrasonography acquired 
ultrasound images from both eyes, using a 15 MHz linear array probe (L15-7io, Philips, 
Bothell, USA). All images were acquired after the patients were anaesthetised, intubated 
and being mechanically ventilated, prior to insertion of the invasive ICP monitor. The 
image acquisition technique was the same as for measurement of the ONSD described in 
the earlier section of this work. The acquired dynamic/video images ranged in length from 
5 to 10 seconds per eye and were all acquired in the axial plane, for uniformity. The elbow 
of the investigators dominant arm was stabilised against the bed to further minimise 
movement during image acquisition. The machine settings were exactly the same as for 
the static image acquisition. Physiological parameters were recorded at the time of image 
acquisition as in the ONSD measurement technique. Ultrasound acquisition was 
performed when the haemodynamic parameters were stable. The image depth varied from 
3 to 5 cm, and spatial image resolution from 0.06 to 0.11 mm per pixel. The temporal 
resolution varied from 40 to 56 frames per second. 
 
iii. Image processing 
 
The anonymised imaging data were then processed by the engineers at SINTEF, and the 
analysis was performed according to anatomical specification agreed upon by the 
neurosurgery and engineering team. The acquired images were then magnified to the 
required size to identify specific regions on either side of the ONS complex before image 
processing.(Figure 7.2) The objective of the image processing was to utilise the high 
temporal resolution of the ultrasound images for analyzing motion related to 















   Figure 7.2 (a-c). Axial ultrasound image with different magnification.  
    Gray-scale pattern, tracked from time frame to time frame. 
 
 
1st step: Tracking 
 
Tracking was initialized by manually selecting a point at similar depths on both sides of 
the ONS in the first frame of each image sequence. Cardiovascular pulsation causes a 
motion dLeft on the left side of the ONS and a motion dRight on the right side of the ONS. 
Within a region of interest, the motion was automatically tracked over the entire sequence 
using normalized two-dimensional cross-correlation 293 from frame to frame for a region 
of interest (25 by 61 pixels) around the selected points (Figure 7.3). The ultrasound data 
were interpolated, and parabolic approximation 294 was applied to the correlation matrix 
for sub-pixel motion estimation. The motion component transverse to the nerve (i.e. in the 
horizontal image direction) was extracted for further analysis. Motion in this plane was 





Figure 7.3. Transorbital ultrasound images magnified, demonstrating dLeft  and dRight.          
Cardiovascular pulsation causes a motion dLeft on the left side of the ONS and a motion dRight on the right side. The 
rectangles show the regions used for tracking the motion. 
 
 
2nd step: Fourier analysis  
 
To extract the motion that was related to the cardiovascular pulsation, Fourier analysis 
295,296 was applied to obtain the frequency components of the transverse motion. The 
amplitude of the (fundamental) frequency component corresponding to the pulse rate of 
each patient was extracted for the left and right side of the ONS in each dataset, yielding 








Figure 7.4.  Illustration of the image processing, with a normal (< 20 mmHg) (left) and a high ICP (≥ 
20 mmHg) patient (right). Transverse pulsatile displacements as a function of time (vertical axis) after extraction of 
the motion component corresponding to the fundamental heart rate frequency. Note that the curves are strongly zoomed 
in compared to the images in the upper row (the squares are 25 pixels wide, pulsation is approx. 0.1 pixel) 
 
 
Figure 7.5. The same curves superimposed, with transverse pulsatile displacement along the vertical 









iv. Data analysis and statistics 
 
Since the data were retrospectively analyzed, we expected some out-of-plane motion., 
Despite stabilising the arm during image acquisition, there was likely still some movement 
which caused  this out-of-plane motion. This out-of plane motion is known to deteriorate 
correlation-based tracking. 293,294 To address and compensate for this issue, each dataset 
was graded with regard to acquisition-based artefactual movement, by one blinded 
operator. The grading was performed on a scale from 0-2 as described below:  
- Grade 0: steady acquisition, barely perceivable probe movement 
- Grade 1: perceivable probe motion, no loss of ONS appearance 
- Grade 2: distinct probe movement, with some loss of ONS appearance 
 
The motion analysis was run five times for the left and five times for right side of the 
ONS, in both eyes for each dataset (appendix III). This was to account for variability due 
to the manual initialization of the tracking region. The mean of the five displacement 
values was used as the motion estimate, and the variation was quantified using pooled 
standard deviation.  
Δ was calculated using equation (1), and one-sided Mann-Whitney U-test was used to 
statistically compare the two groups. Diagnostic accuracy was investigated using receiver 
operating characteristic (ROC) curves. The algorithm was then implemented in Matlab 











Sixteen patients were included in this analysis. The median age in the group with ICP < 
20 mmHg was 45 months (IQR 9.5 – 83), and the median age in the group with ICP ≥ 20 
mmHg was 80 months (IQR 35.5 – 122) (p = 0.3). Demographic and physiological data 
are summarised in table 7.1.  
 






A 120 M 78 
Posterior fossa tumour 
(hydrocephalus) 
28 
B 116 F 103 Hydrocephalus 33 
C 132 M 168 Trauma 32 
D 33 M 117 
Posterior fossa tumour 
(hydrocephalus) 
37 
E 24 F 92 Hemispheral tumour 20 
F 124 F 112 Hydrocephalus 30 
G 38 F 69 Hydrocephalus 26 
H 44 M 134 Hydrocephalus 36 
I 36 M 100 Tethered cord 10 
J 9 M 150 Hydrocephalus 8 
K 72 F 92 Chiari1malformation 5 
L 54 M 102 Spinal dysraphism 10 
M 144 M 80 Hydrocephalus 10 
N 10 M 120 Hydrocephalus 11 
O 8 M 130 Hydrocephalus 10 
P 94 M 103 Trauma 10 
   






A total of thirty two datasets were analysed from all sixteen patients initially, including 
those with out-of plane motion artefact.(Table 7.2) The transverse pulsatile displacement 
on each side of the ONS was assessed five times for each dataset (individual 
measurements included in appendix III). The mean value of transverse pulsatile 
displacement dLeft and dRight of the ONS for both eyes yielded a value of 8.3 (SD 0.54), 
measured in percentage of a pixel. 
Seven datasets were scored as grade 2 by the blinded operator and were subsequently 
excluded, leaving twenty five datasets for further analysis. The twenty five datasets were 
analysed according to ICP and divided into a group with ICP ≥ 20 mmHg, and a group 





















Patient Left eye Right eye 





A 8.12 8.99 0.05 7.34 1.55 0.65* 
B 7.76 8.75 0.06 9.88 9.23 0.03 
C 3.08 6.25 0.34* 2.73 3.42 0.11 
D 5.17 4.17 0.11 9.13 11.42 0.11 
E 15.37 13.58 0.06 13.74 17.44 0.12 
F 20.49 26.12 0.12 12.81 10.87 0.08 
G 4.78 11.23 0.40* 11.22 9.79 0.07 
H 6.76 5.37 0.11 3.51 5.97 0.26* 
Group with 
ICP < 20 
mmHg 
I 5.65 3.16 0.28 2.52 3.78 0.20 
J 4.01 1.83 0.37 5.70 3.63 0.22 
K 13.68 8.38 0.24 7.22 3.04 0.41 
K 7.98 4.60 0.27 9.12 11.78 0.13 
M 17.47 10.64 0.24 13.84 12.23 0.06* 
N 5.20 3.62 0.18 1.52 5.69 0.58 
O 15.94 16.83 0.03* 8.15 3.96 0.35 
P 4.90 5.61 0.07* 5.52 10.32 0.30 
 
   Table 7.2. Results from analysis of all included datasets 
    Transverse pulsatile displacements dLeft and dRight were measured in percentage of a pixel. 




The DI (Figure 7.1) of the ONS was then calculated for each dataset. The median DI was 
Δ = 0.11 for the group with ICP ≥ 20 mmHg, compared to Δ = 0.24 for the group with 
ICP < 20 mmHg (p = 0.002, Mann-Whitney U-test). Fig 7.6 shows a boxplot illustrating 






















 Patient Left eye Right eye 





A - - - 2 - - - 2 
B 7.76 8.75 0.06 
1 
9.88 9.23 0.03 
1 
C - - - 2 2.73 3.42 0.11 1 
D 5.17 4.17 0.11 1 - - - 2 
E 15.37 13.58 0.06 0 13.74 17.44 0.12 1 
F 20.49 26.12 0.12 1 - - - 2 
G - - - 2 11.22 9.79 0.07 1 





I 5.65 3.16 0.28 0 2.52 3.78 0.20 0 
J 4.01 1.83 0.37 
1 
5.70 3.63 0.22 
0 
K 13.68 8.38 0.24 1 7.22 3.04 0.41 0 
L 7.98 4.60 0.27 1 9.12 11.78 0.13 0 
M 17.47 10.64 0.24 0 - - - 2 
N 5.20 3.62 0.18 0 1.52 5.69 0.58 1 
O 15.94 16.83 0.03* 1 8.15 3.96 0.35 0 
P 4.90 5.61 0.07* 
0 
5.52 10.32 0.30 
1 
 
Table 7.3. Results from analysis where datasets with out-of-plane motion (grade 2) were excluded 
Transverse pulsatile displacements dLeft and dRight were measured in percentage of a pixel. 







Figure 7.6. Box and whisker plot: DI in ICP ≥ 20 mmHg (high ICP) and < 20 mmHg (normal ICP).   
 
Choosing a cut-off value of Δ = 0.121 demonstrated a sensitivity of 90% and a specificity 
of 87%. AUROC was 0.85 (95% CI: 0.61- 0.97). Three out of twenty five (12%) datasets 
would be wrongly classified using this cut-off value.(Figure 7.7) 
 
 
Figure 7.7. Receiver operator curve for a cut-off value of Δ = 0.121. 





The hypothesis of this study was that increased ICP leads to increased stiffness (i.e. 
reduced deformability) of the ONS. The aim of this study was therefore to develop a 
method for analyzing the pulsatile dynamic properties of the ONS as a marker of sheath 
stiffness, using transorbital ultrasound imaging, and to further investigate a possible 
relationship with ICP. The DI was formulated as an index to quantify the measurable 
displacement of the ONS during the captured pulsatile dynamic imaging of the ONS. The 
arterial architecture and it’s variability within the ONS, described in chapter 2, played an  
important role in the decision to perform measurements on both the left and the right side 
of the ONS, and calculate the relative motion, resulting in formulation of the DI.    
The most important finding of this study was the difference between the deformability of 
the ONS in the group with ICP ≥ 20 mmHg compared to the group with ICP < 20 mmHg, 
thus clearly supporting the hypothesis. ROC analysis demonstrated an AUC of 0.85, and 
suggested a cut-off value of Δ = 0.121, with lower values indicating ICP mmHg and higher 
values indicating ICP < 20 mmHg in this study.  
The main limitations of this study were the relatively small number of patients, and the 
fact that the analysis was performed retrospectively and not in a blinded fashion. The 
peadiatric cohort examined may warrant further validation of the technique in an adult 
study population. Further, although an exploratory research design was suitable for 
providing insight into the unknown relation between ONS motion and ICP, this may limit 
the ability to draw definite conclusions. Not withstanding these limitations, the difference 
between the two groups in this study appears convincing. These are however preliminary 
data and care should be taken not to overestimate the value for patient-specific diagnosis. 
It has been shown previously that the retrobulbar segment of the ONS is distensible and 
therefore dilates when ICP is increased.28,46,50,56  The technique of ONSD measurement 
has gained steady support as a non-invasive surrogate marker of raised ICP.16-34 However, 
measurement of the ONSD alone has not yet provided a completely accurate assessment 
of ICP, largely because the described optimal cut-off value for ONSD measurement in 
patients  has varied considerably.23,28-33,157,261 Data from SECTION C of this study 
supported the use of ONSD as a marker of raised ICP in children, but the described 
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variability in diagnostic accuracy underscores the need to explore the dynamic nature of 
the ONS. The noted variation in ONSD between studies is likely due to a more complex 
relationship between the ONS and ICP.154,252 The magnitude of ONS distension caused by 
the increase in pressure within the subarachnoid space may depend on a variety of factors, 
including the degree to which ICP is increased, the rapidity of the increase in ICP and the 
elastic characteristics of the ONS, all of which influence the capability for distension and 
retraction of the ONS.252 The relationship between ICP and nerve sheath distension is 
therefore integrally related to the stiffness of the sheath itself.   
This study investigated how pulsatile forces deform the ONS dynamically during the 
cardiac cycle, rather than the absolute distention related to the increased pressure within 
the ONS. This approach may contribute to an overall improvement in assessing the ONS 
in cases of suspected increased ICP, either as an individual marker or by augmenting the 
interpretation of ONSD measurements. The concept of pulsatile dynamics of the ONS 
could also improve specificity when compared to ONSD measurement alone, by 
differentiating between pathological distension of the ONS due to raised ICP and a 
widened ONS not related to raised ICP.  
Since the data were retrospectively analyzed, image acquisition was not optimized with 
respect to avoiding out-of-plane motion, which may deteriorate correlation-based 
tracking. To investigate the effect of the out-of-plane motion, we also processed the 
excluded datasets. We found that if all datasets were included (Table 7.2) the median of 
the group with ICP ≥ 20 mmHg and the group with ICP < 20 mmHg would still be 
significantly different (p = 0.03). However, the AUC would be reduced to 0.69 (95% CI: 
0.46-0.87), and 7 out of 32 datasets (22%) would have been wrongly classified. The 
example in Fig 7.8, shows the influence of out-of-plane motion for the (excluded) right 
eye dataset of patient A. In this dataset, a clear out-of-plane motion occurs at 
approximately 3 seconds into the sequence. An option for this dataset might therefore be 
to constrain the analysis to the period from 4 to 10 seconds. Instead, we chose to let one 
blinded operator grade the datasets, and exclude those interpreted to have extensive out-
of-plane motion (grade 2). Although improving the quality of the study, the grading is to 
some extent subjective, with no definite cut-off. Indeed, some out-of-plane motion could 
still be seen in some of the remaining images (grade 1), and might therefore still be an 
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explanation to why the approach failed for some of the remaining datasets (12%). The 
possibility of minimizing out-of-plane motion by further stabilisation of the image 
acquisition technique should be taken into account in protocols for future studies.  
Also, the calculated displacements were small, and extracted by extensive spatial (region 
of interest window) and temporal (Fourier) averaging. Accuracy, reproducibility and 
possible technical refinements of this novel ultrasound processing method should be 
further studied. Finally, it could be of interest to consider additional information, e.g. 
longitudinal motion, phase content of the Fourier transform (i.e. delay between motion at 
left and right side of the nerve) and perhaps other motion components than the 





Figure 7.8. Illustrating the effect of out-of-plane motion (patient A, right eye)  
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The upper row in Figure 7.8. shows the ultrasound image sequence at 2, 3 and 4 seconds into the sequence. The 
appearance of the ONS at 3 seconds is clearly different compared with the appearance at 2 and 4 seconds, thus scoring 
an out-of-plane motion grade 2 (and hence excluded from the analysis). Lower: transverse motion on left (blue line) and 
right side (black) of the ONS (before extraction of the heart rate frequency component). At approximately 3 seconds, 
the processing method interpreted the out-of-plane motion as if the left side had a large pulsatile motion, with duration 








This study illustrates the feasibility of non-invasive transorbital ultrasound for assessing 
optic nerve sheath pulsatile dynamics. The preliminary results demonstrate a significant 
difference between patient groups with ICP ≥ 20 mmHg versus those with ICP < 20 
mmHg, and thus support the suggested hypothesis of a relationship between deformability 
of the ONS and ICP. The suggested measure may therefore be relevant as a non-invasive 
marker of raised ICP and contribute to our understanding of the ONS response  to changes 






Chapter 8. Perspective and future direction 
The use of transorbital ultrasound measurement of the ONSD as a surrogate marker of 
ICP is certainly an elegant technique. The major shortcoming in children is the lack of 
consensus regarding age appropriate cut-off values, mostly due to the lack of studies 
comparing ONSD to directly measured ICP. This work has specifically addressed this 
shortfall in the literature by comparing these two parameters. The finding that age at 1 
year is a more appropriate age at which to define different ONSD cut-off values, is 
important as it demonstrates that there are a different set of values best suited to patients 
before and after a certain threshold. The previously described age categories of   >1 to ≤ 
4 years and above 4 years of age, were found to be of less clinical value in this study. This 
finding may serve to clarify this discordance in the literature. This study also described 
the best diagnostic accuracy for a range of appropriate ICP thresholds which, in children 
may be of specific benefit. 
Compliance of the skull differs significantly in patients with an open AF compared to 
those where the AF has closed. This physiological concept, well described by the Monroe-
Kellie doctrine served as the basis for evaluating use of the AF as a more reliable clinical 
marker for defining different ONSD cut-off values in children. Using patency of the AF 
for describing ONSD cut-off values in children was a further recommendation of this 
study.  
All current published work assessing the ONS as a marker of ICP, have been based on 
static measurements of the ONSD. These measurements have generally demonstrated a 
strong relationship with ICP and change in ICP, though the diagnostic accuracy for 
detecting raised ICP has varied considerably. The reasons for this variability have been 
described and some of these issues in children have been addressed in this study. The 
limited specificity of this technique has been suggested as a factor preventing its 
widespread use.  
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Analysis of the pulsatile dynamic response of the ONS as a marker of its stiffness in states 
of normal and raised ICP has not been described before. The dynamic analysis in the final 
part of this work uses relative motion on both sides of the ONS, referred to as the DI, to 
describe the pulsatile motion of the ONS. This index has potential to improve our overall 
understanding of the ONS as a marker of ICP, and possibly improve the accuracy of this 
technique by differentiating a widened ONSD that is a normal variant from one that is due 
to raised ICP, based on the stiffness of the ONS.    
Future work will involve testing the validity of the DI in a larger prospective, blinded 
study.This study should ideally include adult and paediatric patients and should allow 
analysis over a spectrum of normal and raised ICP values. The value of a laboratory-based 
study, using cadaver models to evaluate the ONS response and test the dynamic 
parameters described in this study would be an ideal scientific environment.  
Use of a combination of appropriate non-invasive techniques is an appealing option to 
potentially improve their diagnostic accuracy. In this light, future planned work involves 
combining the measurement of the ONSD, with other features detectable on transorbital 
ultrasound, especially bulge of the optic nerve head (described in raised ICP) 238,255 and 
measurement of the optic nerve diameter (OND) to try and better define the physiological 
and morphological changes in the ONS during increases in ICP. Combining the dynamic 
assessment technique described in this work with standard ONSD and possibly with 
Doppler flow assessment of the occular vessels 285,286 may improve the accuracy of this 
promising diagnostic technique. The use of three dimensional imaging of the ONS is an 
interesting option which may in time help to better delineate the ONS.290,291 The option of  
measuring the IOP and interpreting this together with data from the ONS may also serve 
to provide a more holistic picture of the effect that raised ICP has on the ONS complex. 
The value of repeat ONSD measurement in individual patients, before and after treatment 
may also serve to provide reference ranges for individual patients which would make it 
more applicable in monitoring certain groups of patients, especially those with V/P 
shunts.234  
The eye and its ONS complex, apart from its primary role as an organ of vision, can also 
provide valuable information about ICP, and  the search to better understand and interpret 
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the changes that occur in this anatomical structure during changes in ICP remains a 
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Details of analysis in age categories 1 to 4 years old and above 4 year  old 
i. Children aged 1 to 4 years old (> 1 and ≤ 4 years old) 
i) ONSD for ICP dichotomised at 20 mmHg 
 
Thirty nine children were > 1 and ≤ 4 years old, the median age in this group was 23 
months (IQR 17 - 35). Sixteen patients had an ICP < 20 mmHg, with a mean ICP 
reading of 13.75 mmHg (SD 4.34), and twenty three patients had an ICP ≥ 20 mmHg, 
with a mean reading of 22.91 mmHg (SD 3.77) (Table IIa). The correlation between 
ONSD and ICP in this age group was good (r = 0.65, p < 0.001, PCC) (Figure IIa). 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 39 23 (17 – 35) 19.15 (6.04) 5.94 (0.6) 
< 20 mmHg 16 (41%) 22.5 (16.5 – 34.5) 13.75 (4.3) 5.43 (0.6) 
≥ 20 mmHg 23 (59%) 23 (18 – 35) 22.91 (3.8) 6.29 (0.4) 
p – value  p = 0.95 p < 0.001 p < 0.001 
 
Table IIa. Age, ICP and ONSD values for ICP dichotomised at 20 mmHg in patients aged > 1 and 
≤ 4   years old 
 
  










0 10 20 30 40
ICP (mmHg)
AVE ONSD Fitted values
r = 0.65 
201 
 
The mean ONSD in the group with ICP < 20 mmHg was 5.43 mm (SD 0.6), and in the 
group with ICP ≥ 20 mmHg, was 6.29 mm (SD 0.4) (p < 0.001) (Figure IIb).  
 
 
Figure IIb.  Box and whisker plot of ONSD for ICP < 20 mmHg (0) and ICP ≥ 20 mmHg (1) in 
patients aged > 1 and ≤ 4 years old 
 
In this age group, the optimal ONSD for predicting an ICP ≥ 20 mmHg was 5.92 mm, 
with a sensitivity of 82.6%, specificity of 81.3%, PPV of 86.4%, NPV of 76.5%. The 
AUROC was 0.82 (Figure IIc), with an OR of 20.6 (Table 6.23)  
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ii) ONSD for ICP dichotomised at 15 mmHg 
 
There were thirty nine children in this group, eight had an ICP < 15 mmHg and thirty 
one had an ICP ≥ 15 mmHg. The data and comparative p –values are summarised in 
table IIb. 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 39 23 (17 – 35) 19.15 (6.04) 5.94 (0.6) 
< 15 mmHg 8 (20.5) 25.5 (16.5 – 43) 10.78 (4.1) 5.28 (0.6) 
≥ 15 mmHg 31 (79.5) 23 (18 – 34) 21.31 (4.3) 6.11 (0.5) 
p – value  p = 0.47 p < 0.001 p = 0.006 
 
Table IIb. Age,  ICP and ONSD values for ICP dichotomised at 15 mmHg in patients aged > 1 
and ≤ 4   years old 
 
The optimal ONSD cut-off value for detecting ICP ≥ 15 mmHg in this age group was 




iii) ONSD for ICP dichotomised at 10 mmHg 
 
Of the thirty nine children in this group, two had an ICP < 10 mmHg and thirty seven 
had an ICP ≥ 10 mmHg. The data and comparative p – values are summarised in table 
IIc. 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 39 23 (17 – 35) 19.15 (6.04) 5.94 (0.6) 
< 10 mmHg 2 (5) 43  (42 – 44) 4.5 (0.7) 4.92 (0.4) 
≥ 10 mmHg 37 (95) 23 (17 – 34) 19.94 (5.1) 6 (0.6) 




Table IIc. Age,  ICP and ONSD values for ICP dichotomised at 10 mmHg in patients aged > 1 and 
≤ 4   years old 
 
The optimal ONSD cut-off value for predicting an ICP ≥ 10 mmHg in this age group 
was 5.41 mm, with a sensitivity of 86.5% and a specificity of 100%. The OR was not 
defined (Table 6.23). 
 
 
iv) ONSD for ICP dichotomised at 5 mmHg 
 
One patient in this age group had an ICP < 5 mmHg, with a reading of 4 mmHg. Thirty 
eight patients had an ICP ≥ 5 mmHg, with a mean ICP reading of 19.55 mmHg (SD 






ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 39 23 (17 – 35) 19.15 (6.04) 5.94 (0.6) 
< 5 mmHg 1 (2.5) 42 4 5.2 
≥ 5 mmHg 38 23 (17 – 34) 19.55 (5.6) 5.96 (0.6) 
 
Table IId. Age,  ICP and ONSD values for ICP dichotomised at 5 mmHg in patients aged > 1 and 
≤ 4   years old 
 
 
The ONSD measurement for the patient with ICP < 5 mmHg was 5.2 mm. The mean 
reading in the group with ICP ≥ 5 mmHg was 5.96 mm (SD 0.6). The optimal ONSD 
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cut-off value for predicting an ICP ≥ 5 mmHg was 5.2 mm, with a sensitivity of 86.8% 
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c) Relationship between ONSD and ICP in children aged over 4 years 
(> 4 years old) 
 
i) ONSD for ICP dichotomised at 20 mmHg 
Seventy nine patients were aged over 4 years old, with a median age of 82 months (65 
– 108). Thirty eight of these patients had an ICP < 20 mmHg with a mean ICP reading 
of 10.15 mmHg (SD 4.95) and 41 patients had an ICP ≥ 20 mmHg, with a mean ICP 
reading of 24.74 mmHg (SD 4.6).(Table IIf)There was good correlation between 
ONSD and ICP in this group (r = 0.71, p < 0.001, PCC) (Figure IId). 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 79 82 (65 – 108) 17.72 (8.7) 5.9 (0.8) 
< 20 mmHg 38 (48.1 ) 81.5 (63 – 107) 10.15 (5) 5.33 (0.6) 
≥ 20 mmHg 41 (51.9) 87 (69 – 125) 24.74 (4.6) 6.43 (0.6) 
p – value  p = 0.45 p < 0.001 p < 0.001 
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The mean ONSD in the group with ICP < 20 mmHg was 5.33 mm (SD 0.6), and 6.43 
mm (SD 0.6) in the group with ICP ≥ 20 mmHg (Figure IIe). 
 
 
Figure IIe.  Box and whisker plot of ONSD for ICP < 20 mmHg (0) and ICP ≥ 20 mmHg (1) in 
patients aged > 4 years. 
 
 
The optimal ONSD cut-off value for detecting ICP ≥ 20 mmHg was 5.7 mm, with a 
sensitivity of 87.8%, specificity of 68.4%, PPV of 75%, NPV 83.9%. The AUROC 
was 0.78 (Figure IIf), with a diagnostic OR of 15.6 (Table IIj).   
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ii) ONSD for ICP dichotomised at 15 mmHg 
 
Thirty one children had an ICP < 15 mmHg and forty eight children had an ICP ≥ 15 
mmHg, the results are summarised in table IIg. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 79 82 (65 – 108) 17.72 (8.7) 5.9 (0.8) 
< 15 mmHg 31 (39.2) 86 (63 -114) 8.43 (3.7) 5.22 (0.6) 
≥ 15 mmHg 48 (60.8) 82 (68 – 107) 23.72 (4.9) 6.34 (0.6) 
p – value  p = 0.96 p < 0.001 p < 0.001 
 




The optimal ONSD cut-off value for detecting ICP ≥ 15 mmHg in this group was 5.49 
mm, with a sensitivity of 93.8%, specificity of 74.2% and a diagnostic OR of 43.1 
(Table IIj). 
 
iii) ONSD for ICP dichotomised at 10 mmHg 
 
Seventeen children in this group had an ICP < 10 mmHg and sixty two children ahd 
an ICP ≥ 10 mmHg. The results are summarised in table IIh. 
 
ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 79 82 (65 – 108) 17.72 (8.7) 5.9 (0.8) 
< 10 mmHg 17 (21.5) 76 (57 – 116) 5.61 (2.3) 4.99 (0.5) 
≥ 10 mmHg 62 (78.5) 89 (69 – 107) 21.04 (6.6) 6.15 (0.7) 
p – value  p = 0.82 p < 0.001 p < 0.001 
 
Table IIh. Age,  ICP and ONSD values for ICP dichotomised at 10 mmHg in patients aged > 4 
years old 
 
The optimal ONSD cut-off value for detecting ICP ≥ 10 mmHg was 5.2 mm, with a 
sensitivity of 88.7%, specificity of 82.4% and a diagnostic OR of 36.7 (Table IIj). 
 
 
iv) ONSD for ICP dichotomised at 5 mmHg 
 
Four children in this group had an ICP < 5mmHg and seventy five children had an ICP 





ICP in mmHg N (%) Median age in 
months (IQR) 
Mean ICP in 
mmHg (SD) 
Mean ONSD in 
mm (SD) 
Overall 79 82 (65 – 108) 17.72 (8.7) 5.9 (0.8) 
< 5 mmHg 4 (5.1) 109.5 (75.5 – 148.5) 2.75 (1.5) 4.93  (0.2) 
≥ 5 mmHg 75 (94.9) 82 (65 – 107) 18.52 (8.2) 5.96 (0.8) 
p - value  p = 0.19 p = 0.003 p = 0.01 
 
Table IIi. Age,  ICP and ONSD values for ICP dichotomised at 5 mmHg in patients aged > 4 years 
old 
 
The optimal ONSD cut-off value for detecting ICP ≥ 5 mmHg in this age group was 5 
mm, with a sensitivity of 80%, specificity of 75%, PPV of 98.4%, NPV of 16.7%. The 




















≥ 20 5.7 87.8 (73.8 – 
95.9) 
68.4 (51.3 – 
82.5) 
75 (60.4 – 
86.4) 
83.9 (66.3 – 
94.5) 
0.78 (0.69 – 
0.87) 
15.6 (5 – 
48.2) 




84.9 (72.4 – 
93.3) 
88.5 (69.8 – 
97.6) 
0.84 (0.75 – 
0.93) 
43.1 (10.9 – 
167) 
≥ 10  5.2 88.7 (78.1 – 
95.3) 
82.4 (56.6 – 
96.2) 
94.8 (85.6 – 
98.9) 
66.7 (43 – 
85.4) 
0.86 (0.75 – 
0.96) 
36.7 (8.8 – 
150) 
≥ 5 5 80 (69.2 – 
88.4) 




16.7 (3.6 – 
41.1) 
0.78 (0.53 – 
1) 
12 (1.6 - .) 
 
Table IIj. ONSD cut-off values for various ICP thresholds in patients aged > 4 years 
 
The ONSD cut-off values with the best diagnostic accuracy for detecting ICP at the 
selected thresholds, within each of the described age categories are sumaarised in 
below in Table IIk.  
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ICP in mmHg Age threshold (in years) ONSD cut-off values (in mm) 
≥ 20 Overall 5.5 
 ≤ 1 5.16 
 > 1 - ≤ 4 5.94 
 > 4 5.7 
≥ 15 Overall 5.3 
 ≤ 1 4.97 
 > 1 - ≤ 4 5.5 
 > 4 5.49 
≥ 10 Overall 5.04 
 ≤ 1 4.3 
 > 1 - ≤ 4 5.4 
 > 4 5.2 
≥ 5 Overall 5 
 ≤ 1 Nil 
 > 1 - ≤ 4 0.52 
 > 4 0.5 
 












Dynamic study: additional data 
Individual measurements for motion Dleft and Dright for the left eye: 
Left eye 
 Left side of ONS (dLeft) Right side of ONS (dRight) 
A 7.85 7.53 8.36 8.46 8.41 8.94 9.12 8.78 8.93 9.17 
B 7.51 7.51 7.55 8.50 7.74 8.90 8.80 8.56 8.50 8.98 
C 3.16 2.79 3.56 2.94 2.97 6.26 6.14 6.31 6.28 6.28 
D 5.28 4.21 5.91 5.36 5.08 4.25 3.83 4.37 4.18 4.22 
E 15.53 15.25 15.53 15.28 15.28 13.62 12.67 13.83 13.80 14.00 
F 20.37 20.96 20.92 19.98 20.24 26.01 26.38 26.09 26.02 26.10 
G 4.45 4.22 4.56 5.6 5.06 11.4 11.28 11.18 11.28 11.01 
H 6.8 6.96 6.68 6.29 7.09 5.41 5.50 5.27 5.09 5.58 
I 5.78 4.84 5.64 4.46 7.53 3.25 2.81 3.28 3.24 3.22 
J 3.85 4.14 4.01 3.84 4.21 1.94 1.70 1.56 1.99 1.94 
K 13.61 14.30 14.33 12.57 13.61 8.13 8.80 8.63 8.29 8.03 
L 7.68 7.25 8.49 7.68 8.78 4.50 4.32 4.97 5.07 4.12 
M 18.06 17.59 17.73 16.75 17.21 10.30 11.03 11.05 11.39 9.42 
N 5.02 5.18 5.16 5.17 5.48 3.81 3.62 3.58 3.64 3.47 
O 18.25 15.69 16.61 13.95 15.18 17.07 16.59 16.5 16.81 17.16 





Individual measurements for motion Dleft and Dright for the right eye: 
Right eye 
 Left side of ONS (dLeft) Right side of ONS (dRight) 
A 7.35 7.38 7.57 6.97 7.45 1.34 1.59 1.86 1.59 1.36 
B 9.46 10.30 9.29 10.03 10.32 9.48 8.96 9.59 8.97 9.17 
C 3.00 2.87 2.74 2.32 2.74 3.24 3.34 3.49 3.35 3.69 
D 8.90 8.66 9.76 8.84 9.5 11.08 10.12 13.71 12.59 9.62 
E 13.60 14.25 13.91 13.52 13.40 17.67 16.85 17.19 17.80 17.67 
F 12.82 12.86 12.75 12.86 12.77 10.78 10.77 10.96 10.96 10.86 
G 11.35 11.53 10.66 11.11 11.44 9.05 9.44 9.43 10.27 10.78 
H 3.46 3.52 3.54 3.51 3.51 5.98 6.09 5.79 5.99 5.99 
I 2.36 2.55 3.07 2.55 2.09 3.84 3.98 3.64 3.77 3.66 
J 5.75 4.93 5.89 5.54 6.40 3.42 3.79 3.30 4.34 3.28 
K 6.40 6.92 8.18 8.77 5.83 1.95 2.57 3.56 2.67 4.47 
L 9.33 8.76 9.51 9.35 8.65 11.80 11.21 12.24 11.70 11.96 
M 13.46 13.41 14.90 13.58 13.85 11.00 12.07 13.10 12.67 12.30 
N 1.16 1.21 1.65 1.52 2.04 6.2 5.8 5.39 5.46 5.62 
O 8.78 8.71 8.95 5.92 8.39 3.75 3.74 3.91 4.22 4.16 
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